Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,40516,-0.199844234747407,0.00498895174457805,-0.20962258016678,-0.190065889328034,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,40228,-0.110502747171165,0.00273460159943246,-0.115862566306053,-0.105142928036277,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.117314231661895,0.00295831938187525,0.11151592567342,0.123112537650371,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,39980,-0.49606121338358,0.0115457812824474,-0.518690944697177,-0.473431482069983,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,37990,-0.31758391195714,0.00732942048559173,-0.3319495761089,-0.30321824780538,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,40356,-0.253350618456754,0.00472552205432591,-0.262612641683233,-0.244088595230275,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,40332,-0.191823553777794,0.00384336995723256,-0.199356558893969,-0.184290548661618,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,40489,-0.257033998210063,0.00620081457002429,-0.269187594767311,-0.244880401652815,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,40422,0.108544581432419,0.00254521675937158,0.103555956584051,0.113533206280788,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,37998,-0.180878334225389,0.00385564225353883,-0.188435393042325,-0.173321275408452,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,40293,-0.154831623769528,0.00375799511564341,-0.162197294196189,-0.147465953342867,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,38013,0.237353426866575,0.00621531117076144,0.225171416971882,0.249535436761267,3.63514354110451e-303
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,40359,0.154001271880084,0.00432472166884456,0.145524817409148,0.162477726351019,2.75518617266317e-267
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,40305,-0.294292350579118,0.0087091140187122,-0.311362214055794,-0.277222487102442,9.13007924778208e-242
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.0994902586328103,0.00297471420515671,0.0936598187907032,0.105320698474917,4.64183063773765e-237
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,40042,-0.211917873948975,0.00636254959607855,-0.224388471157289,-0.199447276740661,4.83154371328063e-235
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,40332,-0.133099282668413,0.00403718535878242,-0.141012165971626,-0.125186399365199,1.27247012475189e-230
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,40471,-0.411516752408288,0.0125360777960708,-0.436087464888586,-0.386946039927989,8.68998859780516e-229
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,40341,-0.16609480171102,0.00507351197993268,-0.176038885191688,-0.156150718230352,1.53281164139192e-227
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,40280,-0.241019676562804,0.00739326696117521,-0.255510479806707,-0.226528873318901,1.11147238602675e-225
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37900,-0.168675971413943,0.00516275767239283,-0.178794976451833,-0.158556966376053,2.2504794463914e-225
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,40352,-0.232308760051179,0.00722831518725749,-0.246476257818204,-0.218141262284154,1.26393171144908e-219
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FURIN,Furin,40411,-0.101607150504169,0.00319626929781038,-0.107871838327878,-0.0953424626804609,4.36582814462544e-215
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,37562,-0.286778819959176,0.00899262580924362,-0.304404366545293,-0.269153273373058,5.27536030833132e-215
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,37987,0.0728585818756761,0.00229451638123839,0.0683613297684488,0.0773558339829033,1.74780405972454e-213
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40500,0.349959863597387,0.0111636734291645,0.328079063676224,0.371840663518549,2.02047911970141e-209
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,40415,-0.100994939284704,0.00325524605385713,-0.107375221550264,-0.0946146570191443,2.90357510413346e-205
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,40461,0.100310497557134,0.00325822846438747,0.0939243697669348,0.106696625347334,2.95006679792336e-202
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,40400,-0.0994920683136879,0.00325224221309025,-0.105866463051345,-0.093117673576031,8.86971227531471e-200
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40424,-0.133850331478545,0.00439468310952523,-0.142463910373215,-0.125236752583876,4.22850033994032e-198
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37790,-0.0749799732296107,0.0024691034996421,-0.0798194160889092,-0.0701405303703122,6.38956883518691e-196
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,37671,-0.0817589244847707,0.0027504179818455,-0.0871497437291878,-0.0763681052403535,5.06290500747317e-188
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,40453,-0.323776085797586,0.0111683739127822,-0.345666098666639,-0.301886072928533,3.81254855761831e-180
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,40489,-0.0936650593484362,0.00323146798785571,-0.0999987366046334,-0.087331382092239,4.29290728650761e-180
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,40332,0.0735705130958355,0.00257483049849018,0.0685238453187947,0.0786171808728762,3.81158657122998e-175
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,40424,0.0764695042206589,0.0026952269950806,0.0711868593103009,0.0817521491310169,8.35541417213241e-173
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37671,0.0825898098837511,0.00291727391936338,0.0768719530017989,0.0883076667657033,3.11112735813209e-171
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,40372,-0.048496917650241,0.00171994669127912,-0.0518680131651481,-0.0451258221353339,9.77153002732549e-171
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C9,Complement component C9,37987,0.130808840432415,0.00466041651008656,0.121674424072645,0.139943256792184,1.53805975328575e-168
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40313,-0.147418323417251,0.0052674478056459,-0.157742521116317,-0.137094125718185,2.81643055056241e-168
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,40359,-0.158877290977294,0.00568929400169635,-0.170028307220619,-0.147726274733969,1.39709482137503e-167
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,40403,0.0896835702624864,0.00326058438100949,0.0832928248757078,0.096074315649265,9.2730113395081e-163
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,40470,-0.0526228569952452,0.00191453123975634,-0.0563753382251676,-0.0488703757653227,1.48829388012735e-162
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,40471,0.057081007689264,0.00209050664511152,0.0529836146648454,0.0611784007136826,1.71437841167347e-160
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,40338,0.118752261037353,0.00436101084684545,0.110204679777536,0.12729984229717,1.27917112946328e-159
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,40332,0.0981828481661721,0.00361071902441198,0.0911058388783246,0.10525985745402,3.48640487110263e-159
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,40376,-0.0769808885721229,0.0028707355079343,-0.0826075301676741,-0.0713542469765716,5.73318484578356e-155
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,37572,-0.202904482219441,0.00755487213869374,-0.217712031611281,-0.188096932827602,1.01162635011324e-154
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,40536,-0.135575344826361,0.00507543267948534,-0.145523192878152,-0.125627496774569,7.59200610601765e-154
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,-0.192860611204462,0.00721575286322377,-0.207003486816381,-0.178717735592544,2.1367123863135e-153
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40536,0.0884739051488356,0.00332016841576803,0.0819663750539303,0.0949814352437409,3.97038417412353e-153
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,37370,-0.0816642707792147,0.0030672795512562,-0.0876761386996769,-0.0756524028587525,4.33047645085554e-152
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,40126,0.135583382977519,0.00512015387977129,0.125547881373167,0.145618884581871,3.38967487640928e-151
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,40489,0.0869283002149874,0.00331162338814962,0.0804375183742141,0.0934190820557607,9.87670470586167e-149
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,-0.0802625956109091,0.00307062848600286,-0.0862810274434747,-0.0742441637783434,1.79014980456699e-147
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40497,0.158192302412816,0.00610215692108636,0.146232074847487,0.170152529978145,3.431046381679e-145
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,-0.167731604318427,0.00647789407309558,-0.180428276701694,-0.15503493193516,8.06344615057851e-145
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,40372,0.0654143651702648,0.0025726658177822,0.0603719401674117,0.0704567901731179,7.78223131044065e-140
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,40419,-0.142281928776059,0.00561481341343525,-0.153286963066392,-0.131276894485726,6.28436909241544e-139
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,37990,-0.221718468607701,0.00877170336689719,-0.23891100720682,-0.204525930008583,8.84018326949867e-138
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40489,-0.0795286711659141,0.00316647147600361,-0.0857349552588812,-0.0733223870729471,1.43581122242591e-136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,40309,-0.073510758634955,0.00293205100255584,-0.0792575785999645,-0.0677639386699456,4.49321814502487e-136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,-0.0827787035076977,0.00331643583066709,-0.0892789177358052,-0.0762784892795902,6.33230345177198e-135
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,40044,-0.182075151855784,0.00737048809734611,-0.196521308526582,-0.167628995184985,3.38736697673393e-132
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,-0.19958495053009,0.00809238864086651,-0.215446032266188,-0.183723868793991,8.77558681736635e-132
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,37642,-0.0860390533972027,0.00348508019518966,-0.0928698105797744,-0.079208296214631,1.3693397482831e-131
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,-0.186357630437907,0.00760567096899914,-0.201264745537146,-0.171450515338669,3.62484492507856e-130
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,40305,-0.129741695339057,0.0053214940301637,-0.140171823638178,-0.119311567039937,6.41171563360503e-129
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,-0.130571944364451,0.00536033699314305,-0.141078204871012,-0.120065683857891,1.16982673510516e-128
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,40333,-0.191527784567204,0.00795797419258363,-0.207125413984668,-0.17593015514974,9.69894873951476e-126
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,40359,-0.0687831273148485,0.00287636276897889,-0.0744207983420471,-0.0631454562876499,3.43594090601547e-124
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,37987,0.123997936582955,0.00520165715252208,0.113802688564012,0.134193184601898,4.54198303737034e-123
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,40422,-0.0939481171994155,0.0039478705357389,-0.101685943449464,-0.0862102909493673,4.90640064919554e-123
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,-0.104416040692482,0.00442383557320055,-0.113086758415955,-0.0957453229690089,4.54918035446883e-121
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,40332,-0.0538017301931077,0.00228005001472786,-0.0582706282219743,-0.0493328321642411,4.9934437423362e-121
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39961,-0.12434772654229,0.0052731901172173,-0.134683179172036,-0.114012273912544,7.97370771853362e-121
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,40141,-0.334955562659274,0.0142616555927094,-0.362908407620984,-0.307002717697563,6.51942764284164e-120
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,39243,-0.0899576524449793,0.00383773511148672,-0.0974796132634932,-0.0824356916264653,2.45888426283899e-119
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37671,-0.0851242316967786,0.00363269462710439,-0.0922443131659032,-0.078004150227654,5.19139353867487e-119
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AFM,Afamin,38013,-0.041896271315468,0.00179954927559298,-0.0454233878956303,-0.0383691547353058,1.36050517945823e-117
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,40063,-0.094998341237641,0.00408792160465463,-0.103010667582764,-0.086986014892518,1.80555900780183e-117
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,37998,0.135305292370884,0.00583361881454098,0.123871399494384,0.146739185247384,9.69922858717183e-117
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40359,0.0599301650546133,0.00259220398859843,0.0548494452369604,0.0650108848722662,2.42793311144966e-116
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40453,-0.0932323452345067,0.00404069908393017,-0.10115211543901,-0.0853125750300036,6.64090039253128e-116
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,37959,-0.102506400270793,0.00444632427040537,-0.111221195840787,-0.0937916047007984,2.22229827310315e-115
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,37345,0.0989029150607994,0.00430384423529413,0.090467380359623,0.107338449761976,1.45267916495185e-114
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,40516,-0.0756352591999064,0.00330164149012943,-0.0821064765205601,-0.0691640418792527,2.58472073795634e-114
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,-0.231427247201692,0.0101025576652418,-0.251228260225566,-0.211626234177818,2.76662550485643e-114
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40443,-0.0678773259425447,0.00297662569204708,-0.0737115122989569,-0.0620431395861324,2.69865992091496e-113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,37871,-0.0562584462659535,0.00246605091022088,-0.0610919060499864,-0.0514249864819206,4.7352468199135e-113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,40357,-0.11604352931614,0.00510069644684226,-0.126040894351951,-0.106046164280329,8.8842034724415e-113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,-0.128438779423471,0.0056487585174559,-0.139510346117685,-0.117367212729257,1.30569221904132e-112
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,-0.0907899968485329,0.00400276164106568,-0.0986354096650216,-0.0829445840320441,4.09190099379311e-112
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,40042,-0.107021891999515,0.0047182687885747,-0.116269698825122,-0.097774085173909,4.32023483910462e-112
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,39980,-0.164772435416821,0.0072959282769781,-0.179072454839698,-0.150472415993944,3.79883639217116e-111
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,40502,0.117688495255418,0.00523071354524273,0.107436296706742,0.127940693804094,2.12618163244214e-110
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,39963,-0.129146982757257,0.00573859539390624,-0.140394629729313,-0.117899335785201,2.15629858125046e-110
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40372,0.0644530761321222,0.00286538957675242,0.0588369125616874,0.0700692397025569,2.49355292409921e-110
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,-0.0752034856171434,0.00334454375634876,-0.081758791379587,-0.0686481798546998,2.90140732811651e-110
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,40332,-0.121591653631017,0.00545259657288946,-0.13227874291388,-0.110904564348153,1.70912864815897e-108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39980,-0.171660203496086,0.00775450487889604,-0.186859033058723,-0.15646137393345,6.25925590108513e-107
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,40261,0.131305784516587,0.0059498134997689,0.11964415005704,0.142967418976134,2.52184015778287e-106
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,40375,0.0428804054162509,0.00194351861909306,0.0390711089228285,0.0466897019096733,2.77141995214139e-106
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40305,-0.186727493509051,0.00847081155630493,-0.203330284159409,-0.170124702858694,4.29082996481417e-106
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,40372,-0.0718159078494007,0.00326511182544582,-0.0782155270272746,-0.0654162886715269,1.19925056012617e-105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,40516,-0.0556511069673828,0.0025353992581076,-0.0606204895132737,-0.0506817244214919,3.058573302998e-105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40489,-0.0780555707311375,0.0035712403234396,-0.0850552017650791,-0.0710559396971959,2.22929787455653e-104
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,-0.114777245073259,0.00526129864170849,-0.125089390411008,-0.10446509973551,5.91585262184283e-104
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,40337,-0.211388401962918,0.00973750829849204,-0.230473918227962,-0.192302885697874,5.31033113448501e-103
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,37990,-0.0591805035073211,0.00273322127459907,-0.0645376172055353,-0.053823389809107,3.10896985245952e-102
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,37819,-0.0566556366394649,0.00262133485493871,-0.0617934529551447,-0.051517820323785,7.39852781997842e-102
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37920,-0.173684265491776,0.00803787032879529,-0.189438491336215,-0.157930039647338,7.9825524024831e-102
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,40359,-0.123556318025706,0.00574411034127663,-0.134814774294609,-0.112297861756804,3.44753981505396e-101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,39961,-0.103985303078325,0.00485415797010171,-0.113499452699724,-0.0944711534569252,2.3650909291071e-100
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,-0.12706042048667,0.00595245061990538,-0.138727223701684,-0.115393617271655,1.14613623070579e-99
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,37981,-0.0565961454596301,0.00264889012986287,-0.0617879701141614,-0.0514043208050989,1.21716240921742e-99
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,-0.0633663087372826,0.00297216946637546,-0.0691917608913785,-0.0575408565831868,1.84199744516466e-99
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,37671,-0.0859220484346674,0.00404409441186673,-0.0938484734819261,-0.0779956233874086,1.57051082139762e-98
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,40332,0.0553389015477673,0.00261204882016281,0.0502192858602482,0.0604585172352864,2.93134522377036e-98
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,0.07676867184615,0.00363274497935697,0.0696484916866103,0.0838888520056897,8.73557866273341e-98
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,-0.10617645974892,0.0050394653767506,-0.116053811887351,-0.0962991076104886,3.1801578966848e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,37901,-0.225695839549579,0.0107051471692816,-0.246677928001371,-0.204713751097787,4.2174229871466e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,-0.0772106561464079,0.00368893620413068,-0.0844409711065041,-0.0699803411863118,5.40025954262481e-96
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,40434,-0.0958355670981376,0.00460217280606855,-0.104855825798032,-0.0868153083982432,4.78246515296721e-95
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,40516,-0.0604746897663293,0.00290830337420537,-0.0661749643797719,-0.0547744151528868,8.6999056293443e-95
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,40345,-0.0624561816815175,0.00300668540782098,-0.0683492850808466,-0.0565630782821884,1.38320399314709e-94
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,-0.144185218202168,0.00702933175489986,-0.157962708441772,-0.130407727962564,4.20779733599758e-92
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40312,-0.040260448969184,0.00196709196155625,-0.0441159492138342,-0.0364049487245337,6.50974407984079e-92
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40305,-0.152345578503832,0.00744846210971085,-0.166944564238865,-0.137746592768799,8.5689048310729e-92
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40391,-0.0453797635287614,0.00224211029509441,-0.0497742997071464,-0.0409852273503763,5.89119062594894e-90
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,40411,-0.041252041658521,0.00206772776577854,-0.045304788079447,-0.0371992952375951,1.72832539562939e-87
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,40228,-0.0695197150151036,0.00349546423490376,-0.076370824915515,-0.0626686051146923,5.93212516207496e-87
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,40536,0.0531148144834807,0.00267739145393608,0.047867127233766,0.0583625017331954,1.50514483760026e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,40054,-0.142813379591492,0.00720682222792134,-0.156938751158218,-0.128688008024767,2.47188888114695e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,-0.0841996420360845,0.00424907798420663,-0.0925278348851295,-0.0758714491870395,2.49668099632028e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MME,Neprilysin,40305,-0.155266353955978,0.00787398135456068,-0.170699357410917,-0.139833350501039,1.56855552964789e-85
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37835,-0.0630641796140743,0.00319499090015904,-0.069326361778386,-0.0568019974497626,1.65132831380468e-85
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,40422,0.0844832325046224,0.0042975965866616,0.0760599431947657,0.0929065218144791,4.96390291208231e-85
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,40516,-0.0618698618391387,0.00315174648286721,-0.0680472849455584,-0.0556924387327189,8.37826187005655e-85
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,37628,-0.103606994294416,0.00527829539386843,-0.113952453266398,-0.0932615353224339,1.40885072192434e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,38013,-0.0382474067356545,0.00195029421545894,-0.042069983397954,-0.034424830073355,1.83204837801398e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,-0.0397565787226714,0.00203098697151959,-0.0437373131868498,-0.035775844258493,2.43229076395509e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,40353,0.102147174874889,0.00523444131901157,0.091887669889626,0.112406679860151,7.90148710702517e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,40516,-0.146776566130022,0.00752309520866515,-0.161521832739006,-0.132031299521038,8.38813293075937e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37959,-0.10859943229761,0.00556067055622817,-0.119498346587817,-0.0977005180074027,8.71385060135257e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,-0.107526956658553,0.00554946158281432,-0.118403901360869,-0.0966500119562371,1.71844423296531e-82
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40280,-0.0479882325693285,0.00247995327650589,-0.0528489409912801,-0.043127524147377,1.80863549574588e-82
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,37628,-0.0965067201067479,0.0050179492968738,-0.106341900728621,-0.0866715394848752,2.57460144816132e-81
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,40309,-0.0994730642376719,0.00518386387910339,-0.109633437440715,-0.0893126910346292,3.7985274762712e-81
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,40192,-0.136136878696951,0.00709856564544568,-0.150050067362025,-0.122223690031878,4.73482986947093e-81
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40379,0.0588758141286787,0.00307446837631316,0.0528498561111049,0.0649017721462524,7.84107943868149e-81
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,40330,-0.053625437225241,0.00280187774422587,-0.0591171176039237,-0.0481337568465583,9.66553381287868e-81
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,40414,-0.109666903392148,0.00575172103638643,-0.120940276623466,-0.098393530160831,3.70340489407304e-80
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,40332,-0.0645632691434944,0.0033875097866626,-0.0712027883253531,-0.0579237499616357,4.31214315998854e-80
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,40490,-0.0905008816061791,0.00474942109036412,-0.0998097469432928,-0.0811920162690654,4.56115153614789e-80
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40341,-0.050136707678034,0.00267955185178499,-0.0553886293075326,-0.0448847860485354,2.7312773646352e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,40341,-0.0779266828927438,0.00417666280555509,-0.0861129419916317,-0.0697404237938558,7.24567538590474e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,40536,-0.0778385395617995,0.00417664530025935,-0.0860247643503078,-0.0696523147732912,1.0409127219897e-76
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,-0.040206699717492,0.00216005273582999,-0.0444404030797188,-0.0359729963552652,2.22702989428e-76
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,40359,-0.0464345370908944,0.00250721314797208,-0.0513486748609196,-0.0415203993208691,8.84851034884061e-76
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,-0.0534131386434775,0.00288701522317491,-0.0590716884809003,-0.0477545888060547,1.25184058486808e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40471,-0.117497081427882,0.00635400642306354,-0.129950934017087,-0.105043228838677,1.46836608395415e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,37987,-0.0466028841159285,0.00252266661965339,-0.0515473106904492,-0.0416584575414079,2.82636838387598e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,40392,-0.0576190900094588,0.00312433930937979,-0.0637427950558432,-0.0514953849630744,3.65483967669858e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,-0.066715956320666,0.00362028626905274,-0.0738117174080094,-0.0596201952333226,4.61529281911693e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,40489,-0.0805679548219761,0.00438042662877111,-0.0891535910143675,-0.0719823186295848,8.81890760966187e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40422,-0.0506478510468594,0.00276420399821882,-0.0560656908833683,-0.0452300112103506,3.13634117495411e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40341,-0.0669365396403955,0.00365812648234035,-0.0741064675457826,-0.0597666117350084,4.93575489941502e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40471,-0.0616594701619863,0.00337070091466541,-0.0682660439547305,-0.0550528963692421,5.3501549420653e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,-0.162131845054271,0.00890633456716674,-0.179588260805918,-0.144675429302625,2.74711863271607e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,40456,-0.103363500874859,0.00569371965685946,-0.114523191402304,-0.0922038103474145,6.4364439980518e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,40516,-0.0784255993328227,0.00432383151934516,-0.0869003091107392,-0.0699508895549062,8.50345639239438e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40536,-0.0863267018435005,0.0047633879558069,-0.095662942236882,-0.0769904614501189,1.1091400527642e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,-0.0855449067032576,0.00472547254771887,-0.0948068328967866,-0.0762829805097286,2.25592625460985e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,-0.119445430673661,0.00660225396454462,-0.132385848444168,-0.106505012903153,2.80228612035624e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,40471,-0.110357105900661,0.00614656146318381,-0.122404366368501,-0.0983098454328209,2.22317346451431e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,-0.0954669275693561,0.00532998014218358,-0.105913688648036,-0.0850201664906763,4.85968626261982e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POSTN,Periostin,37998,0.0659287494975013,0.00367932772421937,0.0587172671580313,0.0731402318369712,5.54997437508371e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,37628,-0.112068686214077,0.00626377267932903,-0.124345680665562,-0.0997916917625923,9.40832925250863e-71
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,40332,0.0704399569776401,0.00394455725285866,0.0627086247620371,0.0781712891932431,1.23874909381383e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,37901,-0.118786902392498,0.00665079058031583,-0.131822451929917,-0.105751352855079,1.5580308333139e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,40536,-0.0974467507740139,0.00547132789046986,-0.108170553439335,-0.086722948108693,2.77291628910771e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELE,E-selectin,40536,-0.0862572816855928,0.0048535690294422,-0.0957702769832995,-0.076744286387886,5.44082444002111e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,40350,-0.0553718588837561,0.00312133495855106,-0.0614896754025162,-0.0492540423649961,9.70702647913881e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37900,-0.0880766252008346,0.00496202871602806,-0.0978022014842496,-0.0783510489174196,1.07059064261193e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,40447,-0.0637902713067108,0.00359929976826763,-0.0708448988525154,-0.0567356437609063,1.29001332856777e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,40359,-0.109867102367844,0.00620299508139816,-0.122024972727384,-0.0977092320083031,1.57639849651156e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,40145,-0.0614637195994082,0.00348728143799667,-0.0682987912178817,-0.0546286479809348,7.27840295991627e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,-0.0666598583791557,0.00379928033359781,-0.0741064478330074,-0.059213268925304,2.78857500305373e-68
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,40341,-0.0679429036241689,0.00387597769958999,-0.0755398199153653,-0.0603459873329725,3.75169259520147e-68
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,40228,-0.0690369951639686,0.00395959528034158,-0.0767978019134382,-0.0612761884144991,1.90608547007107e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,0.0411635088528575,0.00236373568604809,0.0365305869082033,0.0457964307975118,2.67741772418134e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,40398,-0.108273909544197,0.00622408165940038,-0.120473109596621,-0.096074709491772,3.68888047793821e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40502,-0.0638132894986199,0.00367754615306042,-0.0710212799586183,-0.0566052990386214,7.73725660003332e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40305,-0.0919103694657651,0.00531623556320879,-0.102330191169654,-0.0814905477618759,2.32569385832322e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OCLN,Occludin,37959,-0.0728772684000215,0.0042432808747395,-0.081194098914511,-0.0645604378855321,2.0292085575541e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MLN,Promotilin,40341,-0.147697440368058,0.00861047155026059,-0.164573964606569,-0.130820916129547,2.30407997950573e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,-0.123118824363865,0.00717839962975321,-0.137188487638181,-0.109049161089548,2.40391684305109e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,37301,-0.0385860649888061,0.00225719547334651,-0.0430101681165653,-0.0341619618610469,8.44705766232175e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,40516,-0.0668717133980931,0.00391858247533676,-0.0745521350497532,-0.0591912917464331,1.0004128583213e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37900,-0.112585077681723,0.00659575203386248,-0.125512751668094,-0.0996574036953526,1.20243504087158e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,-0.111043504094198,0.00654076221178897,-0.123863398029304,-0.0982236101590914,4.58528965315613e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,40465,-0.043553476572722,0.0025684624268483,-0.0485876629293447,-0.0385192902160994,6.16979366654049e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,37781,-0.0396116699737114,0.0023349767420208,-0.0441882243880722,-0.0350351155593506,7.03152772512748e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,40470,-0.0549631221806993,0.00324286132643687,-0.0613191303805156,-0.048607113980883,7.05714738199512e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,40536,-0.0732289218281683,0.00432684607952129,-0.08170954014403,-0.0647483035123066,1.05937831756712e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,40403,0.04547117634761,0.00268890633040803,0.0402009199400103,0.0507414327552098,1.34440495602504e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,40341,-0.0868261965663808,0.00515152659250621,-0.0969231886876929,-0.0767292044450686,3.44242904056723e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40359,-0.0578001450575795,0.00343072046340254,-0.0645243571658485,-0.0510759329493105,3.83874961596828e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,-0.0746440299949909,0.00443372504926365,-0.0833341310915477,-0.0659539288984342,6.06346119863673e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,40305,-0.0967226664280928,0.00576427015954261,-0.108020635940796,-0.0854246969153893,1.19259471829031e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39980,-0.176854537590925,0.0105545948532693,-0.197541543503333,-0.156167531678518,1.80520949522836e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37598,-0.137287012651969,0.00819630155167224,-0.153351763693246,-0.121222261610691,2.50906254598775e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,40305,-0.0870182836835269,0.00519995210976318,-0.0972101898186627,-0.0768263775483911,2.5189329958562e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,-0.0439193659642146,0.00262259201895716,-0.0490596463213706,-0.0387790856070585,2.56409880043032e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,40372,-0.0456328696982041,0.00273071362133471,-0.0509850683960201,-0.040280671000388,3.69065237603676e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37998,-0.0502450547642382,0.00300640183895097,-0.0561376023685821,-0.0443525071598942,4.42973193957358e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,40330,-0.0481288689720198,0.0028843476293412,-0.0537821903255286,-0.0424755476185111,5.5651049064331e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,40305,-0.110094020031273,0.00659868738404793,-0.123027447304007,-0.0971605927585393,5.76156044170067e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,40489,-0.210994545195903,0.0126545970205358,-0.235797555356153,-0.186191535035653,6.7964228795789e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,-0.0710203684760775,0.00425953867484664,-0.0793690642787769,-0.0626716726733781,6.90172396264063e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,37981,0.058814886972465,0.00353285508219827,0.0518904910113564,0.0657392829335736,1.28268956316551e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,37598,-0.134916149757171,0.00810959957191335,-0.150810964918121,-0.11902133459622,1.60897527205791e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40341,-0.100028263259129,0.00602059072675104,-0.111828621083561,-0.0882279054346971,1.81001280810589e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,40305,-0.110633875561449,0.00666652655844529,-0.123700267616001,-0.0975674835068958,2.47461732201003e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,-0.0297668414777399,0.00179499678252093,-0.0332850351714809,-0.0262486477839988,3.11913224799262e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,37671,0.035053884076761,0.00211529249559764,0.0309079107853896,0.0391998573681324,4.60856844582883e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,40411,-0.146354018872924,0.00884855488431297,-0.163697186446177,-0.12901085129967,6.08813219220998e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,37990,-0.0896896580431625,0.00542367413335896,-0.100320059344546,-0.0790592567417789,7.87846412935383e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,40305,-0.0579840675487989,0.00351050645847668,-0.0648646602074132,-0.0511034748901846,8.86712996336184e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGRN,Agrin,40422,-0.0532428200071146,0.00322619520896866,-0.0595661626166932,-0.0469194773975361,1.10465507334633e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,40311,-0.145709169427708,0.00887438096316892,-0.163102956115519,-0.128315382739896,4.37263503999833e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,40228,-0.141362585920751,0.00865569109244369,-0.15832774046194,-0.124397431379561,1.80412861518477e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,-0.0550916616556587,0.00337572038817228,-0.0617080736164764,-0.048475249694841,2.15368215025152e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,40203,-0.0467107627307823,0.00286313584410399,-0.0523225089852261,-0.0410990164763384,2.38457162488716e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,37998,-0.178253188360616,0.0109193411043131,-0.19965509692507,-0.156851279796163,2.43157012702365e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,40305,-0.121752002845155,0.00746717384730434,-0.136387663585871,-0.107116342104438,2.76258873582472e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,40417,-0.105478396863127,0.00648831030988565,-0.118195485070503,-0.0927613086557514,5.95717374861071e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40536,-0.106679723535185,0.00656650549572482,-0.119550074306806,-0.0938093727635648,7.01028978197903e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,40403,-0.0792719862815975,0.00488273732539407,-0.0888421514393699,-0.0697018211238252,8.42247954884035e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40303,-0.0762808519508944,0.00470739047469777,-0.0855073372813021,-0.0670543666204868,1.38568470353773e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,37628,-0.0961094189234328,0.00593986089917539,-0.107751546285817,-0.084467291561049,2.52689233063241e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,-0.0862507383617934,0.00534077134256118,-0.0967186501932133,-0.0757828265303735,3.43260538013738e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40357,-0.0440549063420533,0.00273007172596414,-0.049405846924943,-0.0387039657591636,4.06262972442587e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37628,0.0995722405886564,0.00619739390689189,0.0874253485311483,0.111719132646164,1.5339325898237e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37990,-0.102041175561727,0.00635435362502391,-0.114495708666774,-0.0895866424566798,1.69275639974836e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,40216,-0.0586589474083438,0.0036627064552577,-0.0658378520606489,-0.0514800427560388,2.83241116722616e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,-0.131568797213916,0.00822385730336128,-0.147687557528504,-0.115450036899328,4.51341158695824e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37969,0.0753058405649068,0.00472021645399914,0.0660542163150685,0.0845574648147451,8.82194629008168e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,-0.0580507110621306,0.00364600134746085,-0.0651968737031539,-0.0509045484211074,1.23604152157628e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,40305,-0.188795977508592,0.0118829587241655,-0.212086576607957,-0.165505378409228,2.0918289592059e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,40489,-0.0415593930314146,0.00261738408841657,-0.0466894658447111,-0.0364293202181181,2.40996829946296e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,-0.0892804170124792,0.00562575013321456,-0.10030688727358,-0.0782539467513786,3.30912225412729e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,40489,-0.0439357023819744,0.00277531407796396,-0.0493753179747837,-0.038496086789165,5.05936997743873e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40434,-0.111177154740665,0.00702799594874017,-0.124952026800196,-0.0974022826811345,6.09674174665372e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40471,-0.147320775308532,0.009356700887718,-0.165659909048459,-0.128981641568605,1.93704766363543e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,40341,-0.0733484948398824,0.0046599204267846,-0.0824819388763802,-0.0642150508033846,2.0989363796047e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,37671,-0.0695124548253483,0.00442353590523874,-0.0781825851996163,-0.0608423244510804,3.80995476228641e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,-0.0642744377358235,0.00409663708895656,-0.0723038464301784,-0.0562450290414687,4.59932855253347e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40341,-0.0809794361507152,0.00516249175308944,-0.0910979199867705,-0.0708609523146599,4.8696953923559e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,-0.135178271553504,0.00863825877828671,-0.152109258758946,-0.118247284348062,8.75348327335355e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,-0.0440137979700059,0.00281522707779131,-0.0495316430424769,-0.038495952897535,1.08869442506662e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,40536,-0.0869830007022268,0.00556915188446347,-0.0978985383957752,-0.0760674630086784,1.36665565199847e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,0.0588224777475294,0.00376839396460874,0.0514364255768963,0.0662085299181625,1.59516784311675e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,40367,0.0562224932298347,0.00360446659592135,0.0491577387018289,0.0632872477578406,1.89977177320422e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,37628,-0.0860509383528693,0.00553477910490173,-0.0968991053984767,-0.075202771307262,5.00615003229507e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,-0.0413262455425765,0.00266048785996084,-0.0465408017480997,-0.0361116893370533,5.15189512793674e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PXN,Paxillin,39961,-0.078012856016649,0.00503719817146953,-0.0878857644327293,-0.0681399476005688,1.06571834255773e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37942,-0.0703234617406082,0.00454057231730003,-0.0792229834825163,-0.0614239399987002,1.21379525051729e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,40516,-0.0409599360181822,0.00264927786486652,-0.0461525206333206,-0.0357673514030439,1.55051798899455e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,40341,0.0511457524434229,0.00331448865501811,0.0446493546795874,0.0576421502072584,2.46967394211815e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,40374,-0.0702108576302863,0.00455029162265358,-0.0791294292106873,-0.0612922860498853,2.50287357444186e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,40305,-0.170183737493775,0.011035371599279,-0.191813065828362,-0.148554409159188,2.85218446481559e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,-0.145698629282281,0.00945148881997646,-0.164223547369435,-0.127173711195128,3.13716819844312e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,0.04733807334739,0.00307719062326423,0.0413067797257922,0.0533693669689879,5.03539558714698e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,38013,-0.0262790115708654,0.00171020693402832,-0.0296310171615609,-0.0229270059801699,7.71169823335503e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,37882,-0.053647670593572,0.00350204646223097,-0.0605116816595447,-0.0467836595275993,1.58759029780983e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39980,-0.0535526957074283,0.00350110867826979,-0.0604148687168371,-0.0466905226980195,1.96240875614222e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,37990,-0.0643222438091181,0.00420331231329003,-0.0725607359431665,-0.0560837516750696,2.01166353314942e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,40489,-0.0976930386802403,0.00638851026747409,-0.11021451880449,-0.0851715585559911,2.02601123341997e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,-0.0575690131243933,0.00377119342748909,-0.0649605522422719,-0.0501774740065147,3.54349707107911e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,37931,-0.161575646438424,0.0105866120094212,-0.18232540597689,-0.140825886899959,3.72160409049555e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37572,-0.176978297860511,0.0115961436169969,-0.199706739349825,-0.154249856371197,3.84931860454747e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,37990,-0.136220291416115,0.00892736865620484,-0.153717933982276,-0.118722648849953,3.90818580529567e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,40192,-0.0815848993968286,0.00535095613963967,-0.0920727734305224,-0.0710970253631349,4.07551076927978e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,-0.0502182440180375,0.00329576714419092,-0.0566779476206517,-0.0437585404154233,4.66849515782971e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,37990,-0.102826808830186,0.00674861482563253,-0.116054093888426,-0.0895995237719467,5.44265792723682e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEP,Leptin,40359,-0.0944768839077227,0.00621345647008972,-0.106655258589099,-0.0822985092263468,7.5594879435197e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39980,-0.07335877498141,0.00482445907669234,-0.082814714771727,-0.063902835191093,7.66923071607942e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39961,-0.039584387138865,0.00260402852673041,-0.0446882830512566,-0.0344804912264734,8.20075637489862e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37628,-0.107288964468692,0.00705415510939146,-0.121115108483099,-0.0934628204542847,8.43901704120088e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,40411,-0.0379742815352783,0.00250243668198606,-0.042879057431971,-0.0330695056385856,1.18876313147154e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,-0.0857028629373524,0.00566091986927891,-0.096798265881139,-0.0746074599935657,2.02587412685441e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,40044,-0.124829364313781,0.00824692222378003,-0.14099333187239,-0.108665396755172,2.15741457729978e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,40341,-0.0805988580058738,0.00533021728881653,-0.0910460838919542,-0.0701516321197934,2.67350413837032e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,37901,-0.154861660747273,0.0102395977548596,-0.174931272346798,-0.134792049147748,2.97659186422025e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37598,-0.116335422414701,0.00769988754822686,-0.131427202009226,-0.101243642820177,3.81142632521758e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,-0.205201059197403,0.0135973042906194,-0.231851775607017,-0.178550342787789,4.83392112520275e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,40341,-0.106215836329594,0.00705938614736947,-0.120052233178439,-0.0923794394807503,8.20453553948694e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,40305,0.034794455508777,0.00231396099381722,0.0302590919608953,0.0393298190566588,9.43964982041223e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,40042,-0.0784295516343724,0.00522461419950479,-0.0886697954654018,-0.068189307803343,1.39190339521387e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,40011,-0.0450841273219227,0.00300342983769497,-0.0509708498038049,-0.0391974048400406,1.40805227142547e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,40341,-0.0893946375458064,0.00595744300088122,-0.101071225827534,-0.0777180492640792,1.49907352045227e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,0.050168719006828,0.00334517534396643,0.0436121753326538,0.0567252626810022,1.69016025173043e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37815,-0.0452605979343275,0.00302374768297007,-0.0511871433929489,-0.0393340524757062,3.0162648438051e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.0357589928891012,0.00239390691465832,0.0310669353363708,0.0404510504418315,4.11556302989124e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,-0.137993263709574,0.00926114883265413,-0.156145115421576,-0.119841411997572,7.13143607776911e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,40432,-0.100146677100019,0.00672225056154504,-0.113322288200647,-0.0869710659993906,7.36087711686324e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39980,-0.0912309970269815,0.00612840665404282,-0.103242674068905,-0.0792193199850576,8.87969151785743e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,-0.119131750866274,0.00801315942844508,-0.134837543346027,-0.103425958386522,1.18461165403008e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,-0.12146732505221,0.00817275721542312,-0.137485929194439,-0.105448720909981,1.42625230343745e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,37598,-0.0650573395050985,0.0043775961344969,-0.0736374279287124,-0.0564772510814845,1.48036446066526e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,40341,-0.0888625378120221,0.00598708587802897,-0.100597226132959,-0.0771278494910853,1.67265482476463e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,-0.124887977982318,0.00841149105610439,-0.141374500452282,-0.108401455512353,1.77944112763171e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40396,-0.0744977212024683,0.0050434787001889,-0.0843829394548385,-0.064612502950098,4.74682138716469e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,40305,-0.0732856576296595,0.004965652688073,-0.0830183368982826,-0.0635529783610364,5.73068325567255e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37900,-0.114609480359778,0.00776382701744914,-0.129826581313978,-0.0993923794055779,6.21902393257005e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,40203,-0.0748005341628774,0.0050723105435707,-0.0847422628282759,-0.0648588054974788,6.83013707825317e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,-0.147867257548723,0.0100318156290073,-0.167529616181577,-0.128204898915868,7.52147601919631e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40536,-0.0310596860681601,0.00210868330938267,-0.0351927053545501,-0.02692666678177,8.67405072310801e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,40471,-0.0854376345558175,0.00580105937936977,-0.0968077109393823,-0.0740675581722528,8.8903088167281e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,-0.100286431163125,0.00680997115673181,-0.113633974630319,-0.0869388876959307,9.30207306954408e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,40359,0.0745413788001993,0.00506624941407361,0.064611529948615,0.0844712276517836,1.1058996289163e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,37671,-0.0380053355512194,0.0025816053443977,-0.0430652820262389,-0.0329453890761999,1.13727138403055e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,40044,-0.0681993053036687,0.00463950882236654,-0.0772927425955071,-0.0591058680118303,1.36918893311877e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,-0.148925277950195,0.0101463993305489,-0.168812220638071,-0.129038335262319,1.86649186912927e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,40332,0.0414819095196033,0.00283107874146188,0.035932995186338,0.0470308238528685,2.68991410466849e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40305,-0.121596549376286,0.00830235669475606,-0.137869168498008,-0.105323930254564,2.95142695964154e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,-0.0820127620005547,0.00560010841653363,-0.0929889744969606,-0.0710365495041487,3.01278142727901e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40350,-0.0704034200223552,0.00480981953456091,-0.0798306663100946,-0.0609761737346158,3.33666643941209e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,40305,-0.0706003883418319,0.00482535581753675,-0.0800580857442039,-0.0611426909394599,3.66387670565323e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,40292,-0.0673439883466454,0.00461062716492161,-0.0763808175898917,-0.058307159103399,5.25687546592809e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,40469,-0.0876277709323666,0.00600324984236764,-0.0993941406234072,-0.075861401241326,5.98730743845184e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,40516,-0.107244954513468,0.00735114416124164,-0.121653197069502,-0.0928367119574348,6.6930261259522e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,-0.0554172859350811,0.00380080165890888,-0.0628668571865425,-0.0479677146836197,7.63311972330939e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39839,-0.143844871529578,0.00988138930474377,-0.163212394566875,-0.12447734849228,1.09138735633724e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,-0.153699282717058,0.0105669222340957,-0.174410450295886,-0.13298811513823,1.43949379803897e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,40228,-0.0946424586207799,0.00651416525562249,-0.1074102225218,-0.0818746947197598,1.61538291220064e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,40359,-0.122619518121184,0.00846063969956678,-0.139202371932335,-0.106036664310033,2.68752080279634e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,40489,0.0230757848016938,0.00159393321816129,0.0199516756940977,0.0261998939092899,3.34764992361152e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,40516,-0.049600945924358,0.00342704009218731,-0.0563179445050451,-0.0428839473436708,3.53398207152106e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,-0.117494941393853,0.00811826326707652,-0.133406737397323,-0.101583145390383,4.11660240586383e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,40382,0.0546946141038098,0.00378899604172822,0.0472681818620225,0.0621210463455971,6.1530911923263e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,40411,0.0596870695403767,0.00413692669747318,0.0515786932133292,0.0677954458674241,6.81689021380408e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,-0.0987198166908278,0.00684013669583674,-0.112126484614668,-0.0853131487669878,7.36240976881958e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,37901,-0.132280408577257,0.00917075378881784,-0.15025508600334,-0.114305731151174,8.1497652062512e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,39980,-0.103238760128268,0.00716576272156914,-0.117283655062543,-0.0891938651939924,9.33065162385904e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,40471,-0.0579390164257182,0.00402857237405201,-0.0658350182788602,-0.0500430145725763,1.30930986001039e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,40516,-0.0578275453119966,0.00402994368469098,-0.065726234933991,-0.0499288556900023,2.0784015329964e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,40167,-0.0392496513095602,0.00273915060750658,-0.044618386500273,-0.0338809161188473,2.81610479510974e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,37928,0.026677208533712,0.00186269084330467,0.0230263344808349,0.0303280825865892,3.48618835692071e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,40422,-0.0377554000405448,0.00263910115328211,-0.0429280383009778,-0.0325827617801119,3.86148690567656e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,-0.0319194809622583,0.00223306421034833,-0.0362962868145411,-0.0275426751099756,4.60363048350194e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,40536,0.0228027426068272,0.00159617392114585,0.0196742417213813,0.0259312434922731,5.12510205648217e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,-0.123540074698958,0.0086525236489667,-0.140499021050933,-0.106581128346983,5.90192173344252e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,39960,-0.0546434086760115,0.00384254157882004,-0.0621747901704987,-0.0471120271815242,1.32006346341595e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,-0.102829310961283,0.00722899695004614,-0.116998144983373,-0.0886604769391924,1.40779650950313e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40471,-0.113459465809117,0.00798463442731508,-0.129109349286654,-0.097809582331579,1.50801597998981e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,-0.0846477424204658,0.00595732821761387,-0.096324105726989,-0.0729713791139426,1.53167782252651e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,-0.0798487073239931,0.00561938728147968,-0.0908627063956933,-0.0688347082522929,1.70665689464529e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,40305,-0.0456861317489377,0.00321743205328311,-0.0519922985733725,-0.0393799649245028,1.75180079474875e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,-0.0626942245707464,0.0044264346744614,-0.0713700365326908,-0.0540184126088021,2.90618005462659e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,40341,-0.129201506662143,0.00914414407579487,-0.147124029050701,-0.111278984273585,4.6885459807512e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,40305,-0.107841610288402,0.0076383270180158,-0.122812731243713,-0.092870489333091,5.47337179826651e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,-0.0533549105279456,0.0037791297558589,-0.060762004849429,-0.0459478162064621,6.23751979543655e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,40192,-0.110107636860985,0.00781164331756516,-0.125418457763413,-0.0947968159585573,7.60373665489029e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,40255,-0.0614729030455283,0.00436224936066223,-0.0700229117924263,-0.0529228942986303,7.94361729876193e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39961,-0.108277433057727,0.00768790109935174,-0.123345719212457,-0.0932091469029977,8.97410694280722e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EZR,Ezrin,40471,-0.0324353535822515,0.00230325840068965,-0.0369497400476032,-0.0279209671168997,9.01465242227583e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,40411,-0.112812870025857,0.00802811434006403,-0.128547974132383,-0.0970777659193318,1.37660224672739e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,40341,0.0584304459682452,0.00415963123274378,0.0502775687520674,0.066583323184423,1.4841031556246e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,40228,0.0458907074873033,0.00326737929424704,0.0394866440705791,0.0522947709040275,1.53089353090297e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,0.0330594916092359,0.00236188350835946,0.0284301999328514,0.0376887832856204,2.95258480014857e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,40341,-0.0826880934533558,0.00592195208909143,-0.094295119547975,-0.0710810673587366,4.775006210565e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,40044,-0.0947756035156865,0.00678989770857824,-0.1080838030245,-0.0814674040068732,5.15107941067122e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,40293,-0.0425421784349705,0.00305015456398467,-0.0485204813803804,-0.0365638754895605,5.92394357390991e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,37917,-0.0402117353650557,0.00288627137889235,-0.0458688272676847,-0.0345546434624267,8.14483624300317e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,40471,-0.079001414744477,0.00567729440670656,-0.0901289117816219,-0.0678739177073322,9.19047942665e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,40357,0.0459149032498612,0.00330371456759021,0.0394396226973844,0.052390183802338,1.17299740387855e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,40305,-0.0465685670929669,0.00336458030289956,-0.05316314448665,-0.0399739896992838,2.58176764359415e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,37748,-0.0382851249861423,0.00276529749078572,-0.0437051080680823,-0.0328651419042022,2.72860113096115e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,-0.101082805030712,0.00730929494370642,-0.115409023120377,-0.0867565869410479,3.39562805593731e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39980,-0.0819112231043992,0.00592947513381655,-0.0935329943666796,-0.0702894518421188,3.76391422588147e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,-0.0676400234607592,0.00489919571528331,-0.0772424470627145,-0.0580375998588039,4.1971540087712e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,40330,0.235106285838483,0.0170563321231613,0.201675874877087,0.268536696799879,5.61653197140374e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40332,0.0707541934088633,0.00513942173259436,0.0606809268129784,0.0808274600047483,7.10157363208569e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,40332,-0.0597545633429072,0.00434279005193501,-0.0682664318446998,-0.0512426948411146,7.86509044269236e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40341,-0.141955885608394,0.0103171038734591,-0.162177409200374,-0.121734362016414,7.88523936105916e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELP,P-selectin,40403,-0.0772684576528263,0.00562005017406614,-0.088283755993996,-0.0662531593116567,9.08977149816647e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38484,0.0420671558444352,0.00306030440220258,0.0360689592161182,0.0480653524727523,1.01686899432237e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,40097,-0.0560076201008259,0.00407685251922413,-0.0639982510385052,-0.0480169891631466,1.06428360714838e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39961,-0.0654283634182996,0.00476594553353059,-0.0747696166640195,-0.0560871101725796,1.2200235438449e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,-0.0662892774771985,0.00482629188531443,-0.0757488095724148,-0.0568297453819822,1.23532747246897e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37562,-0.0850477457276757,0.00620183570722194,-0.0972033437138307,-0.0728921477415207,1.65984939150937e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,37575,-0.0366888145088431,0.00267638899455096,-0.041934536938163,-0.0314430920795232,1.77515896161692e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,40341,-0.12249564700692,0.00895066561110902,-0.140038951604693,-0.104952342409146,2.15158342263331e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,40341,-0.108771051823899,0.00795262714878971,-0.124358201035526,-0.0931839026122707,2.40768793246545e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAST,Gastrin,37942,-0.173928476333104,0.0127143847879382,-0.198848670517462,-0.149008282148745,2.57266056582202e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,40341,-0.0707983571046333,0.00518703761944683,-0.0809649508387491,-0.0606317633705175,3.53464033233063e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40332,-0.057551860147955,0.00422788207230292,-0.0658385090096687,-0.0492652112862412,5.80752285869274e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,40341,-0.0568757888216272,0.00417994392508084,-0.0650684789147857,-0.0486830987284688,6.26473361031869e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,38013,-0.0274907097344488,0.00202004800960634,-0.0314500038332772,-0.0235314156356204,6.67599107991934e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,40224,0.0376604815926508,0.00276915236657106,0.0322329429541715,0.04308802023113,6.89781607568113e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,40516,-0.0718778597819704,0.00528869736823798,-0.0822437066237168,-0.0615120129402239,7.7304325398051e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39980,-0.0849565105528062,0.0062504335748945,-0.0972073603595994,-0.072705660746013,7.740449144439e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,40234,-0.0391682972585514,0.00288259576908021,-0.0448181849659486,-0.0335184095511542,8.12504713202971e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,40266,-0.0511333771501798,0.0037637681861437,-0.0585103627950215,-0.0437563915053382,8.35744191862335e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,40268,-0.0958085355138224,0.0070644175799124,-0.109654793970451,-0.0819622770571941,1.14832474097332e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,40359,-0.051419936968753,0.00379290890400822,-0.0588540384206091,-0.0439858355168969,1.22905688271688e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",40357,-0.122951737939048,0.00906951545071606,-0.140727988222451,-0.105175487655644,1.23356188542011e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,37967,-0.0746873463893789,0.00551989226081509,-0.0855063352205765,-0.0638683575581813,1.92075043313716e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,-0.0694907521807875,0.00514849021403283,-0.0795817930002918,-0.0593997113612831,2.77223377407061e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,39757,-0.12263948631788,0.00908658165653222,-0.140449186364683,-0.104829786271077,2.81405258391634e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,40360,0.0502457433496686,0.00372502465941082,0.0429446950172234,0.0575467916821138,3.07214636778084e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,37598,-0.120481689883187,0.008928356617082,-0.137981268852668,-0.102982110913707,3.17873231762811e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,-0.0670709711013444,0.00497392860082218,-0.0768198711589559,-0.0573220710437329,3.571858036562e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,40341,-0.0511167843561746,0.00379899361678322,-0.0585628118450697,-0.0436707568672795,4.80502335350122e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,40288,-0.0391512295483179,0.00291666184613507,-0.0448678867667427,-0.0334345723298932,7.38579663268968e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,-0.0392377695602144,0.00292255415949403,-0.0449659757128227,-0.0335095634076061,7.81547998973828e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,-0.0550022352168746,0.0040998550943482,-0.063037951201797,-0.0469665192319521,8.16056267575636e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,-0.0421703604191341,0.00315034316131172,-0.0483450330153051,-0.0359956878229631,1.21423190208936e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REN,Renin,40359,-0.0930905483393138,0.0069556428300503,-0.106723608286212,-0.0794574883924152,1.25317208181909e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,40358,-0.0749982423701726,0.00561668917907413,-0.0860069531611579,-0.0639895315791873,1.88495210520613e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,40471,-0.0478134531236239,0.00358112327051132,-0.0548324547338261,-0.0407944515134217,1.90915562992194e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40341,-0.0704040965793289,0.00527319698514976,-0.0807395626702224,-0.0600686304884354,1.92229917807401e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,40068,0.0389262194119553,0.00291550425518459,0.0332118310717935,0.0446406077521171,1.93546364670339e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,40422,-0.0878627697407,0.00658220505683597,-0.100763891652098,-0.0749616478293015,1.98955006565805e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,37998,-0.0364112599174698,0.00272698210732782,-0.0417561448478323,-0.0310663749871073,2.07001739094297e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,37987,-0.0945178353920425,0.00708144071697901,-0.108397459197321,-0.0806382115867637,2.21159385408401e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,-0.0523529351288458,0.003924063732265,-0.0600441000440852,-0.0446617702136064,2.39125517441152e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,40305,-0.071319407429913,0.00535275422523281,-0.0818108057113693,-0.0608280091484567,2.76930115125951e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,40332,-0.0684607433628053,0.00514758842050324,-0.0785500166669917,-0.058371470058619,3.81667244052394e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,-0.0892265781269203,0.00672691885082306,-0.102411339074534,-0.0760418171793071,6.15253772103741e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,-0.144652549710617,0.0109092520671326,-0.166034683762197,-0.123270415659037,7.11841199872236e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASPN,Asporin,37990,0.035312363785508,0.00266812607588831,0.030082836676767,0.0405418908942491,9.73846940621611e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,-0.0355455279115412,0.00269977267032807,-0.0408370823453842,-0.0302539734776982,2.21270607527771e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,37714,-0.165797595919209,0.0125863184215387,-0.190466780025425,-0.141128411812993,2.22215924051662e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,-0.123843099518005,0.00940982756700351,-0.142286361549331,-0.105399837486678,2.38382903488582e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,-0.0990503136915116,0.00752631082354667,-0.113801882905663,-0.0842987444773601,2.58009943264465e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,40042,0.0303264481935289,0.00230573718930701,0.0258072033024872,0.0348456930845706,2.66201320074581e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,-0.128094423917499,0.00974058350734852,-0.147185967591902,-0.109002880243096,2.6947754234516e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,40411,-0.0404529637182274,0.00307639759643531,-0.0464827030072406,-0.0344232244292142,2.7433301536132e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,0.0537166359105795,0.0040908474565922,0.0456985748956588,0.0617346969255002,3.50612065155465e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,40403,-0.128022264088327,0.00977108200503882,-0.147173584818203,-0.108870943358451,5.08937107913123e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,37671,-0.0800334357656372,0.00610699020768946,-0.0920031365727085,-0.0680637349585659,5.37852557596123e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,37562,-0.0554500098860204,0.00423331806064544,-0.0637473132848854,-0.0471527064871553,5.89868929348424e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37628,-0.0388249418510631,0.00296449495800688,-0.0446353519687566,-0.0330145317333696,6.02376118194151e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,40516,-0.119570884019432,0.0091442225453803,-0.137493560208378,-0.101648207830487,7.12193118061834e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,40341,-0.0851888281573885,0.00652347716821148,-0.097974843407083,-0.072402812907694,8.96395069150096e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,-0.0689649462825485,0.00528782795444162,-0.0793290890732541,-0.0586008034918429,1.11567790691345e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,40471,0.0474006280488042,0.00363502245557116,0.0402759840358847,0.0545252720617237,1.14042293680388e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40310,-0.086447364506255,0.0066305141953147,-0.0994431723290718,-0.0734515566834382,1.17844209358491e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,37900,-0.125085396097475,0.0095959385400163,-0.143893435635907,-0.106277356559043,1.32142711568447e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37942,-0.112711532062183,0.0086548359593643,-0.129675010542537,-0.0957480535818292,1.5466635965741e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,40332,-0.0301524289574845,0.00231818076183036,-0.034696063250672,-0.025608794664297,1.75706970892037e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,40332,-0.0661293770787918,0.00508660502586299,-0.0760991229294833,-0.0561596312281003,1.90499437544854e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,40411,-0.0730812239528876,0.00562227143653218,-0.0841008759684906,-0.0620615719372845,1.95482846787444e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,40341,-0.104467462222807,0.00803978143848715,-0.120225433842242,-0.0887094906033721,2.0815562120663e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,40332,0.0362670269875199,0.00279451997146381,0.0307897678434509,0.041744286131589,2.55740359569503e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40536,-0.0433646327467824,0.0033487059082184,-0.0499280963268904,-0.0368011691666743,3.66119373749874e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,-0.0914281386132055,0.00705781730210351,-0.105261460525328,-0.0775948167010827,3.7633625243718e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,40341,-0.104188460270993,0.00805433709573303,-0.11997496097863,-0.0884019595633567,4.40681356805548e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37671,-0.0934112273269675,0.0072340754678401,-0.107590015243934,-0.0792324394100009,6.47180149739473e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,40152,-0.046598818314519,0.00361150255810094,-0.0536773633283968,-0.0395202733006411,6.75519835611059e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,40154,-0.0442777096629023,0.00343227333617364,-0.0510049654018027,-0.037550453924002,6.97398035109849e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,40305,-0.128664359581106,0.00998381210848029,-0.148232631313728,-0.109096087848485,8.21706613998873e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,37990,-0.0937429206204017,0.00729135231413545,-0.108033971156107,-0.0794518700846962,1.30846954705431e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,40489,-0.0456622287546513,0.00355467813896844,-0.0526293979070295,-0.0386950596022732,1.39363918332931e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40536,-0.0392269352999595,0.00305510302459728,-0.0452149372281702,-0.0332389333717488,1.50031271417939e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD248,Endosialin,37998,0.050286918674991,0.0039148255342852,0.0426138606277921,0.05795997672219,1.51454994546996e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,40359,-0.0440455859106086,0.00343649981917372,-0.0507811255561891,-0.0373100462650281,2.01741201158601e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,0.0563717095528452,0.00441079724524783,0.0477265469521594,0.0650168721535309,3.20703943070252e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39961,-0.106017496814026,0.00829925290246668,-0.122284032502861,-0.0897509611251913,3.51118153374172e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,37959,-0.128788457573437,0.0100782386601781,-0.148541805347386,-0.109035109799488,3.53229857335646e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,39934,-0.0858786880688875,0.00672914915778788,-0.0990678204181518,-0.0726895557196233,4.10071483574279e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,-0.100163462107038,0.0078700816820441,-0.115588822203845,-0.0847381020102319,6.89568376042885e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,-0.0938795494109496,0.0073801856862744,-0.108344713356047,-0.0794143854658518,6.89638172030009e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,-0.117207718131055,0.00922488177260393,-0.135288486405359,-0.0991269498567516,8.33737980304337e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37900,-0.1417412388129,0.011151377885242,-0.163597939467974,-0.119884538157825,8.40117926457491e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,40341,-0.105310015773629,0.00829603480993934,-0.121570244001111,-0.0890497875461483,9.62535095111067e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37959,-0.0783333139511002,0.00617741439991839,-0.0904410461749403,-0.0662255817272602,1.22504705257276e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,40341,0.0425030407178165,0.00335458911770262,0.0359280460471193,0.0490780353885136,1.30176398759415e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,37942,-0.0794062867042373,0.00626562814424331,-0.0916869178669542,-0.0671256555415204,1.34363143637371e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,40341,-0.112266019059757,0.00886870386624349,-0.129648678637594,-0.0948833594819198,1.50396779746791e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,40332,0.0300369987299859,0.00237292739193127,0.0253860610418006,0.0346879364181712,1.51322982472476e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,40489,-0.0695316139578866,0.00549430569236754,-0.080300453114927,-0.0587627748008462,1.56516734985712e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNST,Consortin,40359,-0.132978439343379,0.0105108406683126,-0.153579687053272,-0.112377191633486,1.64448002478832e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37959,-0.0763475834919056,0.00603293281652921,-0.0881721318123029,-0.0645230351715083,1.68829279853629e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,40359,0.037789458702545,0.00299146424670741,0.0319261887789985,0.0436527286260916,2.09226288561441e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,40228,-0.0635924057854502,0.00503396669076983,-0.0734589804993591,-0.0537258310715413,2.09303508005074e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,-0.0851258579901685,0.00673676162525081,-0.0983299107756601,-0.0719218052046769,2.14830830605245e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,37900,-0.054860108657887,0.00434211607209584,-0.0633706561591949,-0.0463495611565792,2.19523247188102e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,40341,-0.104019153401973,0.00824257413889436,-0.120174598714205,-0.0878637080897396,2.45538148843417e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,-0.0533213795999659,0.00422617678874314,-0.0616046861059024,-0.0450380730940293,2.76385331939949e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,-0.118115807390373,0.00936297475434429,-0.136467237908888,-0.0997643768718584,2.78846704126431e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,40332,0.0313596638444374,0.00248717489445863,0.0264848010512985,0.0362345266375764,2.8268704012756e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,39961,-0.0736836619295554,0.00584984939554412,-0.0851493667448218,-0.0622179571142889,3.34817275362888e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39961,-0.075090774853782,0.00596988201604434,-0.0867917436052289,-0.0633898061023351,4.17243394214521e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,-0.126986660524981,0.0100992822927252,-0.146781253818723,-0.10719206723124,4.36867761126786e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,38013,-0.0364410781804162,0.00290044278799224,-0.042125946044881,-0.0307562103159514,5.28630395757871e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,37990,-0.0976138237231659,0.00776984415787837,-0.112842718272608,-0.0823849291737243,5.34404381806627e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,-0.131684021862944,0.010483016312993,-0.15223073383641,-0.111137309889478,5.45471288766012e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,-0.0765060103908485,0.00609106964390226,-0.0884445068928969,-0.0645675138888,5.54379557452513e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37598,-0.0596717338414401,0.00475230670211502,-0.0689862549775855,-0.0503572127052946,5.89714108440492e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,-0.0231857691755965,0.00184891566138247,-0.0268096438719062,-0.0195618944792869,6.65907379524333e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,-0.092934977795155,0.00742195975815316,-0.107482018921135,-0.0783879366691748,8.39862443432214e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,40422,-0.0577225376354056,0.00461745992580838,-0.06677275908999,-0.0486723161808212,1.08399388951858e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,40411,-0.067971188077814,0.00544048224558088,-0.0786345332791525,-0.0573078428764754,1.1879616648274e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,-0.0548213073633254,0.00439008758785318,-0.0634258790355176,-0.0462167356911332,1.28696865615003e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,40228,-0.0423197450374262,0.00338913090382541,-0.048962441608924,-0.0356770484659284,1.29690853061735e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,40422,-0.104374521693576,0.00835974837273881,-0.120759628504144,-0.0879894148830083,1.3157558416228e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,37671,-0.0377471329811897,0.00302230976330788,-0.0436708601172731,-0.0318234058451062,1.352743638834e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,40228,-0.0749128341103277,0.0060056209254198,-0.0866838511241505,-0.0631418170965049,1.52667655168689e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,-0.0714952852007167,0.00573820187283733,-0.0827421608714779,-0.0602484095299555,1.96206897797829e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37990,-0.0725460702702475,0.00583153519449594,-0.0839758792514595,-0.0611162612890355,2.46309829344005e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40516,-0.0677763853915619,0.00545298676326372,-0.0784642394475588,-0.057088531335565,2.63610825131493e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37901,-0.102780747311951,0.0082706310469648,-0.118991184164002,-0.0865703104598998,2.90521191254164e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,-0.0810555562642848,0.00652947600732899,-0.0938533292386496,-0.06825778328992,3.23206773202517e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,37628,-0.0746100231772045,0.00602200417052686,-0.0864131513514371,-0.0628068950029718,4.66526110587757e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,40309,-0.0808686574601821,0.00653442008132323,-0.0936761208195756,-0.0680611941007886,5.12743639483163e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,37598,-0.0535610193917981,0.00433527266187485,-0.0620581538090728,-0.0450638849745234,7.17246429788535e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,37671,-0.0612924347939773,0.00496123886176822,-0.071016462963043,-0.0515684066249116,7.19431630448453e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,37901,-0.125234226981129,0.0101440982089181,-0.145116659470609,-0.10535179449165,7.94958175173787e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,40042,-0.0878246198525096,0.00711850008706224,-0.101776880023152,-0.0738723596818676,8.26796776492591e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,40411,-0.0627082447131795,0.00509286373844034,-0.0726902576405225,-0.0527262317858364,1.10842660656793e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40332,0.0517142817334543,0.00420656950934904,0.0434694054951302,0.0599591579717784,1.40648556875483e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,-0.133694191617854,0.0108826879307556,-0.155024259962135,-0.112364123273573,1.56895038100877e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,40228,-0.0707075527440486,0.00577450487218924,-0.0820255822935395,-0.0593895231945577,2.56463278044769e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,-0.0345280912700071,0.0028193874769237,-0.0400540907247775,-0.0290020918152366,2.68517344375342e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,40411,-0.0477647081170076,0.00390243707573998,-0.055413484785458,-0.0401159314485572,2.71723534660148e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,39806,-0.0477004130149453,0.00391108586479691,-0.0553661413099473,-0.0400346847199434,4.6804143195724e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,-0.0568023394661814,0.00465997620774329,-0.0659358928333582,-0.0476687860990045,5.34945235427177e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,0.0314267933601331,0.00257948736139544,0.026370998131798,0.0364825885884681,5.41059016953316e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,37878,-0.0497007464528244,0.00407809134967622,-0.0576938054981898,-0.041707687407459,5.49445933256139e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,40359,-0.143314108745438,0.0117665717909331,-0.166376589455667,-0.120251628035209,5.64450959667864e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40422,-0.0498326833404139,0.00409548572421052,-0.0578598353598665,-0.0418055313209613,6.52550938986668e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37628,-0.122371877839327,0.0100580727688877,-0.142085700466346,-0.102658055212307,7.11868307207313e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,37966,-0.0530280783087254,0.00435925875060504,-0.0615722254599112,-0.0444839311575395,7.22333435200024e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COCH,Cochlin,37990,-0.0554257342218297,0.00456032354049726,-0.0643639683612044,-0.0464875000824551,8.20342005550154e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,37942,-0.0890029686629486,0.00732903341049396,-0.103367874147517,-0.0746380631783804,9.27331471004736e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,-0.0913023591721139,0.00752178531129988,-0.106045058382262,-0.0765596599619662,9.90586934210587e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,-0.0454829814150146,0.00375105681185453,-0.0528350527662495,-0.0381309100637797,1.0913440258404e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,40228,-0.0620709441916921,0.00512366210264219,-0.0721133219128708,-0.0520285664705134,1.24718793787853e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,39980,-0.0650046692614669,0.00536598989715465,-0.07552200945989,-0.0544873290630438,1.25959041432448e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,-0.0390857306824689,0.00323398932693017,-0.045424349763252,-0.0327471116016858,1.75673386127004e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,40290,-0.051597227212008,0.00426928409593048,-0.0599650240400317,-0.0432294303839842,1.76498230080713e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,40422,-0.123141538143918,0.0101940709686914,-0.143121917242553,-0.103161159045283,1.89127453018163e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40305,-0.162200956417988,0.013430361752669,-0.18852446545322,-0.135877447382757,1.95479172583507e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,37919,-0.07066883184247,0.00585362801347382,-0.0821419427488787,-0.0591957209360613,2.19069171532708e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,37628,-0.0633733277040499,0.00525104894480929,-0.0736653836358761,-0.0530812717722237,2.31746106712568e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40536,-0.0482724541045782,0.00400471050715048,-0.0561216866985932,-0.0404232215105633,2.57420841122651e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,-0.0705631012138421,0.00585382184862068,-0.0820365920371386,-0.0590896103905456,2.57802675398438e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,40332,0.0345625262965666,0.00286822971571347,0.0289407960537682,0.040184256539365,2.70574761857976e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,39961,-0.0416565268699639,0.00346187311867565,-0.0484417981825682,-0.0348712555573596,3.35243564236346e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,37671,0.0338969192759581,0.0028162385061197,0.0283770918039635,0.0394167467479527,3.41699551646179e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,40471,-0.0707879235640087,0.00588962609343708,-0.0823315907071454,-0.0592442564208721,3.91653245637165e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39961,-0.0648935961522338,0.00540024324982647,-0.0754780729218937,-0.0543091193825739,4.06919421039179e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,-0.111591881124015,0.00928892150952511,-0.129798167282685,-0.0933855949653463,4.19610271971587e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,40422,-0.146371272252876,0.0121956711599552,-0.170274787726388,-0.122467756779363,4.81688565721958e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,37628,-0.0381716959158687,0.00318027338874203,-0.044405031757803,-0.0319383600739343,5.11496331337108e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,37990,-0.0294366966258272,0.00245327870618657,-0.0342451228899528,-0.0246282703617015,5.29194541239736e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,-0.0517467366567124,0.00431436979732063,-0.0602029014594608,-0.043290571853964,5.30492322493752e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37671,-0.0927348655414882,0.00773453382088148,-0.107894551830416,-0.0775751792525605,5.96184805312763e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,40291,-0.0480012311751499,0.00400726308853838,-0.0558554668286852,-0.0401469955216147,6.3861551756861e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,40377,-0.0465596890716489,0.00389207156647063,-0.0541881493419313,-0.0389312288013664,7.70435930262324e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,37990,-0.0958591941497129,0.00802147386647561,-0.111581282928005,-0.0801371053714207,9.4498694277414e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,40471,-0.0776041310587856,0.00650082095929337,-0.0903457401390006,-0.0648625219785706,1.03748918122338e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,-0.0634933994227786,0.00531866898675175,-0.073917990636812,-0.0530688082087451,1.03788784859917e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,-0.0889076820427239,0.00746247090202591,-0.103534125010695,-0.0742812390747531,1.45777352771974e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37901,-0.0461485419845071,0.003873599928391,-0.0537407978441534,-0.0385562861248607,1.46582437614204e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,-0.0449047712367866,0.00377244490073467,-0.0522987632422266,-0.0375107792313467,1.65535834085944e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,37562,-0.0787391272912818,0.00663452874516271,-0.0917428036318007,-0.0657354509507629,2.53800962312736e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,40379,-0.0562758769890795,0.00475394623077382,-0.0655936116013962,-0.0469581423767628,3.39953892765083e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,-0.100860729885412,0.008520730013918,-0.117561360712691,-0.0841600990581327,3.42336198363603e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,38013,-0.0253153468318708,0.00213796337168333,-0.0295057550403701,-0.0211249386233714,3.45666251610437e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,37934,-0.0972695628921901,0.00821773189980709,-0.113376317415812,-0.0811628083685682,3.64533811631729e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,40333,0.0253066287410445,0.0021389207547959,0.0211143440616446,0.0294989134204445,3.66220399112801e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,40305,-0.03472585426145,0.00293788392984022,-0.0404841067639368,-0.0289676017589632,4.19559701738395e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,39980,-0.0714469989998199,0.00605120131886705,-0.0833073535847993,-0.0595866444148404,4.91915560745257e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,39991,-0.0572932040483489,0.00485350335610012,-0.0668060706263051,-0.0477803374703926,5.06939757470111e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37987,-0.0312561301992563,0.00265106453174357,-0.0364522166814737,-0.0260600437170389,6.29507533543358e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,-0.0562402664112372,0.00477459833542987,-0.0655984791486798,-0.0468820536737947,6.83275966192427e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,37998,-0.0286473068095487,0.00243288624509484,-0.0334157638499346,-0.0238788497691628,7.50577423429001e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,40305,-0.107989226818833,0.00918099867904465,-0.125983984229761,-0.0899944694079059,8.28191426467892e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40291,-0.0332555664403442,0.00283403694855903,-0.0388102788595199,-0.0277008540211685,1.14925952688919e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,40309,0.0356533704859653,0.00303920724720445,0.0296965242814446,0.0416102166904861,1.19279822018715e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,40359,0.0453531699338199,0.00386641726413525,0.0377749920961148,0.0529313477715249,1.20736848353731e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,40263,-0.0972323426335103,0.00829265539640183,-0.113485947210458,-0.0809787380565627,1.28112675343417e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,0.0296997208836278,0.00253362495073941,0.0247338159801785,0.034665625787077,1.39319267586335e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,37598,-0.0622071826446423,0.00531041090722561,-0.0726155880228045,-0.0517987772664801,1.54652783028048e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,40453,-0.0671458880938623,0.00573507152281689,-0.0783866282785834,-0.0559051479091412,1.56066091364406e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37901,-0.0872935186609129,0.00746685903061709,-0.101928562360922,-0.0726584749609034,2.015673204782e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,37959,-0.0895046609433573,0.00766722255939938,-0.10453241715978,-0.0744769047269345,2.45688859548464e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40536,-0.0816621030278422,0.00701854413251303,-0.0954184495275677,-0.0679057565281166,3.63887039388778e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,37990,-0.114008064650217,0.00982122637332606,-0.133257668341936,-0.0947584609584976,5.2419310400355e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,37900,-0.0233086908177745,0.002008075195551,-0.0272445182010544,-0.0193728634344945,5.30590984976341e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,40483,0.0376986736185828,0.00325131109645424,0.0313261038695325,0.0440712433676331,5.81198131207504e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37998,0.0374232311998686,0.00322759428932501,0.0310971463927916,0.0437493160069456,6.13107855529198e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,40029,-0.0434423746019619,0.00374946831879744,-0.0507913325068049,-0.0360934166971189,6.47637726610708e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37959,-0.0859378137416694,0.0074157921387106,-0.100472766333542,-0.0714028611497967,6.59977866442101e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,40042,-0.0388599635877166,0.00335764466197998,-0.0454409471251974,-0.0322789800502359,7.49903216380436e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,37942,-0.0417798519698895,0.00361554585092451,-0.0488663218377016,-0.0346933821020775,9.64947690086349e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,-0.0535229811678843,0.00463506612047639,-0.062607710764018,-0.0444382515717505,1.0602497193858e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,40346,0.0311171574651428,0.00269910825206723,0.025826905291091,0.0364074096391945,1.25202824767134e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37671,-0.0412824836602086,0.00358073525254461,-0.048300724755196,-0.0342642425652212,1.31900005081055e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37990,-0.0825426886001838,0.00716383694863291,-0.0965838090195043,-0.0685015681808633,1.41699068251685e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,40489,-0.123518158366052,0.0107431826497493,-0.144574796359561,-0.102461520372544,1.79080061570518e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,40372,-0.0283181060211572,0.00246517333642019,-0.0331498457605407,-0.0234863662817736,2.01470936244241e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,40309,-0.128582898387768,0.0111953367805443,-0.150525758477635,-0.106640038297902,2.06065462434169e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,-0.116061288517467,0.0101074604127901,-0.135871910926536,-0.0962506661083989,2.12046117402882e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,40332,-0.0849826196162047,0.00740846674891279,-0.0995032144440737,-0.0704620247883356,2.42929854282764e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,40204,-0.0576172634144843,0.00502513444175898,-0.0674665269203319,-0.0477679999086367,2.58412472794141e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40516,-0.0759529275295663,0.00662524392432626,-0.0889384056212458,-0.0629674494378869,2.61922782922855e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,40411,-0.0455064708246722,0.00397156077566341,-0.0532907299449725,-0.0377222117043719,2.81337175215514e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,37901,-0.0787005772860065,0.00686755052373163,-0.0921609763125205,-0.0652401782594925,2.90256679711338e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREH,Trehalase,37998,-0.0833965433144679,0.00727896767790615,-0.097663319963164,-0.0691297666657719,2.98260304625772e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,-0.0511266174159862,0.00446752978349482,-0.059882975791636,-0.0423702590403364,3.30799890885413e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,40341,-0.0571951979389674,0.00500126881033116,-0.0669976848072165,-0.0473927110707183,3.62046526349589e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,-0.0828120369519066,0.00724606121376923,-0.0970143169308943,-0.0686097569729189,4.13692926975424e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BGN,Biglycan,39956,0.135595840956353,0.0118703010158106,0.112330050965364,0.158861630947342,4.22914044808799e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,40422,-0.04737015433482,0.00415407889992887,-0.0555121489786806,-0.0392281596909594,5.26008086658414e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,-0.0865130473087134,0.00759193487564697,-0.101393239664982,-0.0716328549524454,6.08786552265237e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,37628,-0.0553455444464679,0.00485742015754668,-0.0648660879552594,-0.0458250009376764,6.18329519362854e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,-0.0309027041515442,0.00272047600512457,-0.0362348371215884,-0.0255705711815001,8.68465250105756e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,37778,-0.121637235486262,0.0107088874099885,-0.14262665480984,-0.100647816162685,9.21778280296533e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40341,-0.0723688739614006,0.00637922893154085,-0.0848721626672207,-0.0598655852555805,1.02810559989787e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,-0.0353126571661699,0.00311582277892164,-0.0414196698128563,-0.0292056445194835,1.22153510014232e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,40516,-0.0602535679826225,0.00532438997277211,-0.0706893723292558,-0.0498177636359891,1.4067390390558e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,-0.113276203252444,0.0100371770258226,-0.132949070223056,-0.0936033362818315,2.09424532822738e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,40453,-0.0306197464310895,0.00271435388799596,-0.0359398800515616,-0.0252996128106175,2.11102042334053e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,40228,-0.0410390296284174,0.00364055221907026,-0.0481745119777951,-0.0339035472790397,2.31674741495085e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,-0.0399215305078002,0.00354681237099853,-0.0468732827549573,-0.032969778260643,2.80529137028194e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HLA_E,,40341,-0.0316408804222272,0.00281366493911662,-0.0371556637028958,-0.0261260971415586,3.14501766251173e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37572,-0.0793034891446853,0.00705110148325541,-0.0931236480518659,-0.0654833302375047,3.26070395571469e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37901,-0.0915245652218114,0.008145249060342,-0.107489253380082,-0.0755598770635411,3.6373759724031e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,37936,-0.0831047043815131,0.00739673004916217,-0.097602295277871,-0.0686071134851553,3.68498894756493e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,-0.0852734136126273,0.00760944872743308,-0.100187933118396,-0.0703588941068585,4.89088760954705e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,40192,-0.0706236960726409,0.0063083915802904,-0.0829881435700101,-0.0582592485752718,5.53870267922262e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,-0.0614810575523214,0.00550001414451242,-0.0722610852755658,-0.0507010298290771,7.03037748440283e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,37057,-0.0269493034701135,0.00241174358404807,-0.0316763208948478,-0.0222222860453793,7.45175026822939e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,37959,-0.060243166305809,0.00539271701557482,-0.0708128916563356,-0.0496734409552823,7.5466517732688e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,40307,-0.0713698069164749,0.00639162339714053,-0.0838973887748703,-0.0588422250580794,7.65036099134636e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40471,-0.0729389330738828,0.00653894042891358,-0.0857552563145534,-0.0601226098332122,8.68573214041766e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,37848,-0.101327699686337,0.00908837950984708,-0.119140923525637,-0.0835144758470367,9.67307694203911e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,40516,0.0424723915475284,0.0038137729133871,0.0349973966372897,0.0499473864577672,1.06047680263463e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NBN,Nibrin,40044,-0.055421476465995,0.00497696284322767,-0.0651763236387213,-0.0456666292932688,1.07994648531365e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDK,Midkine,40352,-0.0550341976797373,0.0049440840283611,-0.0647246023753251,-0.0453437929841495,1.12721608937004e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.0359749003579351,0.00323410246260959,0.0296360595312203,0.0423137411846499,1.28117220313347e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,-0.0381766108225429,0.00343752773828177,-0.0449141651895751,-0.0314390564555106,1.58122960666321e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,37901,-0.0640195577974794,0.00576868496158855,-0.0753261803221929,-0.0527129352727658,1.70983127961966e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,37671,-0.0763740586522178,0.00688485408938781,-0.0898683726674179,-0.0628797446370177,1.81051740862777e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,40489,0.0497332296117762,0.00448609708678451,0.0409404793216786,0.0585259799018739,1.85970042718152e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,-0.0481641416815314,0.00434438183596017,-0.0566791300800134,-0.0396491532830495,1.86475355400104e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,40341,0.0571250375050268,0.00515406977431914,0.0470230607473613,0.0672270142626924,1.91827888169164e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,-0.0625836000414464,0.00564708834115306,-0.0736518931901064,-0.0515153068927864,1.95230420952782e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37901,-0.0508090143168995,0.00458492141207185,-0.0597954602845603,-0.0418225683492387,2.04161185442795e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,-0.028631272602854,0.00258628325721033,-0.0337003877869862,-0.0235621574187217,2.21700514407593e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,0.0479149647558685,0.0043329020508914,0.0394224767361213,0.0564074527756156,2.53012941458155e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPARC,SPARC,40411,-0.0763296494801242,0.00690551484852257,-0.0898644585832284,-0.06279484037702,2.67268652064615e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,37990,-0.0693029207690072,0.00628584343130448,-0.081623173894364,-0.0569826676436504,3.80414147235269e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,40305,-0.0901857065756461,0.00819190253237934,-0.10624183553911,-0.0741295776121826,4.36491714949454e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,40516,-0.0404244884761766,0.00367398545686223,-0.0476254999716266,-0.0332234769807267,4.66060300956966e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,40489,-0.0439094028803326,0.00399373060966132,-0.0517371148752688,-0.0360816908853965,5.10919870897537e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,37959,-0.0579595591114654,0.0052731239696287,-0.0682948820919377,-0.0476242361309932,5.51665773310576e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39535,-0.0408655999390464,0.00371907673950557,-0.0481549903484774,-0.0335762095296155,5.56650213864287e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,-0.098793139563863,0.00900113125872493,-0.116435356830964,-0.0811509222967622,6.33339442247862e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40359,-0.0332108015525707,0.00302747120115224,-0.0391446451068291,-0.0272769579983124,6.71987757704472e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,-0.073257743129096,0.00668558262918386,-0.0863614850822963,-0.0601540011758956,8.06713472897739e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,-0.0664528699109681,0.00606621843412951,-0.0783426580418619,-0.0545630817800742,8.33740025181043e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,39961,-0.0336355681879761,0.00307978737741074,-0.0396719514477012,-0.0275991849282511,1.14870584580718e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,40502,-0.0566274814890726,0.005185582932195,-0.0667912240361748,-0.0464637389419704,1.15505632698485e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,-0.0422429947294983,0.00386891029567013,-0.0498260589090117,-0.0346599305499848,1.22615866099782e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,40332,-0.0566839089524643,0.00519914896790467,-0.0668742409295574,-0.0464935769753711,1.40377531210738e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40396,0.0903353022393921,0.00828866050443628,0.074089527650697,0.106581076828087,1.46307372515766e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40422,-0.111126648808519,0.0101972892614092,-0.131113335760881,-0.091139961856157,1.47851062478679e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,-0.110002183808992,0.0100960091004535,-0.129790361645881,-0.090214005972103,1.57624570185044e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37959,-0.0555126062425357,0.00509577094214933,-0.0655003172891483,-0.045524895195923,1.60479727996002e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,-0.0765147798110996,0.00703334712681782,-0.0903001401796625,-0.0627294194425367,1.81689381365916e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,40341,-0.0831675922782872,0.00764745569626437,-0.0981566054429654,-0.0681785791136091,1.89074096152788e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,40536,-0.0449801733323158,0.00413799484346645,-0.0530906432255101,-0.0368697034391216,1.99451945561063e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,37900,-0.0872997618895804,0.00802951728104163,-0.103037615760422,-0.0715619080187388,2.03003473933107e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,40042,-0.0629057695185965,0.00579045090904982,-0.0742550533003341,-0.0515564857368588,2.1515623579827e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELN,Elastin,37990,-0.0373795038185892,0.00344078246984008,-0.0441234374594758,-0.0306355701777026,2.22717914310392e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,37671,-0.121143811503121,0.0111666236637343,-0.14303039388404,-0.0992572291222016,2.63500181150601e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,-0.0684590204385685,0.00631887336251099,-0.08084401222909,-0.0560740286480469,3.07053421819523e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,40471,-0.023715002103778,0.00218979590829417,-0.0280070020840346,-0.0194230021235215,3.09127186317194e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37671,-0.0713894399992599,0.00659798810479959,-0.084321496684667,-0.0584573833138527,3.60175141720314e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,40411,0.0298960913568127,0.00276419729051627,0.0244782646674008,0.0353139180462246,3.61252465182507e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,37998,-0.0432379201867884,0.00400286099738983,-0.0510835277416724,-0.0353923126319043,4.35378267961077e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,40042,-0.0399015228047815,0.00369718712235177,-0.047148009564591,-0.0326550360449721,4.65987067376011e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,-0.0674668825895759,0.00625252653117458,-0.0797218345906781,-0.0552119305884737,4.74402231502099e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,40330,-0.038208737720869,0.00354540310381511,-0.0451577278043466,-0.0312597476373914,5.48218130437179e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,-0.0445704071916255,0.00413766097662771,-0.0526802227058158,-0.0364605916774352,6.04063117938373e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,-0.0556253915780366,0.00516543993185811,-0.0657496538444785,-0.0455011293115947,6.24745727274114e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40400,-0.074937664789376,0.00696372481850099,-0.088586565433638,-0.0612887641451141,6.49657776681718e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,-0.114647687051118,0.0106530231048028,-0.135527612336531,-0.0937677617657044,6.69634316572346e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,38013,0.0291203626331163,0.00270608280276199,0.0238164403397028,0.0344242849265298,6.7482601049998e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,37628,-0.0806538139218793,0.00749487991185987,-0.0953437785491247,-0.065963849294634,6.78925015779773e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,39980,-0.0438113670289284,0.00407363202469574,-0.0517956857973321,-0.0358270482605248,6.99111750711959e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39961,-0.0709893554855888,0.0066031150388285,-0.0839314609616926,-0.0580472500094849,7.29886143801688e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,37419,-0.0566114859972074,0.00526514042283606,-0.0669311612259661,-0.0462918107684488,7.51450806754173e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,40044,-0.0631779688856603,0.00587849852727405,-0.0746998259991174,-0.0516561117722032,7.57774500502936e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,39980,-0.102453433492915,0.00953552289690211,-0.121143058370843,-0.0837638086149867,7.82489411271952e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37598,-0.0807722824645506,0.00751586293462636,-0.0955033738164183,-0.0660411911126829,7.92052487299282e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,-0.028771561122671,0.0026795577750548,-0.0340234943617784,-0.0235196278835636,8.38342376824227e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,40471,-0.0832809324687006,0.00775896497692823,-0.09848850382348,-0.0680733611139213,8.73848014469745e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,40305,-0.0947740880948447,0.00884801265346088,-0.112116192895628,-0.0774319832940614,1.11109479311009e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,37934,-0.102125353765489,0.00953228771522898,-0.120808637687337,-0.0834420698436397,1.12484469326311e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,-0.068795711436572,0.00642928214056379,-0.081397104432077,-0.056194318441067,1.29576143212853e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,40228,-0.100881198044228,0.0094308963789564,-0.119365754946982,-0.0823966411414731,1.29866259703612e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40422,0.0215432997284072,0.00201456421934906,0.017594753858483,0.0254918455983313,1.33919597462383e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,40288,-0.0917336991083536,0.00857892243789963,-0.108548387086637,-0.0749190111300703,1.35395227530071e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,-0.082911808760897,0.00775915088962654,-0.0981197445045651,-0.067703873017229,1.51621214166811e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,37987,-0.0253944438927783,0.00237747733580365,-0.0300542994709534,-0.0207345883146031,1.58882231699243e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,0.0214480094587932,0.00201039834447958,0.0175076287036132,0.0253883902139731,1.83189632884997e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,-0.0685719600758773,0.00643702667064869,-0.0811885323503488,-0.0559553878014059,2.07531245333081e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37959,-0.11886589561603,0.0111634801043899,-0.140746316620634,-0.0969854746114254,2.27264649119209e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,38013,-0.033149721008643,0.00311353808912806,-0.039252255663334,-0.027047186353952,2.2895135717547e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37562,-0.0385937728198065,0.00362472200159745,-0.0456982279429375,-0.0314893176966755,2.29824115784838e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40489,-0.0560102260195065,0.00527163258153787,-0.0663426258793208,-0.0456778261596923,2.79329256165239e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,40324,-0.086234253891922,0.00811976304350944,-0.102148989457201,-0.0703195183266435,2.93773300655408e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,40536,-0.0550050645241588,0.00518021327820583,-0.0651582825494423,-0.0448518464988754,2.99262815855857e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39980,-0.0570361120672105,0.00539142467711953,-0.0676033044343648,-0.0464689197000562,4.57221164691243e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40536,0.0268467748100553,0.00254109498809213,0.0218662286333947,0.0318273209867158,5.26592889444324e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,40374,-0.109923530188728,0.0104055207842502,-0.130318350925859,-0.089528709451598,5.3370262963275e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,-0.0220130439090973,0.00208424916337727,-0.0260981722693168,-0.0179279155488779,5.695768578649e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,0.0376156140914503,0.00356261428730471,0.030632890088333,0.0445983380945675,5.89541050397829e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,40295,0.0657554189176175,0.00623505208463097,0.0535347168317408,0.0779761210034943,6.45356733298177e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37598,0.033343383886912,0.00316077736333718,0.0271482602547712,0.0395385075190529,6.50861466359021e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40411,-0.034206062374078,0.00324564516548828,-0.040567526898435,-0.0278445978497209,6.94074375025031e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,37628,-0.092340293787146,0.00876179540496112,-0.10951341278087,-0.0751671747934222,7.2393980072133e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,40411,-0.0259657798678036,0.00246480431223276,-0.0307967963197798,-0.0211347634158274,7.27402967331803e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,37901,-0.0293217887317602,0.00278321056993794,-0.0347768814488385,-0.0238666960146818,7.49386543900574e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,37987,-0.0249632341785778,0.00237141820138493,-0.0296112138532922,-0.0203152545038633,8.18650756159431e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,37990,-0.0300194072941477,0.00285800507533642,-0.0356210972418071,-0.0244177173464883,1.04373069088681e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,-0.073359767318712,0.00698837391991488,-0.0870569802017452,-0.0596625544356788,1.1203339684001e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,37900,-0.0399758052027054,0.00380848650730564,-0.0474404387570244,-0.0325111716483863,1.12646674705877e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C3,Complement C3,37360,-0.0485202027649669,0.00462531599732381,-0.0575858221197216,-0.0394545834102123,1.21585791045338e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,37942,-0.0837197795123812,0.00798436156292147,-0.0993691281757073,-0.0680704308490551,1.26397409452092e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,37671,-0.0581049722924539,0.00554318935466297,-0.0689696234275933,-0.0472403211573144,1.31376176100288e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,39980,-0.0303740837086965,0.0029007932923501,-0.0360596385617027,-0.0246885288556903,1.4289907757014e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,40429,0.0262813100093622,0.00251115493846879,0.0213594463299633,0.031203173688761,1.49977710209174e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40359,-0.0809314448857106,0.00774095779514655,-0.0961037221641979,-0.0657591676072234,1.68201388930435e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,-0.093127559363546,0.00890863310483888,-0.11058848024903,-0.0756666384780618,1.76451645551077e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,40359,-0.0783144707999709,0.00750586742945526,-0.0930259709617032,-0.0636029706382386,2.0998544843379e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37987,0.026530582201499,0.00254210172310677,0.0215480628242097,0.0315131015787883,2.10958108182757e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,37959,-0.0676293392873508,0.00648191278148996,-0.0803338883390711,-0.0549247902356305,2.17610863187391e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,40333,-0.0920764510957367,0.00884362712714049,-0.109409960264932,-0.0747429419265413,2.64732708793679e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40451,-0.0435036460165231,0.00418164985000905,-0.0516996797225408,-0.0353076123105054,2.87831554094297e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,40042,-0.0759491454125877,0.00730504719820093,-0.0902670379210615,-0.0616312529041138,3.10020305371121e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,-0.0661573491839791,0.00636497693063908,-0.0786327039680317,-0.0536819943999265,3.29065995939076e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,37671,-0.0691505750125658,0.00665444355052128,-0.0821932843715875,-0.0561078656535441,3.38410823148582e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,40228,-0.0492012865993588,0.00474201479694289,-0.0584956356013669,-0.0399069375973508,3.85697109869478e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40490,-0.0324539902954547,0.00313050045010615,-0.0385897711776627,-0.0263182094132466,4.20401020027877e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,-0.0581329611714726,0.00561120610576641,-0.0691309251387748,-0.0471349972041705,4.53884274446918e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,40489,0.0346077647972125,0.00334354549962812,0.0280544156179414,0.0411611139764836,4.98513726672864e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0386951184027662,0.00373914813951983,0.0313663880493073,0.046023848756225,5.09588100845248e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37959,-0.0727161561486036,0.0070303379718502,-0.0864956185734299,-0.0589366937237772,5.56879944556617e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,40359,-0.0540883408896526,0.00523101314661726,-0.0643411266570224,-0.0438355551222828,5.5773995440246e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40341,-0.112745798349804,0.0109057242513652,-0.13412101788248,-0.0913705788171285,5.67852819675462e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,37671,-0.0549678749697298,0.00531892843773553,-0.0653929747076915,-0.0445427752317682,6.12864947713204e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,-0.0672590552223789,0.00651642572858406,-0.0800312496504036,-0.0544868607943541,6.99998627812447e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,-0.0787564216672432,0.00765298810768104,-0.093756278358298,-0.0637565649761883,9.2978445540085e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,39961,-0.0721219835169177,0.0070170772488193,-0.0858754549246035,-0.0583685121092319,1.06196407775361e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,37959,-0.0552344144865478,0.00537319798990162,-0.065765882546755,-0.0447029464263407,1.07365035058036e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37572,-0.0817311835148817,0.00795089044564218,-0.0973149287883404,-0.066147438241423,1.08155798947097e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37608,-0.0570294109592736,0.00554855095880999,-0.0679045708385412,-0.0461542510800061,1.09489164792246e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,38013,-0.0421108254520987,0.00409786620163314,-0.0501426432072997,-0.0340790076968978,1.11022774055936e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37557,-0.0851510973287554,0.00828984018300435,-0.101399184087444,-0.0689030105700669,1.17172141615816e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,40147,-0.0464436177271384,0.00453193299565886,-0.0553262063986298,-0.0375610290556471,1.44267791206265e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,-0.037968342059002,0.00370879399178993,-0.0452375782829102,-0.0306991058350937,1.60395034512401e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,40214,-0.022992699996421,0.00224769850359886,-0.0273981890634748,-0.0185872109293672,1.74562226850491e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,-0.100351849042673,0.00981066756824625,-0.119580757476436,-0.0811229406089104,1.75377808883679e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,37671,-0.0517934848968863,0.00506230134967001,-0.0617155955422395,-0.0418713742515331,1.77300749532498e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,40309,-0.0344385951491287,0.00336935676556958,-0.0410425344096451,-0.0278346558886123,1.89913506354659e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,40341,-0.033547911757466,0.00328464605342109,-0.0399858180221714,-0.0271100054927607,2.05145676283614e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39865,-0.0377341144292304,0.00369527441335688,-0.0449768522794099,-0.030491376579051,2.10734427713736e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,37987,-0.046915382236674,0.00459337202486778,-0.0559183914054148,-0.0379123730679331,2.11064565342132e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RETN,Resistin,40283,-0.04135708613677,0.00405127167467672,-0.0492975786191364,-0.0334165936544037,2.16355327641486e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37959,-0.0683068281345486,0.00669204027555115,-0.0814232270746289,-0.0551904291944684,2.25754194096612e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,-0.0447805764929695,0.00439428453184127,-0.0533933741753784,-0.0361677788105606,2.68781082788617e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,-0.0854245486074128,0.00838921324464183,-0.101867406566911,-0.0689816906479148,2.91367227614599e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,40203,-0.0525563916267817,0.00516825270743289,-0.0626861669333502,-0.0424266163202133,3.23676317031127e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37687,-0.0640878128309292,0.00630443834375786,-0.0764445119846946,-0.0517311136771638,3.46796987089042e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,40483,-0.0691628968105224,0.0068061095041489,-0.0825028714386543,-0.0558229221823906,3.47286777943572e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,40341,-0.0827926376692478,0.00815125955087672,-0.0987691063889662,-0.0668161689495294,3.65422551053338e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,-0.0311294797513158,0.00306661588259669,-0.0371400468812054,-0.0251189126214263,4.01976888254916e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,40422,-0.130769869087822,0.0128925001192492,-0.156039169321551,-0.105500568854094,4.20783816826064e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,-0.0288115430951522,0.002843244055068,-0.0343843014430855,-0.023238784747219,4.78827019394058e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37993,-0.0192612099201454,0.00190219389916101,-0.022989509962501,-0.0155329098777898,5.16926785160031e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,39961,-0.0664861201057473,0.00656969864763387,-0.0793627294551097,-0.0536095107563849,5.34104395721123e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,40411,-0.0679146007847738,0.00671135095355908,-0.0810688486537496,-0.054760352915798,5.35618549829761e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,37901,-0.066738772141317,0.00659529536384639,-0.079665551054456,-0.0538119932281781,5.536704087718e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,-0.0577546630413673,0.00571391054540305,-0.0689539277103573,-0.0465553983723773,6.03217372013791e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,37942,-0.0563187761188793,0.00557085805607777,-0.0672376579087917,-0.0453998943289668,6.09972185646721e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,40472,-0.0229943900042712,0.00227850254189019,-0.0274602549863759,-0.0185285250221664,7.07226803703006e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,40516,-0.0449461607730992,0.00445606807810979,-0.0536800542061944,-0.036212267340004,7.46475520432595e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37598,-0.0964558510770967,0.00956787491496504,-0.115208885910428,-0.0777028162437653,8.16390854601131e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,40228,-0.0799193452398731,0.00793348229998261,-0.095468970547839,-0.0643697199319072,8.52407777615459e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,39961,-0.0611807197652996,0.00607760972133589,-0.0730928348191179,-0.0492686047114813,9.18411474377126e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,-0.0622786093405956,0.00619238552889855,-0.0744156849772368,-0.0501415337039544,1.00846239231924e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,39980,-0.0585050075300921,0.00581759637791373,-0.0699074964308029,-0.0471025186293812,1.01590327550117e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,37671,-0.0418401706169526,0.00415964685424252,-0.0499930784512679,-0.0336872627826372,1.02470578436628e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,-0.0687045097485866,0.00683304797008712,-0.0820972837699574,-0.0553117357272159,1.03204187350924e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,37598,-0.0412602871952634,0.00410289353825319,-0.0493019585302396,-0.0332186158602871,1.04881226837019e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,40341,-0.0479570044955652,0.00477049740323335,-0.0573071794059026,-0.0386068295852279,1.05086549229563e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37901,-0.0632745348187496,0.00629482211315451,-0.0756123861605324,-0.0509366834769667,1.09315809622739e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37671,-0.0411727606006572,0.00410846445276197,-0.0492253509280707,-0.0331201702732438,1.48894615251017e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39980,-0.0907838079684775,0.00906192027120549,-0.10854517170004,-0.0730224442369147,1.49542786792979e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37998,0.0207944815415406,0.00207521790038809,0.0167270544567799,0.0248619086263012,1.49794527639549e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37598,-0.0880911590436489,0.00879476570685231,-0.105328899829079,-0.0708534182582184,1.56933322114712e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,37628,-0.0722380496425835,0.00721406535770209,-0.0863776177436796,-0.0580984815414874,1.61360749234711e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37598,-0.0868818959110733,0.00868153673146631,-0.103897707904747,-0.0698660839173993,1.71168023800981e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,0.0194588069283112,0.00194528553613168,0.0156460472774931,0.0232715665791293,1.734608360461e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39980,-0.0444287452892005,0.00444267750490397,-0.0531363931988123,-0.0357210973795887,1.78670970038207e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,-0.0890322521849721,0.00890320759884072,-0.1064825390787,-0.0715819652912443,1.84002411259335e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,-0.0258717067298046,0.00259007474817726,-0.030948253236232,-0.0207951602233771,1.99947533331644e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,40335,-0.0438931585372663,0.0043946694971472,-0.0525067107516748,-0.0352796063228578,2.02053138246227e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,40159,0.036913041723324,0.00369597254276493,0.0296689355395048,0.0441571479071433,2.03324715521299e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39980,-0.0393872376907539,0.00394540677677647,-0.0471202349732358,-0.031654240408272,2.12684585801324e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,37671,0.0527359443550444,0.00528420528053099,0.0423789020052037,0.0630929867048852,2.25759043259548e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,-0.0565780279422876,0.00567257126717795,-0.0676962676259564,-0.0454597882586188,2.32810573394802e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,40009,-0.0504137420827956,0.00505541009334228,-0.0603223458657464,-0.0405051382998447,2.36959949813433e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,37942,-0.060862209521069,0.00610453100096007,-0.0728270902829508,-0.0488973287591873,2.4833931122845e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",38013,-0.0159881294600259,0.00160455214546479,-0.0191330516651369,-0.0128432072549149,2.62834236226499e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,-0.0684268454856531,0.00686901057049479,-0.0818901062038229,-0.0549635847674834,2.7120036124084e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,-0.0409607237007909,0.00411661193415523,-0.0490292830917351,-0.0328921643098466,2.94671442203522e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,40471,-0.062575885857297,0.00628910884030215,-0.0749025391842892,-0.0502492325303047,2.9493287734021e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37990,-0.104346153500204,0.0104842413296909,-0.124895266506399,-0.0837970404940101,2.95097080879556e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37959,-0.0604609115690845,0.00609033404838515,-0.0723979663039194,-0.0485238568342496,3.79921072677144e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,40357,-0.0248133330998945,0.00250024579065208,-0.0297138148495725,-0.0199128513502164,3.8085821705047e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,40403,0.0295253335146684,0.00297585542754073,0.0236926568766885,0.0353580101526482,3.9117658205399e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,-0.0560897462304567,0.00565323598236965,-0.0671700887559012,-0.0450094037050122,3.9251586123353e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,-0.0302050889105089,0.00304670254863534,-0.0361766259058342,-0.0242335519151836,4.21586723482616e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,-0.0557766635489699,0.00562436550943825,-0.0668004199474689,-0.0447529071504709,4.21609023273597e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,-0.063484985947082,0.00641065790884344,-0.0760498754484151,-0.0509200964457489,4.72623266346254e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40332,-0.033278966442495,0.00336593795930034,-0.0398762048427237,-0.0266817280422663,5.52419291278445e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,40305,-0.057689366571378,0.00583708775317799,-0.0691300585676069,-0.0462486745751492,5.73436816448631e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,40411,-0.0691961565747147,0.00700195433597686,-0.0829199870732294,-0.0554723260762,5.77642843979379e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,40376,-0.0652641484325887,0.00661035677719004,-0.0782204477158812,-0.0523078491492963,6.34233662376863e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,-0.077165645573365,0.0078233002843105,-0.0924993141306135,-0.0618319770161164,6.96694471071451e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,37598,-0.0449258402509779,0.00455392720613837,-0.0538515375750091,-0.0360001429269467,7.06746849957618e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,37705,-0.0217147948349675,0.00220169027196295,-0.0260301077680148,-0.0173994819019201,7.23465482213191e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,-0.104082447811153,0.0105554650773179,-0.124771159362696,-0.0833937362596097,7.37288221157662e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,40330,-0.0188171823895556,0.00190897376684605,-0.0225587709725739,-0.0150755938065373,7.4191816547287e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,37572,-0.0396081250875734,0.00402238080960479,-0.0474919914743988,-0.031724258700748,8.47658830148055e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,-0.0823612451932121,0.00836697842907149,-0.0987605229141922,-0.065961967472232,8.51740222586948e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37671,-0.0217208309783196,0.00220706519487294,-0.0260466787602705,-0.0173949831963686,8.93177382146837e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,40270,-0.0758372754662132,0.00771069413585588,-0.0909502359724908,-0.0607243149599357,9.21653933624539e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,-0.0464523749474064,0.00472344457585358,-0.0557103263160795,-0.0371944235787334,9.2822014308352e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,37900,-0.034274781858246,0.00348493324183574,-0.0411052510122441,-0.027444312704248,9.48184729251639e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,40044,-0.0760692522702388,0.00774999221608686,-0.091259237013769,-0.0608792675267086,1.12442461328138e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,-0.100201728700019,0.0102101446379246,-0.120213612190351,-0.0801898452096868,1.13750066574313e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,-0.0510329456205286,0.00520409466684597,-0.0612329711675467,-0.0408329200735105,1.25950877674346e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,40324,-0.0984251824139669,0.0100491967533747,-0.118121608050581,-0.0787287567773524,1.37987379741048e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,37671,-0.0708575402027224,0.00724339687935475,-0.0850545980862577,-0.0566604823191871,1.59829662513468e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,-0.0508243257399874,0.00520227401473279,-0.0610207828088636,-0.0406278686711111,1.81248306148005e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,-0.141044397082865,0.0144393846558022,-0.169345591008238,-0.112743203157493,1.83392090203549e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,40516,-0.0485648038397261,0.00498611096592649,-0.058337581332942,-0.0387920263465101,2.34677803212834e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,37598,-0.0416545916295606,0.00427801951360361,-0.0500395098762236,-0.0332696733828975,2.49698882958279e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,37970,-0.043739767178738,0.00449509349187157,-0.0525501504228062,-0.0349293839346697,2.64358489106021e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,-0.080114210012411,0.00823915676421287,-0.0962629572702682,-0.0639654627545538,2.82990120990904e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,40422,-0.0876886372703559,0.00902183629813887,-0.105371436414708,-0.0700058381260037,2.86739754778394e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,40396,-0.0546052859260014,0.00561917690730254,-0.0656188726643144,-0.0435916991876884,2.92270304920385e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,40228,-0.0753201895162676,0.00776017350294124,-0.0905301295820324,-0.0601102494505028,3.28013074454649e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,40341,-0.0354605980300625,0.00365491063771199,-0.042624222879978,-0.028296973180147,3.40091230349537e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40422,-0.0363254488255016,0.00374616312938101,-0.0436679285590884,-0.0289829690919148,3.5845631898898e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,40307,-0.0652603162126133,0.00673408072355975,-0.0784591144307904,-0.0520615179944362,3.79141493964887e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,37562,-0.0565461282752086,0.00583501045939748,-0.0679827487756277,-0.0451095077747896,3.91301292585017e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,37572,-0.124001196770429,0.0128003697128513,-0.149089921407618,-0.0989124721332407,4.0487780114634e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,-0.0846373483451353,0.00874307193560079,-0.101773769338913,-0.0675009273513578,4.20116229634689e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,40536,0.0287511107412593,0.00297221953738631,0.0229255604479821,0.0345766610345365,4.49777824539628e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,40330,-0.036526756506966,0.0037760643135714,-0.0439278425615659,-0.029125670452366,4.50779973255519e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37598,-0.0545036566649466,0.00563459561343614,-0.0655474640672814,-0.0434598492626118,4.64935402930856e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,40471,0.0284093815304122,0.00293876308122791,0.0226494058912055,0.0341693571696189,4.77771494962194e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40328,-0.0343248179324604,0.0035521909888425,-0.0412871122705918,-0.0273625235943292,4.97904938071903e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,37901,-0.0726781054356732,0.00751993067401464,-0.0874171695567419,-0.0579390413146045,5.02052448737874e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,-0.0796792912909436,0.00824836475048248,-0.0958460862018892,-0.0635124963799979,5.27064529190243e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,-0.0533708644632246,0.0055330917210946,-0.06421572423657,-0.0425260046898791,5.88467702563769e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,40341,0.0450086513589907,0.0046682277479599,0.0358589249729892,0.0541583777449921,6.13331845487604e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,-0.0384513536420845,0.00398888564101537,-0.0462695694984747,-0.0306331377856944,6.26149342374049e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,40335,0.0166844909254278,0.00173114081331529,0.0132914549313299,0.0200775269195258,6.35290755556032e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,40341,-0.0307932805588744,0.00320534609010323,-0.0370757588954767,-0.0245108022222721,8.57322617199361e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,40434,-0.0564389605279769,0.00587885612152008,-0.0679615185261562,-0.0449164025297975,9.12275890539364e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,-0.0442053657385735,0.00460895900213709,-0.0532389253827622,-0.0351718060943847,9.96092690512029e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,37973,0.0691434954559019,0.00721483584243903,0.0550024172047214,0.0832845737070824,1.09920322647283e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,-0.0476149935852439,0.00497243390953046,-0.0573609640479236,-0.0378690231225642,1.15493210316174e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,-0.0575948419740767,0.00602232138251458,-0.0693985918838053,-0.0457910920643481,1.30487187975665e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,40403,-0.0285280189365698,0.00298501259875388,-0.0343786436301274,-0.0226773942430122,1.38362940833994e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,37562,-0.0624145652373157,0.00653223380020686,-0.0752177434857211,-0.0496113869889102,1.45467415472592e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,39925,-0.0416838753663676,0.00436684511495705,-0.0502428917916835,-0.0331248589410518,1.55216027823372e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,37572,-0.074814735443799,0.00784002113815824,-0.0901811768745892,-0.0594482940130089,1.63472499634155e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37671,-0.0658387209017865,0.00690953292152625,-0.079381405427978,-0.0522960363755951,1.86676454343034e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37990,-0.0438714665141786,0.00460602546845189,-0.0528992764323443,-0.0348436565960129,1.93015388274219e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,-0.0282189822229391,0.00296708673146182,-0.0340344722166043,-0.022403492229274,2.15777112596206e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,40042,-0.0457922837004442,0.00481704430030146,-0.055233690529035,-0.0363508768718533,2.25736232369267e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,-0.0711737038654843,0.00749292760986839,-0.0858598419808264,-0.0564875657501422,2.41829664281297e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,-0.0716529831254291,0.00754544467229485,-0.0864420546831271,-0.0568639115677312,2.53908119636724e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,-0.0507330049470332,0.00534680612304297,-0.0612127449481975,-0.040253264945869,2.67623304513221e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,40303,-0.0253335425309664,0.00267028268515216,-0.0305672965938646,-0.0200997884680682,2.70263960906359e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,37810,0.0994523201940804,0.0104809188982081,0.0789097191535924,0.119994921234568,2.72482028013796e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37990,-0.0836877042442308,0.00882005281697808,-0.100975007765508,-0.0664004007229537,2.73349798687401e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37959,-0.0569436955749279,0.00600293506226075,-0.068709448296959,-0.0451779428528968,2.79687629863445e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,37572,-0.0455600963609689,0.00480308844664757,-0.0549741497163981,-0.0361460430055397,2.81994108664875e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,40516,-0.0452847786076983,0.0047767248122622,-0.0546471592397322,-0.0359223979756644,2.8818542988841e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,40332,0.0424919465282793,0.00448552907254875,0.0337003095460837,0.0512835835104748,3.09044896848407e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,37562,-0.0622309501214482,0.00657456362633419,-0.0751170948290632,-0.0493448054138332,3.41693490898572e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,-0.0413787461294709,0.00437494643726545,-0.0499536411465112,-0.0328038511124307,3.65936426638432e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,40309,-0.0360686908296665,0.00381536766349544,-0.0435468114501176,-0.0285905702092155,3.72418948540162e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,40312,-0.0565337872656757,0.00598052452875241,-0.0682556153420305,-0.044811959189321,3.7435477467675e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,-0.0962794312410844,0.0101968120852038,-0.116265182928084,-0.076293679554085,4.25740325906074e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,37998,-0.0765834972139805,0.00811169586697669,-0.0924824211132548,-0.0606845733147062,4.28180989742998e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,-0.0324514897827033,0.0034405410117716,-0.0391949501657757,-0.025708029399631,4.66949997957068e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,-0.0407076878184695,0.00431764298857724,-0.0491702680760809,-0.0322451075608581,4.72769452673501e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,37959,-0.0691122118106855,0.00733985514417731,-0.083498327893273,-0.054726095728098,5.43315709066799e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,37900,-0.0585261513255456,0.00621711057407841,-0.0707116880507393,-0.0463406146003519,5.55602554535908e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,40359,-0.0309431750390401,0.00328828343537132,-0.0373882105723679,-0.0244981395057123,5.61804929214432e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,37671,-0.0997174384420616,0.0105968647360769,-0.120487293324772,-0.0789475835593509,5.76491294219446e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,37977,0.0309782642880601,0.00329282205257768,0.0245243330650078,0.0374321955111123,5.8700862255094e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,40228,0.023136707210382,0.00245999544839206,0.0183151161315335,0.0279582982892304,5.89330328298311e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,-0.0270772895677336,0.00287918143467946,-0.0327204851797054,-0.0214340939557619,5.93094299195451e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,0.0245999141882898,0.00261767079619758,0.0194692794277426,0.0297305489488371,6.46386044615251e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,-0.0710810518730148,0.00756875792494447,-0.085915817405906,-0.0562462863401236,6.70910207022568e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,37150,0.102266393363627,0.0108996129807035,0.0809031519214477,0.123629634805805,7.5201134837401e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,-0.0566841300936452,0.00605617482270098,-0.0685542327461391,-0.0448140274411513,9.23564657939897e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40357,-0.0460524919104585,0.00492268965659646,-0.0557009636373875,-0.0364040201835294,9.43792911486673e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,40379,0.0219272758632274,0.00234592738323429,0.0173292581920882,0.0265252935343666,1.01922268094065e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,40305,-0.0818597092938645,0.00875966440038208,-0.0990286515186134,-0.0646907670691157,1.03798679524907e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,40516,-0.0310183863236287,0.00332447978617712,-0.0375343667045358,-0.0245024059427215,1.19058706090679e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,-0.0709913876896527,0.00761658966174183,-0.0859199034266667,-0.0560628719526387,1.30905748666114e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0235751639926328,0.00253150550307123,0.0186134132066132,0.0285369147786524,1.40409247148127e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,-0.0847106188833974,0.00910025783164617,-0.102547124233424,-0.0668741135333709,1.49231709602016e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37942,-0.0274961631941252,0.00295554865422071,-0.0332890385563978,-0.0217032878318526,1.56930822431789e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,40376,-0.0836884111767904,0.00900057707590344,-0.101329542245561,-0.0660472801080196,1.61120516041324e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,40332,-0.0226243031691539,0.00243352488570702,-0.0273940119451396,-0.0178545943931681,1.62976147176267e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VASN,Vasorin,40116,0.0249472334488683,0.00268650508232918,0.0196816834875032,0.0302127834102335,1.80577251563445e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPART,Spartin,37671,-0.0703551862688349,0.00757871106030881,-0.0852094599470401,-0.0555009125906296,1.8964533047005e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,-0.0450262148485584,0.00485170880802896,-0.0545355641122951,-0.0355168655848216,1.95345049437176e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.0219891331604638,0.00237027461570466,0.0173433949136827,0.0266348714072449,1.96136715832983e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,-0.0749115641231926,0.00807348200834363,-0.0907355888595461,-0.0590875393868391,1.97381809094339e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,37441,-0.0651847749997477,0.00702692324960623,-0.0789575445689759,-0.0514120054305195,2.0263165138494e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,-0.0812347768865515,0.0087584502778545,-0.0984013394311463,-0.0640682143419566,2.04308746744971e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37951,-0.0614968743852631,0.00666024596188926,-0.074550956470566,-0.0484427922999601,3.00656663418228e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,-0.0883709514689629,0.00957291230017057,-0.107133859577297,-0.0696080433606286,3.07511915595605e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,-0.0362427159936132,0.00392802824531164,-0.043941651354424,-0.0285437806328024,3.19900406682536e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.0348026262916704,0.00377342756345707,0.0274067082672946,0.0421985443160463,3.24941010164025e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,40287,-0.0800041615256907,0.00869314418856927,-0.0970427241352864,-0.0629655989160949,3.9023122021424e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,38013,-0.0589317871075101,0.00640379268297276,-0.0714832207661367,-0.0463803534488835,3.99656610610469e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39836,-0.108569662272779,0.0118018839506652,-0.131701354816083,-0.0854379697294753,4.05503412514448e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,37942,-0.0833878218657421,0.00907283889682459,-0.101170586103518,-0.0656050576279659,4.45662067639427e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,40396,0.0410240923163657,0.00446582847659016,0.032271068502249,0.0497771161304824,4.55962351192374e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,40536,-0.0502346294010072,0.00547119504190168,-0.0609581716831345,-0.0395110871188799,4.75147026350163e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,-0.0987557532292348,0.0107556611077105,-0.119836849000347,-0.0776746574581223,4.75213935735538e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37928,-0.0367107557691142,0.00399768540442279,-0.0445462191617828,-0.0288752923764455,4.79578671170679e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39961,-0.0597270934442014,0.00650771549660097,-0.0724822158175393,-0.0469719710708635,4.94018370370434e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,40332,-0.0812037524522864,0.00886806431611362,-0.0985851585118691,-0.0638223463927037,5.98079128961333e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37598,-0.109129342431843,0.0119155951136641,-0.132483908854625,-0.0857747760090614,6.02966716667024e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,39961,-0.0553303823682262,0.00604344703585108,-0.0671755385584943,-0.0434852261779581,6.07701329378803e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,40332,-0.0478109351842662,0.0052322930954372,-0.0580662296513231,-0.0375556407172093,7.13776356331087e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,39980,-0.0339575787694177,0.00371767227465329,-0.0412442164277381,-0.0266709411110972,7.3943858472041e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,40516,0.00771116447376962,0.000845851205773343,0.00605329611045386,0.00936903283708537,8.66208423578516e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,39980,-0.0864338179728489,0.00948134489159507,-0.105017253960375,-0.0678503819853226,8.7153496753688e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40305,-0.0288657145639697,0.00316737232111649,-0.035073764313358,-0.0226576648145814,8.91651684606646e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,37642,-0.0917000248570422,0.0100655179864451,-0.111428440110475,-0.0719716096036099,9.38423271823593e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,39759,-0.0274925636653074,0.00301900017930267,-0.0334098040167406,-0.0215753233138741,9.540264780002e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,40044,-0.0819188458201515,0.00900551619726563,-0.0995696575667921,-0.0642680340735108,1.04330863594276e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,37942,-0.121512131484461,0.0133559127095915,-0.14768972039526,-0.0953345425736613,1.04728854826391e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,40310,-0.0414622708077876,0.00456087326729266,-0.0504015824116812,-0.0325229592038939,1.09669271689391e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,-0.102983554637175,0.0113313458824733,-0.125192992566823,-0.0807741167075273,1.12194457698697e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,39980,-0.0382597190522893,0.00421219939722865,-0.0465156298708575,-0.0300038082337212,1.18040334802707e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37562,-0.0604732208542364,0.00665713318937377,-0.073521201905409,-0.0474252398030639,1.19504394020941e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,0.103637017905474,0.0114248770876806,0.08124425881362,0.126029776997328,1.31371558026114e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,40192,0.0450720926966707,0.00496930956688185,0.0353322459455823,0.0548119394477592,1.32706331322887e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40422,-0.022922190175959,0.00252929744728056,-0.0278796131726288,-0.0179647671792891,1.41782478755953e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,40203,-0.040373954292227,0.00445595926518971,-0.0491076344519988,-0.0316402741324552,1.44616329980291e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,37901,-0.0911268269166503,0.0100617410813738,-0.110847839436143,-0.0714058143971577,1.52662381038269e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,-0.083922046780498,0.00927400396384591,-0.102099094549636,-0.06574499901136,1.60562888857664e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,37942,-0.0946773574453633,0.0104713622091123,-0.115201227375223,-0.0741534875155033,1.75268430558207e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,40341,0.0229739358727471,0.00254364149556371,0.0179883985414422,0.0279594732040519,1.87736638933279e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37628,-0.049680878887594,0.00550045121933267,-0.060461763277486,-0.0388999944977019,1.91482604946595e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,-0.0315841170427906,0.00349889719202875,-0.0384419555391669,-0.0247262785464142,2.00970591622188e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,-0.0593230949779597,0.00657253958075476,-0.072205272556239,-0.0464409173996804,2.02785342527167e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,37628,-0.0601986032190134,0.006681539497216,-0.0732944206335568,-0.04710278580447,2.34754277208836e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,37959,-0.0426287364587018,0.00473313879772508,-0.051905688502243,-0.0333517844151606,2.41017827805241e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,40341,-0.062625990516005,0.00695545985193823,-0.0762586918258039,-0.048993289206206,2.42185208686623e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37950,-0.0175395051330387,0.00194771248615759,-0.0213570216059075,-0.0137219886601698,2.4380366667235e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,37541,-0.0346314158299993,0.00384789427470809,-0.0421732886084272,-0.0270895430515715,2.56284614015164e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWC2,Brorin,40167,-0.0341970379958352,0.00380084874635884,-0.0416467015386985,-0.0267473744529719,2.57528027783214e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,-0.036419226755584,0.00404817689930123,-0.0443536534782144,-0.0284848000329535,2.58899532015535e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,37959,-0.0593630005458266,0.00659993206168964,-0.0722988673867383,-0.0464271337049149,2.68571194328216e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,0.0288571940514852,0.00321075768068115,0.0225641089973501,0.0351502791056202,2.80535351222839e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAX,Protein max,39961,-0.0915835740915103,0.0102207462910933,-0.111616236822053,-0.0715509113609674,3.59213822177742e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,40516,-0.0553735468690509,0.00618049890740608,-0.0674873247275668,-0.043259769010535,3.6166588185463e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,37562,-0.0412547342657584,0.00460363751700378,-0.0502778637990858,-0.032231604732431,3.63670745938551e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,40359,-0.0212182982145622,0.00237012671180893,-0.0258637465697077,-0.0165728498594167,3.85651600455748e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37628,-0.0819100714599761,0.00914877467443645,-0.0998416698218715,-0.0639784730980806,3.91368533328245e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37959,-0.103606792178218,0.0116049267896106,-0.126352448685855,-0.0808611356705814,4.89871212917385e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,-0.0332497329755322,0.00372530912720996,-0.0405513388648637,-0.0259481270862007,4.92903109780224e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40333,-0.0845497046157596,0.00948500208198519,-0.103140308696451,-0.0659591005350686,5.44643307393661e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,40332,-0.0642800274677769,0.00721613547208953,-0.0784236529930723,-0.0501364019424814,5.75933325326894e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37671,-0.0477156974075079,0.00535526107378029,-0.0582120091121173,-0.0372193857028986,5.76056748314664e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,40471,0.0202765262075026,0.00227679435983104,0.0158140092622338,0.0247390431527715,5.86290869120472e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,-0.0860098650466809,0.00966158447076432,-0.104946570609379,-0.0670731594839828,6.06802256774602e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40305,0.0547632854842952,0.00615995852576909,0.0426897667737878,0.0668368041948026,6.74563146011161e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40359,-0.0589590580083273,0.00663835780394917,-0.0719702393040676,-0.0459478767125869,7.28495700728133e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,40471,-0.029567366100947,0.00333407035109771,-0.0361021439890985,-0.0230325882127955,8.20088341840129e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,37900,-0.0278154501772308,0.00313605025233645,-0.0339621086718103,-0.0216687916826514,8.25767415588983e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40411,-0.0531393088833104,0.00599716512304367,-0.064893752524476,-0.0413848652421448,8.77309397919207e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,37901,-0.0591046555054276,0.0066716406889917,-0.0721810712558513,-0.0460282397550039,9.06795506826865e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,-0.0832454459639002,0.00941447422669575,-0.101697815448224,-0.0647930764795766,1.0347035297987e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,40332,-0.0289711360133115,0.0032787482436551,-0.0353974825708755,-0.0225447894557475,1.09396555232383e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,37671,-0.0599287559014564,0.0067888625418739,-0.0732349264835292,-0.0466225853193835,1.20353534090895e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37598,-0.0798875774136707,0.00905384971073185,-0.0976331228467051,-0.0621420319806363,1.24685352824731e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,40433,-0.0514407744952878,0.00583454058214361,-0.0628764740362893,-0.0400050749542863,1.29965168141051e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,40436,-0.0344179126044711,0.00390442156810371,-0.0420705788779544,-0.0267652463309878,1.31685148317802e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,-0.062326890348785,0.00710739371027184,-0.0762573820209178,-0.0483963986766522,1.97638581659111e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,40228,0.0363689941948544,0.00415238094024801,0.0282303275519683,0.0445076608377405,2.17494560968356e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,40359,-0.108322578665156,0.0123983189805354,-0.132623283867005,-0.0840218734633066,2.63175210947009e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37990,-0.0407546869626579,0.00466480447527877,-0.0498977037342043,-0.0316116701911115,2.68079889418915e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37959,-0.0321441002859066,0.00367964367073466,-0.0393562018805465,-0.0249319986912666,2.70463971174697e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37901,-0.0503952011233679,0.00577100058065624,-0.0617063622614541,-0.0390840399852817,2.78234187347339e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,-0.0537557586837118,0.00616135740860612,-0.0658320192045798,-0.0416794981628438,2.92820397609396e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,40341,-0.0576186637120263,0.00660508409922348,-0.0705646285465043,-0.0446726988775482,2.96391390802752e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,40228,-0.0861347770296184,0.00988257986586068,-0.105504633566705,-0.0667649204925315,3.16970174929458e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,37628,0.0362697031067152,0.00416402751341283,0.028108209180426,0.0444311970330043,3.39033025474808e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,37987,-0.0583486663741695,0.00670757339802018,-0.071495510234289,-0.0452018225140499,3.73313072314055e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,37900,-0.0595009419602132,0.00686491417804128,-0.0729561737491741,-0.0460457101712523,4.92182247280375e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,40185,-0.0491011099022356,0.00567571011810807,-0.0602255017337274,-0.0379767180707438,5.58714265717553e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,39877,-0.0720572993849793,0.00833205949105255,-0.0883881359874423,-0.0557264627825163,5.74050699336271e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,37998,-0.070020655088454,0.0081024367773443,-0.0859014311720488,-0.0541398790048592,6.14107818880318e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,40536,0.0249064076659899,0.00288339774211092,0.0192549480914525,0.0305578672405273,6.25756356255358e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40305,-0.0473961516061637,0.0054888420086255,-0.0581542819430697,-0.0366380212692577,6.42404001258013e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39980,-0.0395706158582366,0.00458416554428444,-0.0485555803250342,-0.0305856513914391,6.60513150842734e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,-0.0900049279500674,0.0104255825218427,-0.110439069692879,-0.0695707862072556,6.64710676722979e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,40442,-0.0589886465178312,0.00683812006891168,-0.072391361852898,-0.0455859311827643,6.91548341156951e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,37628,-0.0350274268983869,0.00406003963309386,-0.0429851045792509,-0.027069749217523,6.99107297595372e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,37987,-0.076686982104699,0.00889564448117194,-0.094122445287796,-0.059251518921602,7.38445984593173e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,38013,-0.0158233276212154,0.00183799178951468,-0.0194257915286642,-0.0122208637137666,8.17243443342142e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,37942,-0.0591120218309516,0.00687132891087909,-0.0725798264962746,-0.0456442171656285,8.63786124681773e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,37942,-0.0185778671544931,0.00216041754312129,-0.0228122855390108,-0.0143434487699753,8.90418379289087e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37598,-0.0768072329854504,0.00893702751647815,-0.0943238069177476,-0.0592906590531533,9.3179085116324e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,40261,-0.0653825834143649,0.00760990830026644,-0.0802980036828871,-0.0504671631458427,9.35379006453775e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,37671,-0.0480838003583344,0.00559906372277783,-0.059057965254979,-0.0371096354616899,9.84649926119425e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37942,-0.0446991771524191,0.00520929532998463,-0.054909395999189,-0.0344889583056492,1.04546535107765e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,40422,-0.0568686575546102,0.00663016955242143,-0.0698637898773562,-0.0438735252318641,1.05969392926372e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,37721,-0.0212328227302534,0.00247527972737183,-0.0260843709959022,-0.0163812744646046,1.07205950858571e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37990,0.0275209343765643,0.00320902618347211,0.021231243056959,0.0338106256961696,1.08706560416663e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,37959,-0.0641903562597484,0.00748482523999003,-0.0788606137301288,-0.0495200987893679,1.08765248922165e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39961,-0.0504155071621308,0.00588754653833435,-0.0619550983772661,-0.0388759159469955,1.20093939790913e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,37942,-0.0384136224353487,0.00449445925353727,-0.0472227625722818,-0.0296044822984157,1.39926081286362e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37671,-0.0690771122451454,0.00808262413821069,-0.0849190555560384,-0.0532351689342525,1.40835584029232e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,37942,0.0341333282281134,0.00399511091720192,0.0263029108303976,0.0419637456258291,1.43723806675056e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,37598,-0.0282991131330505,0.00331261494888326,-0.0347918384328617,-0.0218063878332393,1.45277525171548e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,-0.0172947090877005,0.00202791112806129,-0.0212694148987006,-0.0133200032767003,1.61882496219528e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,40374,-0.0246515319019827,0.00289302788423364,-0.0303218665550806,-0.0189811972488847,1.7215696429228e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,-0.0359667713647004,0.00422822241890193,-0.0442540873057481,-0.0276794554236526,1.98742963558476e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,40250,-0.0238343474607696,0.00280526896393258,-0.0293326746300774,-0.0183360202914617,2.13021545719613e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,40471,0.0246830953952308,0.00290739732476616,0.0189845966386891,0.0303815941517724,2.25004889695968e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,40411,-0.0528406558493923,0.00623465268541402,-0.0650605751128038,-0.0406207365859808,2.54683246122756e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,40341,-0.054750888061105,0.00647306026288298,-0.0674380861763556,-0.0420636899458544,2.94719163170788e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39980,-0.029005724310207,0.00343268166114874,-0.0357337803660585,-0.0222776682543554,3.17207736890154e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,-0.0800654566153628,0.00947489899231223,-0.0986362586402947,-0.0614946545904308,3.20164590612883e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,0.0370477804021027,0.0043852721992909,0.0284526468914925,0.0456429139127128,3.20959915276206e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,37598,-0.0468267612948577,0.00554344417798251,-0.0576919118837034,-0.035961610706012,3.29387203247285e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,-0.0693112421367747,0.00820732688767868,-0.0853976028366249,-0.0532248814369244,3.29876549700364e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,-0.0810479743462054,0.00960350318810223,-0.0998708405948857,-0.062225108097525,3.5104193484092e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37901,-0.0725493668401749,0.00859688937634997,-0.0893992700178208,-0.0556994636625289,3.52438919698518e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39980,-0.048970208318512,0.00580688525354769,-0.0603517034154655,-0.0375887132215586,3.65835813670716e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40332,-0.0246788837535598,0.00292825049790238,-0.0304182547294484,-0.0189395127776711,3.81903013741004e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,40470,-0.0495754316484251,0.00589753191761792,-0.0611345942069562,-0.038016269089894,4.58997289468192e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,0.0172141625767042,0.00204779015980154,0.0132004938634932,0.0212278312899152,4.59681606351901e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,-0.0472612365453388,0.00562347932521494,-0.05828325602276,-0.0362392170679175,4.66565780592833e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,37572,-0.056498708596839,0.00672509562806335,-0.0696798960278432,-0.0433175211658349,4.87177620398108e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,37882,-0.0379617200829142,0.00452630553550626,-0.0468332789325064,-0.0290901612333219,5.48480675198053e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,40359,0.0292979164292806,0.00349499241849556,0.0224477312890293,0.0361481015695319,5.59510159290857e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,40370,0.0232075134447677,0.00277079136734249,0.0177767623647765,0.028638264524759,5.93886488101834e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,37562,-0.0324232062978318,0.00387021672192164,-0.0400088310727982,-0.0248375815228653,5.94653690607427e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,40354,-0.0631777303551198,0.00754775964180981,-0.077971339253067,-0.0483841214571726,6.21541953132303e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37562,-0.0554685436546191,0.00663070160964091,-0.0684647188095153,-0.0424723684997229,6.59220953383418e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39978,-0.0401415593260513,0.00480092777174137,-0.0495513777586644,-0.0307317408934383,6.72958858669255e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,-0.0290749155529396,0.00348137322553992,-0.0358984070749979,-0.0222514240308814,7.28781788193964e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,37598,0.02483978594875,0.00297702673299521,0.0190048135520794,0.0306747583454206,7.90526970143903e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,40359,-0.0346312108109607,0.00415180687865168,-0.042768752293118,-0.0264936693288034,7.94825838367883e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,40332,0.0322029617646296,0.00386203529025509,0.0246333725957297,0.0397725509335296,8.14571123323732e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,-0.0698811672694118,0.00838291414252631,-0.0863116789887634,-0.0534506555500602,8.41180816392728e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,40305,-0.0595174348746314,0.00714329660438644,-0.0735182962192288,-0.045516573530034,8.59839325318234e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,40359,-0.0537389194407353,0.00645546577336914,-0.0663916323565388,-0.0410862065249318,9.14545796683975e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,40305,-0.0669880303750697,0.00805549988067862,-0.0827768101411998,-0.0511992506089396,9.84544238088315e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,37998,-0.0284672939752192,0.00342438521509135,-0.0351790889967982,-0.0217554989536401,1.02042648114366e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,40228,0.0277769620005489,0.00334463910683371,0.0212214693511548,0.034332454649943,1.07917313188583e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,40349,-0.0345693560432253,0.00416892932699208,-0.0427404575241298,-0.0263982545623208,1.20043157457018e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39980,-0.0464061379642173,0.00559917390241773,-0.057380518812956,-0.0354317571154785,1.24469033815317e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,-0.0307027574420993,0.00370739329759671,-0.0379692483053889,-0.0234362665788097,1.31240924710352e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,37905,-0.0780803475487718,0.00944263968742843,-0.0965879213361315,-0.0595727737614121,1.47786827470909e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,40228,-0.033371100275179,0.00404012825483274,-0.0412897516546511,-0.0254524488957068,1.57244344065148e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,37884,-0.0716773697725514,0.00867906405019823,-0.0886883353109399,-0.0546664042341628,1.61009031751151e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,-0.0517379486050745,0.00626594790162028,-0.0640192064922503,-0.0394566907178988,1.61314411809829e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,-0.0293444586339952,0.00355352086521963,-0.0363093595298257,-0.0223795577381647,1.62394822823296e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,37671,-0.0240138127059663,0.00290969048674004,-0.0297168060599768,-0.0183108193519558,1.68945996146421e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,37942,-0.0541825541454169,0.006565416011288,-0.0670507695275413,-0.0413143387632924,1.69098920542096e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,37942,-0.0676529278729213,0.00820913409947433,-0.0837428307078909,-0.0515630250379516,1.86153621913765e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,40044,-0.0396188095502153,0.00480875649664018,-0.0490439722836301,-0.0301936468168006,1.87509159198154e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37959,-0.0399872888172239,0.00485641342461733,-0.0495058591294739,-0.0304687185049739,1.97719452294797e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PI3,Elafin,40074,-0.0430996647636291,0.00523983941106469,-0.0533697500093159,-0.0328295795179424,2.09768607715448e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,40228,-0.0580120562196873,0.0070584384201266,-0.0718465955231354,-0.0441775169162392,2.21344103670334e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37987,-0.0487305802174288,0.00592961669549221,-0.0603526289405936,-0.0371085314942641,2.25294715347093e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,37484,-0.0440405209456423,0.00536345734103899,-0.0545528973340787,-0.0335281445572059,2.39448204470893e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,-0.0696378877908546,0.00849425803608088,-0.0862866335415731,-0.0529891420401361,2.6590545076547e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40264,-0.0213923292507619,0.00261398164770975,-0.026515733280273,-0.0162689252212508,2.95780900315658e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,-0.0761811986449251,0.00931544103654685,-0.0944394630765569,-0.0579229342132933,3.10564852246305e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,37770,-0.0263625996149897,0.0032273191260394,-0.0326881451020269,-0.0200370541279525,3.40002108942919e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,-0.086364564312873,0.0105799263448725,-0.107101219948823,-0.065627908676923,3.55527010443735e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OPTC,Opticin,40305,0.0360085493562483,0.00441332940745112,0.0273584237176441,0.0446586749948525,3.62813417446644e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,0.0244312504043495,0.00299543368827281,0.0185602003753348,0.0303023004333642,3.71395368606047e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,39980,-0.0420791862494257,0.00516182939773739,-0.0521963718689909,-0.0319620006298604,3.85099178782438e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,40260,-0.0451307477043381,0.00553804327699691,-0.0559853125272521,-0.0342761828814242,3.9347135227004e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,37598,-0.0402378562081869,0.00493741682121042,-0.0499151931777593,-0.0305605192386145,3.98040704246873e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,40341,-0.0261705394222824,0.00321947335302458,-0.0324807071942105,-0.0198603716503542,4.65162563381664e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37671,-0.0946188948066783,0.0116431234540558,-0.117439416776628,-0.0717983728367289,4.80555190443376e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,37942,-0.0365036804758853,0.00449291143514354,-0.0453097868887666,-0.0276975740630039,4.87130638866338e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,37622,-0.0528165247196042,0.00650122051287283,-0.065558916924835,-0.0400741325143735,4.90653446773791e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,40411,0.032755027713553,0.00403353675850462,0.0248492956668839,0.040660759760222,4.97218808502609e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,39934,-0.0709705375338204,0.00875062307696721,-0.0881217587646761,-0.0538193163029647,5.42341060674502e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,40517,-0.0188091360023163,0.002324817721869,-0.0233657787371796,-0.0142524932674531,6.3589731913524e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,40152,-0.0919573057879451,0.0113686794916138,-0.114239917591508,-0.0696746939843821,6.47048605515829e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37628,-0.0582869341543099,0.00720729988700626,-0.0724132419328422,-0.0441606263757776,6.63545135795315e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37572,-0.0342813416062556,0.00423976513982061,-0.042591281280304,-0.0259714019322072,6.72170424806233e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,-0.0483441890307659,0.00598033064833476,-0.0600656371015021,-0.0366227409600298,6.72309446999571e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,-0.029566495552379,0.00366186112072049,-0.0367437433489911,-0.0223892477557668,7.27690454349706e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37998,-0.0477389486127106,0.00592459247445653,-0.0593511498626454,-0.0361267473627758,8.4170454008411e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,40209,-0.0533075050032904,0.00662908029298571,-0.0663005023775424,-0.0403145076290384,9.50372673645835e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37628,-0.0610099193135365,0.00758806667325739,-0.075882529993121,-0.046137308633952,9.72683869693473e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,40139,-0.060223330471263,0.00749805172982463,-0.0749195118617193,-0.0455271490808067,1.02776635835303e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,40014,-0.0312929147667207,0.00389731162252335,-0.0389316455468665,-0.0236541839865749,1.04945044753679e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,40044,-0.0520549568115171,0.00649112031396022,-0.0647775526268791,-0.0393323609961551,1.13750735693032e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,40311,-0.0688857208870088,0.00860084249441526,-0.0857433721760627,-0.0520280695979549,1.23437261360554e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",40042,-0.0729485413619922,0.00910942381497968,-0.0908030120393524,-0.055094070684632,1.24737747463228e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,40516,-0.0598453641536967,0.00748593182968148,-0.0745177905398724,-0.045172937767521,1.39027767894387e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,38013,-0.0196986547132396,0.00246526782911425,-0.0245305796583036,-0.0148667297681757,1.45218162648783e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,40457,-0.0204178633316095,0.00255715427911524,-0.0254298857186754,-0.0154058409445436,1.50486600283119e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,-0.0458058735489914,0.00573744073796024,-0.0570512573953935,-0.0345604897025894,1.5345202714199e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,37671,-0.0683839571269556,0.00856549348505928,-0.0851723243576718,-0.0515955898962394,1.53735329895923e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37628,-0.0394613821011786,0.00494693852975779,-0.0491573816195038,-0.0297653825828533,1.62345166922977e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,40192,-0.0595661999459742,0.00748542707291253,-0.0742376370088827,-0.0448947628830656,1.87251149240376e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,39961,0.0572632543447188,0.00720802143156966,0.0431355323388422,0.0713909763505953,2.08492274891945e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,40332,-0.0205944768771835,0.00259673049951046,-0.025684068656224,-0.015504885098143,2.31913924856869e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.0395727715855777,0.004997032567967,-0.049366955418793,-0.0297785877523624,2.54584336332575e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,40536,-0.0681807352732698,0.00861606542261751,-0.0850682235016002,-0.0512932470449395,2.67071644458015e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,40305,0.031831018299051,0.00402779839186029,0.0239365334510049,0.0397255031470972,2.90451140605463e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37942,-0.0226104351692839,0.00286131838684793,-0.0282186192075059,-0.017002251131062,2.95395420617944e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,40198,0.0261675545862198,0.00331442004616983,0.0196712912957269,0.0326638178767126,3.09187906109705e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37541,-0.0478752105360861,0.00607173577906028,-0.0597758126630442,-0.0359746084091279,3.39545200813034e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,-0.0729211219588234,0.00924997445130257,-0.0910510718833765,-0.0547911720342704,3.43054094532187e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37900,-0.0391581961096484,0.00497048062990844,-0.0489003381442689,-0.0294160540750278,3.57665967758532e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,40042,-0.0852095018433406,0.0108225561231144,-0.106421711844645,-0.0639972918420363,3.67951590570159e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40403,-0.0209565651087776,0.00266317001562774,-0.026176378339408,-0.0157367518781472,3.8020923852992e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,37990,-0.0553545244279419,0.0070364262323575,-0.0691459198433626,-0.0415631290125212,3.91130352360778e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,-0.061416803846526,0.00781482921896523,-0.0767338691156978,-0.0460997385773541,4.17196635632998e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,-0.0428387918523812,0.00545223761534069,-0.053525177578449,-0.0321524061263135,4.18212267725665e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,39980,-0.0469584038508641,0.0059778432249672,-0.0586749765717998,-0.0352418311299284,4.2442841804727e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,-0.0376295879212483,0.00479175997507527,-0.0470214374723958,-0.0282377383701007,4.37660540406001e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,-0.0586943023341696,0.00748776921585734,-0.0733703299972499,-0.0440182746710892,4.84674643363231e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,40350,-0.0713120894477293,0.00910516946205932,-0.0891582215933656,-0.0534659573020931,5.1015628885802e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,40042,-0.0275044251147992,0.00351637524822833,-0.0343965206013267,-0.0206123296282716,5.5388420400189e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,40042,-0.0292099767173762,0.0037377492776914,-0.0365359653016513,-0.0218839881331011,5.85212707203301e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37990,-0.0229037612452429,0.00293260201423804,-0.0286516611931495,-0.0171558612973364,6.13563702222062e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,40471,-0.0270769849879682,0.00346808797755755,-0.033874437423981,-0.0202795325519554,6.19395903630744e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0281710123857033,0.00360920285634101,0.0210969747872749,0.0352450499841317,6.37019965114051e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40411,-0.06371432438169,0.00817988387992084,-0.0797468967863349,-0.0476817519770452,7.15913731130992e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,40330,-0.0556366526267763,0.00714606378331856,-0.0696429376420807,-0.0416303676114719,7.36227867930501e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,37987,0.0452863527427364,0.00581738744169436,0.0338842733570155,0.0566884321284574,7.49610635064961e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,40396,-0.0657154359598075,0.00844511199718989,-0.0822678554742997,-0.0491630164453153,7.60570150225769e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.0196158440377055,0.00252321333707503,0.0146703458970385,0.0245613421783726,8.05822497723668e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,40489,-0.0294394672696495,0.0037880951331878,-0.0368641337306976,-0.0220148008086014,8.21931567693532e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNC,Tenascin,40403,0.0359833689188827,0.00463184200723094,0.0269049585847101,0.0450617792530554,8.41028637739247e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,-0.0316177959480823,0.00406973390396137,-0.0395944743998466,-0.023641117496318,8.49192896955233e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37901,0.0222934897355415,0.00287119166816475,0.0166659540659386,0.0279210254051444,8.78451173439536e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37900,-0.0331211265359119,0.00426833525087643,-0.0414870636276297,-0.0247551894441941,9.12289200259144e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,-0.0375597149017713,0.00484407185990215,-0.0470540957471795,-0.0280653340563631,9.57048779504265e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,-0.0571993020637074,0.00737891846217084,-0.0716619822495623,-0.0427366218778526,9.62601512212057e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37978,-0.0367797236816903,0.00474440251182653,-0.0460787526048703,-0.0274806947585103,9.67154687470634e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,40471,-0.0992678658074583,0.0128131306083227,-0.124381601799771,-0.0741541298151458,9.94235692055278e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40470,-0.0462591514553232,0.00597586656238811,-0.0579718499176039,-0.0345464529930425,1.04506961244199e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,40442,-0.0554469901836464,0.00716363370373831,-0.0694877122429735,-0.0414062681243194,1.05281789535919e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39980,-0.0390769193392532,0.00505063174817339,-0.048976157565673,-0.0291776811128333,1.07994972026079e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37901,-0.0353952286465006,0.00458631377797228,-0.0443844036513262,-0.0264060536416749,1.26897525257779e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,40332,-0.0270296946006895,0.00350573343384533,-0.0339009321310263,-0.0201584570703527,1.33098466679768e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37653,-0.0412509067131262,0.00535304063801626,-0.0517428663636381,-0.0307589470626143,1.38993948737984e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,-0.0308242405101739,0.00400245308350288,-0.0386690485538396,-0.0229794324665083,1.42614472494755e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37628,-0.0655134480419663,0.00851350047673603,-0.0821999089763689,-0.0488269871075637,1.51248685333255e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,-0.0267871644298425,0.00348964453968957,-0.0336268677276341,-0.019947461132051,1.75435031226996e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37628,-0.0429574914301523,0.00559780219991926,-0.053929183741994,-0.0319857991183105,1.78423469508418e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,39809,-0.058400282333697,0.00761414867631297,-0.0733240137392704,-0.0434765509281235,1.82328448928102e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,37990,-0.0403961980113509,0.00526665148572183,-0.0507188349233657,-0.0300735610993361,1.83443024579839e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37942,-0.027015549627662,0.00352515442806745,-0.0339248523066742,-0.0201062469486498,1.93031986480632e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,37598,-0.0432606942727577,0.00565046459034061,-0.0543356048698253,-0.0321857836756901,2.049700698928e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,-0.0673798664531034,0.00881083426573658,-0.0846491016139471,-0.0501106312922597,2.18903236841527e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,37572,-0.0339040650306684,0.00443334686772084,-0.0425934248914012,-0.0252147051699355,2.19148943229438e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,-0.0549979317605248,0.00719407164184248,-0.0690983121785361,-0.0408975513425136,2.23466563054179e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,-0.0427465834833231,0.00560188908192594,-0.0537262860838979,-0.0317668808827483,2.46496935420547e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,40305,-0.045746716122956,0.00600051223784314,-0.0575077201091285,-0.0339857121367834,2.60227632673372e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40341,-0.0270752078193984,0.00355227722945097,-0.0340376711891223,-0.0201127444496745,2.63983674063412e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,-0.0505123934871224,0.00662882730991849,-0.0635048950145626,-0.0375198919596822,2.70833373388287e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,40341,-0.0583701880787256,0.00766244140218981,-0.0733885732270176,-0.0433518029304336,2.7274238034856e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,37598,-0.0286531437563995,0.00376123151321899,-0.0360251575223087,-0.0212811299904903,2.75180470501199e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37901,-0.0711840949331263,0.00934583542251766,-0.0895019323612609,-0.0528662575049917,2.77663017741796e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,-0.0394272561903544,0.00518307123097794,-0.0495860758030711,-0.0292684365776376,2.99691521990103e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,40396,-0.0424577217475312,0.00558540226624999,-0.0534051101893812,-0.0315103333056812,3.08843807748867e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40306,-0.0267524568931889,0.00352527743640914,-0.0336620006685508,-0.019842913117827,3.40912313394388e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,-0.0421746151651287,0.00555899966909326,-0.0530702545165515,-0.0312789758137059,3.50115997416852e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,37900,-0.0358846367239626,0.00473703335423156,-0.0451692220982564,-0.0266000513496687,3.8154169471416e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,39961,-0.0338035882043275,0.00446709528452185,-0.0425590949619903,-0.0250480814466647,4.02609678392332e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,40332,0.0663454098244811,0.00877357495953945,0.0491492029037837,0.0835416167451784,4.18714172710519e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,-0.0694738627570311,0.0091966749599814,-0.0874993456785947,-0.0514483798354676,4.44212868446129e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,-0.0597956155194116,0.00792007252909636,-0.0753189576764405,-0.0442722733623827,4.59261361383042e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,40536,0.0216390874147335,0.00286920504017123,0.0160154455359979,0.0272627292934691,4.88077989739499e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,-0.073261713043306,0.00971907979621724,-0.0923111094438918,-0.0542123166427202,5.07877221394836e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,37942,-0.0736432866240577,0.00978625105691315,-0.0928243386956075,-0.0544622345525079,5.59789356343376e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELL,L-selectin,38013,0.0171465491863065,0.00227907253912033,0.0126795670096306,0.0216135313629823,5.6691542824104e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,-0.062069161784925,0.00827426686497393,-0.0782867248402739,-0.0458515987295761,6.65180021039295e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,40305,-0.0548235051141066,0.00731488353850977,-0.0691606768495858,-0.0404863333786274,6.99075342134386e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,40332,-0.0204600421696422,0.00273211994137085,-0.0258149972547291,-0.0151050870845553,7.32061252433985e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,37812,-0.0734342166845397,0.00982283996506039,-0.0926869830160581,-0.0541814503530213,8.14700726707672e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,37942,-0.0200666760732939,0.00268502217724281,-0.0253293195406898,-0.014804032605898,8.28555802986754e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,-0.0544777183483605,0.00729211477599519,-0.0687702633093111,-0.0401851733874099,8.46062248432278e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,-0.0853025642792166,0.0114241274577048,-0.107693854096318,-0.0629112744621153,8.71697740277813e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,40536,0.0170751421347948,0.0022884070881657,0.01258986424199,0.0215604200275996,8.98519532401764e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,-0.0448222486234427,0.00600804222838294,-0.0565980113910733,-0.0330464858558122,9.16578257702199e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,40332,-0.0882771665940606,0.0118369809377605,-0.111477649232071,-0.06507668395605,9.25591853674035e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,-0.0323290070281921,0.00433509683380046,-0.040825796822441,-0.0238322172339432,9.36490584956302e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37541,-0.0731007251304408,0.00981009955339135,-0.0923285202550879,-0.0538729300057938,9.80138290423237e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37835,-0.0429104207430804,0.00576275470152184,-0.0542054199580632,-0.0316154215280976,1.01965493662462e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40283,-0.0234868161472774,0.00315528684622985,-0.0296711783658879,-0.0173024539286669,1.02981351718921e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,37990,-0.0473356475392141,0.00636064023868223,-0.0598025024070313,-0.0348687926713969,1.05177876732169e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,37628,-0.0380187721749887,0.00510971004766272,-0.0480338038684076,-0.0280037404815698,1.06518827999979e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,40341,-0.0223927765692757,0.00301287943777933,-0.0282980202673232,-0.0164875328712282,1.12111985783101e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37901,-0.0560673255838661,0.00755168540674242,-0.0708686289810812,-0.0412660221866509,1.20029321875667e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,37541,-0.0400773684336968,0.00539986796500103,-0.0506611096450988,-0.0294936272222948,1.22560891990993e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,37987,-0.049656668245587,0.00669082824090211,-0.0627706915977551,-0.0365426448934188,1.22608974472542e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,40251,-0.0421126218759587,0.00567817458953482,-0.0532418440714469,-0.0309833996804704,1.2628317915271e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",40305,-0.0747600762458602,0.0100919707448883,-0.0945403389058412,-0.0549798135858792,1.34795351361235e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,-0.0580815796135246,0.00786055192030588,-0.0734882613773241,-0.0426748978497251,1.56624251462065e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,40228,-0.024241308918307,0.00328318698245878,-0.0306763554039262,-0.0178062624326878,1.61913831260347e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.0217992747389629,0.00296064028478949,-0.0276021296971502,-0.0159964197807755,1.90233207956309e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37910,-0.0296577892504888,0.00403035365297181,-0.0375572824103135,-0.021758296090664,1.96604656616702e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,37482,-0.0408223243818436,0.00555428334556837,-0.0517087197391576,-0.0299359290245296,2.10487792507947e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37790,-0.0404666618678992,0.00550723632108488,-0.0512608450572256,-0.0296724786785729,2.13036029560727e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BSG,Basigin,40502,-0.0144917578699713,0.00197631214451714,-0.0183653296732248,-0.0106181860667177,2.36271256934465e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,40332,0.0227099100914571,0.00310256748884419,0.0166288778133225,0.0287909423695917,2.60394082688543e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,37572,-0.0320093014971169,0.00437344989727786,-0.0405812632957815,-0.0234373396984523,2.64350710117613e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,40291,-0.05059716509302,0.0069155938607816,-0.064151729060152,-0.0370426011258881,2.66939855975803e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,40042,-0.0604835688896699,0.00828011999097869,-0.0767126040719881,-0.0442545337073517,2.91388783522167e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,37681,0.0151577530567793,0.00207494396064864,0.011090862893908,0.0192246432196507,2.9283809977032e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,37901,-0.0589668423625643,0.00808281788030256,-0.0748091654079573,-0.0431245193171713,3.14602054476096e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,-0.0496834042860871,0.00681512779775582,-0.0630410547696885,-0.0363257538024857,3.24182871587305e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGMN,Legumain,40422,-0.0253063439658069,0.00347623437403075,-0.0321197633389072,-0.0184929245927067,3.49842770353525e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,-0.0785974593416185,0.0108181229265883,-0.0998009802777315,-0.0573939384055055,3.89258222602889e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,40411,0.0195077863950545,0.00268663509661249,0.014241981605694,0.024773591184415,4.01815838811929e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,40514,0.0298207449507245,0.00410916333135117,0.0217667848212762,0.0378747050801728,4.13455691959519e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,-0.0526127720854023,0.00725014687133991,-0.0668230599532285,-0.0384024842175761,4.14888959307649e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,40359,0.02584979608661,0.00356270872419847,0.018866886987181,0.032832705186039,4.18153484881965e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,40044,-0.0470526481985362,0.0064857639592443,-0.059764745558655,-0.0343405508384174,4.21316567175629e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37879,-0.0501475078870789,0.00691218708269896,-0.0636953945691689,-0.0365996212049889,4.2387369908761e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,40516,-0.0324220870346234,0.00447321357834682,-0.0411895856481832,-0.0236545884210636,4.42035996380702e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37998,-0.0164317504732447,0.00226890839963815,-0.0208788109365355,-0.0119846900099539,4.65494158554858e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,40332,0.0167584503717497,0.00232025618387442,0.0122107482513559,0.0213061524921436,5.32887302716583e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,37942,-0.0265489122467315,0.00367594133569576,-0.0337537572646952,-0.0193440672287679,5.38377384448125e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,38013,0.0181154331987726,0.00251491037434878,0.013186208865049,0.0230446575324962,6.19120967570363e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,-0.0665329363740316,0.00924582068417983,-0.084654744915024,-0.0484111278330391,6.47809294709554e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,-0.041250801809953,0.00573576163172714,-0.0524928946081382,-0.0300087090117678,6.67839469480722e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,40471,-0.0376418066785859,0.00523885104493406,-0.0479099547266566,-0.0273736586305151,7.01023743096237e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,37567,-0.0302859300080681,0.00421458673563997,-0.0385465200099225,-0.0220253400062138,7.03344679524442e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,-0.0201305693536128,0.0028016103637956,-0.0256217256666521,-0.0146394130405734,7.06550358087865e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37990,-0.0228138589201144,0.00317828787177325,-0.02904330314879,-0.0165844146914389,7.4405080440819e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,-0.033481926816113,0.0046759295777383,-0.0426467487884801,-0.0243171048437459,8.45484287410329e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,37628,-0.0356979806742713,0.00498995739125706,-0.0454782971611351,-0.0259176641874075,8.87613928053754e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39980,-0.036853209309651,0.00516209261021196,-0.0469709108256664,-0.0267355077936356,9.8035663729059e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,39980,-0.0413016649468891,0.00578592061778394,-0.0526420693577456,-0.0299612605360325,9.8673688102273e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37714,-0.024345316553433,0.00341748839339526,-0.0310435938044877,-0.0176470393023783,1.1045331658949e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,-0.0439073191448919,0.00617141176545691,-0.0560032862051875,-0.0318113520845964,1.17012447919923e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,40471,-0.0207592967485853,0.00291810540695112,-0.0264787833462095,-0.0150398101509611,1.17528718134726e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,38013,-0.0183206683733362,0.00257583908017719,-0.0233693129704835,-0.0132720237761889,1.19667111071032e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,37671,-0.0660149045701392,0.00928971128192771,-0.0842227386827176,-0.0478070704575609,1.25361678034141e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37755,-0.00948224229249521,0.00133438489019836,-0.012097636677284,-0.00686684790770641,1.25468017963258e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37990,-0.04941143095195,0.0069545969117006,-0.0630424408988832,-0.0357804210050168,1.26466803965294e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,40341,-0.0369252390085808,0.00519989329194739,-0.0471170298607977,-0.0267334481563639,1.28961936992218e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,39665,-0.0157001526844917,0.00221189199022032,-0.0200354609853235,-0.0113648443836599,1.32109236493397e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,37572,-0.0339328982412229,0.00478558764008809,-0.0433126500157955,-0.0245531464666502,1.40325093880682e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40373,-0.0186647372738639,0.00263419226649726,-0.0238277541161985,-0.0135017204315292,1.4428325136925e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,38013,-0.025621713987348,0.0036212788088366,-0.0327194204526677,-0.0185240075220282,1.56419727985662e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37628,-0.0571976941804241,0.00808609326173341,-0.0730464369734216,-0.0413489513874266,1.58601439291583e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,-0.0400580526601478,0.00566917635681118,-0.0511696383194977,-0.0289464670007979,1.66316829286248e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,-0.0315831652339099,0.00447021852198555,-0.0403447935370015,-0.0228215369308182,1.68229868643919e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,-0.0359986553121219,0.00510439366345967,-0.0460032668925029,-0.025994043731741,1.82968381140479e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,37598,-0.0301818787182496,0.00428025180055802,-0.0385711722473434,-0.0217925851891559,1.85944345674784e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40489,0.0420447956642435,0.005996272303458,0.0302921019494659,0.0537974893790212,2.44619333435509e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,40032,-0.0298005957333509,0.00425195730840135,-0.0381344320578175,-0.0214667594088842,2.50449745059845e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,40312,-0.0460851521929327,0.00658637612039235,-0.0589944493889017,-0.0331758549969637,2.71882604480543e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),37735,0.120977152257868,0.0173195806303703,0.0870307742223424,0.154923530293394,2.98432308956e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,-0.0702475942254386,0.0100611090585664,-0.0899673679802288,-0.0505278204706484,3.04752611679733e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,-0.0685805294955706,0.00983900164839631,-0.0878649727264274,-0.0492960862647138,3.28767627584346e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37671,-0.0598616477544887,0.00858773681690788,-0.0766936119156281,-0.0430296835933492,3.3057544905147e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,39924,-0.0463400714629091,0.00665713523126614,-0.0593880565161908,-0.0332920864096275,3.51538847885093e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,37562,-0.04193388781589,0.00602871733165301,-0.05375017378593,-0.0301176018458501,3.67486446527869e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,40116,-0.0460499496113676,0.00662499349045296,-0.0590349368526554,-0.0330649623700798,3.77173821533609e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,40329,-0.0659778450900761,0.00951379644304845,-0.084624886118451,-0.0473308040617011,4.21994236752513e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,37900,-0.0267193746115299,0.00385636791338861,-0.0342778557217716,-0.0191608935012882,4.44252178092382e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,39980,-0.0329465432256571,0.00476075903210833,-0.0422776309285894,-0.0236154555227247,4.67861287091407e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,37177,-0.0839392978485519,0.0121416864878662,-0.10773700336477,-0.0601415923323341,4.96055208947529e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37746,-0.0377559859469532,0.00546932565712132,-0.0484758642349109,-0.0270361076589954,5.31417336931082e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40471,-0.0301616814242226,0.00437432548320138,-0.0387353593712973,-0.0215880034771479,5.58134554105378e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,0.0195285664236161,0.00283869434477892,0.0139647255078494,0.0250924073393827,6.23128410108474e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37959,-0.0609278755285846,0.00886498721610527,-0.0783032504721509,-0.0435525005850182,6.56846563903886e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,-0.0187058843203334,0.00272742412533576,-0.0240516356059915,-0.0133601330346753,7.21652710572932e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,-0.0232560897395353,0.00339440990329953,-0.0299091331500024,-0.0166030463290683,7.58801067836122e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,-0.0801473472865535,0.0117026106048323,-0.103084464072025,-0.0572102305010822,7.72636268435213e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39961,-0.0352759481079892,0.00516512757371144,-0.0453995981524636,-0.0251522980635147,8.82931836409657e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37598,-0.0586201803717643,0.00859636335980526,-0.0754690525569826,-0.041771308186546,9.5560698272089e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,40341,-0.0429489595550398,0.00630250698293365,-0.0553018732415898,-0.0305960458684899,9.79351674941631e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,40497,0.0317690035694566,0.00466716586188598,0.0226213584801601,0.0409166486587531,1.03246100046003e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,37931,-0.0430028528236626,0.00631827032847013,-0.055386662667464,-0.0306190429798611,1.04511205125249e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,37987,0.0318259920181607,0.00467855506588116,0.0226560240890336,0.0409959599472877,1.0711926029317e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37942,0.0438261972033923,0.00644827285184907,0.0311875824137682,0.0564648119930165,1.1163267568132e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,-0.0186771107194864,0.00274816690519784,-0.0240635178536741,-0.0132907035852986,1.12053682721233e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,40305,-0.0570453067456597,0.00840226548029509,-0.0735137470870381,-0.0405768664042813,1.16697141644298e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,37900,-0.02519929310227,0.00371471729845202,-0.032480139007236,-0.0179184471973041,1.22088539747364e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,-0.0360689548624191,0.00531724036074725,-0.0464907459694837,-0.0256471637553545,1.22257162717601e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,39980,-0.0306642822672818,0.00452240454461801,-0.0395281951747331,-0.0218003693598306,1.24057249677175e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,37990,-0.0201223437322644,0.00296953649285914,-0.0259426352582683,-0.0143020522062605,1.28429390437039e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,40359,-0.0455264887412341,0.00672162043846278,-0.0587008648006212,-0.0323521126818471,1.30430720353129e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,37901,-0.0224854193391315,0.00332005387840667,-0.0289927249408086,-0.0159781137374544,1.31737296503775e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,37671,0.0215982343615282,0.00319406494573461,0.0153378670678884,0.0278586016551681,1.41828470885064e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,37598,-0.0234796967979317,0.00347270536971518,-0.0302861993225734,-0.0166731942732899,1.42622002586899e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40305,-0.0355989084023256,0.00526869451323345,-0.0459255496482631,-0.025272267156388,1.46101049228162e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39925,-0.0436698512822339,0.0064764726454165,-0.0563637376672502,-0.0309759648972176,1.6081294013386e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,-0.0429012403130861,0.00637188919101975,-0.0553901431274848,-0.0304123374986874,1.7321597491477e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAYN,Layilin,40192,-0.0226462775423309,0.00336428348574924,-0.0292402731743994,-0.0160522819102624,1.73866309631789e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,39961,-0.0405695639036231,0.00602717388995924,-0.0523828247279432,-0.0287563030793029,1.74280114910335e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,-0.0738785544438687,0.011001690332451,-0.0954418674954726,-0.0523152413922647,1.94333094449108e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,37477,0.0409580366687927,0.00609928826420949,0.0290034316709421,0.0529126416666433,1.95579453030904e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,40192,-0.0156034906149622,0.00232640145756656,-0.0201632374717927,-0.0110437437581317,2.05242243481014e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,40332,-0.0307064585301962,0.0045797114065039,-0.0396826928869438,-0.0217302241734485,2.08354063937973e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,37628,-0.0770928008670283,0.0115058368064684,-0.0996442410077063,-0.0545413607263502,2.16414524156576e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37990,-0.0165273384462291,0.00246981322840706,-0.0213681723739069,-0.0116865045185512,2.29213545003043e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,-0.0295605084698411,0.00442045451413091,-0.0382245993175377,-0.0208964176221445,2.35049083945526e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40291,-0.0282527447590475,0.00422718218373404,-0.0365380218391662,-0.0199674676789288,2.40943554099279e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFP,Properdin,38013,-0.0143558019063273,0.00214861530238249,-0.018567087898997,-0.0101445159136577,2.45872996879577e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37562,-0.0455427049935373,0.00682609190575064,-0.0589218451288086,-0.0321635648582661,2.62732687814947e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,39961,-0.0462571532795717,0.00693545765755657,-0.0598506502883825,-0.0326636562707608,2.65064575579285e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,39990,-0.0586507505623219,0.00879943478535378,-0.0758976427416153,-0.0414038583830285,2.73042401326764e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,37990,-0.0342403309411748,0.00513745325877745,-0.0443097393283786,-0.024170922553971,2.75200496546351e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,37921,-0.0208269495648715,0.00313008421451576,-0.0269619146253224,-0.0146919845044206,2.96664699718727e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,37628,0.045707444814047,0.00687008258810144,0.0322420829413682,0.0591728066867259,2.98293869787121e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40516,-0.0477008695572609,0.00717694292326649,-0.0617676776868632,-0.0336340614276586,3.10003109262329e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37628,-0.0365089910140035,0.0054952545130523,-0.047279689859586,-0.025738292168421,3.17858389502024e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,-0.0571315412788896,0.00860692345270859,-0.0740011112461984,-0.0402619713115807,3.2877708984061e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,40044,-0.073929731013491,0.0111438879393513,-0.0957717513746195,-0.0520877106523625,3.37225098214292e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,37714,-0.0219234249578519,0.0033060110788065,-0.0284032066723126,-0.0154436432433911,3.45441407887843e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37671,-0.0259617852868257,0.003915405966664,-0.0336359809814872,-0.0182875895921643,3.47138830848494e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37628,-0.0402456625910135,0.00606986893178558,-0.0521426056973132,-0.0283487194847137,3.47826324409032e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,37671,-0.0233938157651945,0.00353242111664076,-0.0303173611538104,-0.0164702703765786,3.66579935630963e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,40355,0.0235247886372246,0.0035565502390449,0.0165539501686966,0.0304956271057526,3.84709948169103e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37671,-0.0814217865013195,0.0123149999848229,-0.105559186471572,-0.0572843865310665,3.94806861373668e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,37402,-0.0512602453476079,0.0077567189522216,-0.0664634144939622,-0.0360570762012536,4.03444532076779e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,40516,-0.0573301467540337,0.00868253852021348,-0.0743479222536521,-0.0403123712544153,4.15763653101942e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40359,-0.0467078673423939,0.00708977540129896,-0.0606038271289399,-0.032811907555848,4.59594900773231e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,40359,0.045017544148952,0.0068366905357542,0.0316176306988737,0.0584174575990302,4.70086348247045e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40341,0.021936703409319,0.00333417510786727,0.0154017201978992,0.0284716866207389,4.87279339730372e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,37990,-0.0361761636846255,0.00551707395295499,-0.0469896286324173,-0.0253626987368337,5.68437007721869e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,37990,-0.0624853029190742,0.00954976976293173,-0.0812028516544204,-0.043767754183728,6.24150727846729e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,39725,0.0202554167782312,0.0030961852694696,0.0141868936500707,0.0263239399063916,6.26089102641638e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,-0.0393051979129692,0.0060171856823118,-0.0510988818503003,-0.027511513975638,6.72208831049077e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,40299,-0.0181299490124938,0.00277700104058307,-0.0235728710520366,-0.0126870269729509,6.84015695709465e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,-0.0254248593535004,0.00390074881149622,-0.033070327024033,-0.0177793916829678,7.38087799142824e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,-0.0213162612135416,0.00327503682783328,-0.0277353333960948,-0.0148971890309883,7.80637875412267e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,-0.0195226621207293,0.00300016575072588,-0.025402986992152,-0.0136423372493066,7.92618159256631e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,40332,-0.0249146083562211,0.00384386666112111,-0.0324485870120185,-0.0173806297004238,9.33970728404598e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,37598,-0.0256108215712221,0.00395540712682492,-0.0333634195397989,-0.0178582236026453,9.82545805652379e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,37628,-0.019080057121158,0.00294742673806616,-0.0248570135277677,-0.0133031007145483,9.91760420805521e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,40194,0.0180653661757453,0.00279609618766624,0.0125850176479195,0.0235457147035712,1.07120409519503e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,40270,-0.0253697012110658,0.00393302392200049,-0.0330784280981867,-0.0176609743239448,1.14769659360343e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,40422,-0.0273731753745727,0.00424479922255062,-0.0356929818507719,-0.0190533688983734,1.16100329156719e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,40346,-0.0326198890237882,0.00506457879963395,-0.0425464634710707,-0.0226933145765057,1.22266149609501e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,40171,-0.0368320706083667,0.00572784396427951,-0.0480586447783546,-0.0256054964383789,1.3097947748562e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37900,-0.0182891807075126,0.00284688095369693,-0.0238690673767586,-0.0127092940382666,1.36950020977684e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,39980,-0.0432602132888628,0.00674598448953764,-0.0564823428883566,-0.0300380836893691,1.47061877232628e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37628,-0.0334481306809442,0.00522233155473348,-0.0436839005282218,-0.0232123608336666,1.55653029493219e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,38013,-0.0130596008497392,0.00203983241704652,-0.0170576723871504,-0.00906152931232803,1.58103715585853e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,-0.0451440610307374,0.00705619294106735,-0.0589741991952294,-0.0313139228662454,1.62133622253895e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37900,-0.0307687871793138,0.00482147495446269,-0.0402188780900607,-0.0213186962685669,1.8097869207379e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,37598,-0.032382163586242,0.00507898131910137,-0.0423369669716807,-0.0224273602008033,1.88193702243967e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,-0.0296582964247756,0.00465243220560885,-0.0387770635477689,-0.0205395293017822,1.89316930061717e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,-0.0427720862076529,0.0067134269880326,-0.0559304031041968,-0.029613769311109,1.93732256982546e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37562,-0.0439852821563649,0.00691462941281744,-0.057537955805487,-0.0304326085072427,2.06846091897929e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,37562,-0.0249891751102639,0.00394256259472247,-0.03271659779592,-0.0172617524246079,2.39911162910826e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,-0.0270682698697623,0.00428209705138559,-0.035461180090478,-0.0186753596490465,2.66483850815779e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,-0.0230299992228773,0.00364462265915664,-0.0301734596348243,-0.0158865388109303,2.70467082569241e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,-0.0734926789876462,0.0116316337443523,-0.0962906811265767,-0.0506946768487157,2.71381345753264e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,40208,-0.0249290384711849,0.00395113034709545,-0.032673253951492,-0.0171848229908779,2.877035848037e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,-0.0406943741525301,0.00645091603148361,-0.053338169574238,-0.0280505787308222,2.90936468027992e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37714,-0.0416842628039833,0.00660809277383347,-0.0546361246406969,-0.0287324009672697,2.9152509620614e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,40422,-0.0537534810981213,0.00852622646643469,-0.0704648849723333,-0.0370420772239093,2.9674320766976e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C2,Complement C2,40372,-0.014779697221123,0.00234966314394187,-0.0193850369832491,-0.010174357458997,3.2547142254978e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,0.0301117590001843,0.00478686287928065,0.0207295077567942,0.0394940102435744,3.26447644081953e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,-0.0390838394075204,0.00621871752380963,-0.0512725257541873,-0.0268951530608535,3.38431036839344e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,37541,-0.0395802547889353,0.00630090601700294,-0.0519300305822611,-0.0272304789956095,3.45544977956409e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,40359,-0.0468778031120512,0.00747311652789948,-0.0615251115067342,-0.0322304947173682,3.63640205918065e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGN,Mimecan,40332,-0.0250062529673927,0.00399036205233814,-0.0328273625899754,-0.0171851433448099,3.78380391465192e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,40411,-0.035407646557879,0.005659485409473,-0.046500237960446,-0.0243150551553119,4.0417243295365e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37959,-0.077093062715169,0.0123334661469754,-0.101266656363241,-0.0529194690670972,4.20847466118206e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,37714,-0.0335675790766003,0.00537347916223838,-0.0440995982345875,-0.023035559918613,4.31478672424524e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37714,-0.0473355950538853,0.00758986765083616,-0.0622117356495241,-0.0324594544582464,4.60519133088206e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39980,-0.0468726381334695,0.00752043041033441,-0.061612681737725,-0.0321325945292141,4.70280148779607e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,40172,-0.042811833471368,0.00688526913507144,-0.056306960976108,-0.029316705966628,5.16619540740783e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,37901,-0.0634885475713829,0.0102133486716281,-0.083506710967774,-0.0434703841749917,5.24282183329913e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,40042,-0.0338019979724722,0.00543879056159621,-0.0444620274732008,-0.0231419684717436,5.26349728427285e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,39959,0.0285402001922518,0.00459385821207049,0.0195362380965936,0.0375441622879099,5.34160070502415e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,39980,-0.0458428395360451,0.0073806735597937,-0.0603089597132408,-0.0313767193588495,5.39206941754161e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,-0.0147117606540974,0.00237051467676865,-0.0193579694205639,-0.0100655518876309,5.5658453280799e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCN,Decorin,40042,0.0138711137423095,0.00223660876338104,0.00948736056608263,0.0182548669185363,5.72101170519833e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,40489,0.0271654428037051,0.00438931719831378,0.01856238109501,0.0357685045124001,6.2022435723305e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,40489,0.0275267113746927,0.00445608048455726,0.0187927936249604,0.0362606291244249,6.67645749452116e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,37990,-0.0166446621517905,0.00269691694807589,-0.0219306193700192,-0.0113587049335618,6.94709069268488e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,40305,-0.0176778323989378,0.00286570453317008,-0.0232946132839512,-0.0120610515139244,7.05001311989396e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37959,-0.0421978171667415,0.00684000830741638,-0.0556042334492776,-0.0287914008842054,7.05675308315553e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,37900,-0.0241522369240328,0.00391498948653524,-0.0318256163176418,-0.0164788575304237,7.06179475955049e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,-0.0221109036486357,0.00358529374058075,-0.029138079380174,-0.0150837279170974,7.15758436235941e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37942,-0.0227776878832224,0.00369406077278142,-0.030018046997874,-0.0155373287685708,7.20238257410209e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,-0.0409704809964732,0.00664597172595336,-0.0539965855793418,-0.0279443764136046,7.23587963612715e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,40359,-0.0342196092948185,0.00557769933342997,-0.0451518999883413,-0.0232873186012958,8.7133679541867e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37572,-0.041516394694713,0.00677975584800444,-0.0548047161568017,-0.0282280732326243,9.41069316479893e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,40360,0.0376563106632892,0.00615458194190405,0.0255933300571572,0.0497192912694211,9.67218321304861e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,-0.0219387073168025,0.0035958914866173,-0.0289866546305724,-0.0148907600030326,1.08327718602773e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40311,-0.0523738590776949,0.00858688826659694,-0.0692041600802249,-0.0355435580751649,1.09017969314572e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37978,-0.0145854849636115,0.00239174731843756,-0.0192733097077491,-0.00989766021947384,1.10153318576235e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,37628,-0.0557814764424513,0.00914789317350295,-0.0737113470625171,-0.0378516058223855,1.10586247524736e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,40314,-0.0241411532013009,0.00395983340505328,-0.0319024266752054,-0.0163798797273965,1.1092179305889e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,37572,0.0187761441818033,0.00308228440465358,0.0127348667486823,0.0248174216149243,1.14890990940216e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,0.0413858075373289,0.00679490598536562,0.0280677918060123,0.0547038232686455,1.15474883383973e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,40305,0.0171139516750001,0.00281144865390974,0.011603512313337,0.0226243910366632,1.17522650231389e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,37981,-0.0133633923268369,0.00219752938927908,-0.0176705499298239,-0.00905623472384995,1.22576442220051e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37572,-0.0369294521914477,0.00607808175109716,-0.0488424924235982,-0.0250164119592973,1.26754964887157e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,-0.0895068817355061,0.0147343014296677,-0.118386112537655,-0.0606276509333574,1.2702887052399e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,40216,-0.0288208413755449,0.00474498994705471,-0.0381210216717721,-0.0195206610793177,1.2766633185749e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39961,-0.0435813578548065,0.00717910413296643,-0.0576524019554207,-0.0295103137541923,1.30414773377603e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,-0.0212683356273212,0.00351190223251254,-0.0281516640030458,-0.0143850072515966,1.43300030408568e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,39980,-0.0482364241096829,0.00797056796676369,-0.0638587373245398,-0.0326141108948261,1.46512691693783e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,-0.0143413182350857,0.00237158668665047,-0.0189896281409206,-0.00969300832925075,1.50725765462721e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,37671,-0.0664126963210703,0.0109816952326554,-0.087936818977075,-0.0448885736650657,1.51002461254714e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40380,-0.0280862591216898,0.00465245167912448,-0.0372050644127738,-0.0189674538306058,1.60615667120892e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,-0.0281525290116328,0.00466361107503919,-0.0372932067187096,-0.019011851304556,1.61482230572677e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,0.0221353309157504,0.00366867974823172,0.0149447186092163,0.0293259432222846,1.64058806317419e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,-0.0219372403271654,0.00363583469342764,-0.0290634763262835,-0.0148110043280472,1.64599410808767e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,37562,-0.0723903811046269,0.012008450659389,-0.0959269443970294,-0.0488538178122244,1.70157947722099e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,0.0185676089699087,0.00308820218285835,0.0125147326915063,0.024620485248311,1.86755207506033e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,-0.0150544917535049,0.00250406926347898,-0.0199624675099237,-0.0101465159970861,1.87274789417478e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,-0.0239512791384102,0.00398879207232805,-0.0317693116001731,-0.0161332466766472,1.96808464681095e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37901,-0.0576596808473847,0.00960536289933366,-0.0764861921300787,-0.0388331695646908,1.98858415931796e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,-0.0367177246998801,0.0061223370474268,-0.0487175053128366,-0.0247179440869235,2.05707136857163e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,39934,-0.040875808674775,0.00681712207411724,-0.0542373679400448,-0.0275142494095052,2.06668479259284e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,-0.0197116938933066,0.00328955545552382,-0.0261592225861333,-0.01326416520048,2.11485176947746e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,40355,-0.023227133938203,0.00387833005770066,-0.0308286608512963,-0.0156256070251097,2.15745296186102e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,40422,0.0366551294479037,0.00612061067106832,0.0246587325326098,0.0486515263631976,2.15924217543957e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39961,-0.0378263078944549,0.00632369980468967,-0.0502207595116467,-0.0254318562772632,2.25711546734642e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,40359,-0.0396948344887234,0.00663820419308145,-0.0527057147071631,-0.0266839542702838,2.28255957188743e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,40359,0.0221855282231596,0.00371509060890916,0.0149039506296976,0.0294671058166215,2.39744092617576e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37942,-0.0617888072394756,0.0103585963797277,-0.0820916561437419,-0.0414859583352094,2.50790080556011e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,-0.0168034906733458,0.00281838492577558,-0.0223275251278659,-0.0112794562188257,2.55392374819442e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,37998,0.0191252452667964,0.00320795642459491,0.0128376506745904,0.0254128398590024,2.55655153072018e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37900,-0.0194494831695556,0.00326336862310845,-0.0258456856708482,-0.0130532806682631,2.58644525803687e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,40536,-0.0143825613296304,0.00241465822045168,-0.0191152914417157,-0.00964983121754513,2.63300798967183e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,-0.0196465727004376,0.00330911655845411,-0.0261324411550077,-0.0131607042458676,2.96085298242351e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,40453,-0.0301319802667801,0.00507702930587594,-0.040082957706297,-0.0201810028272633,2.99982434680663e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,37901,-0.0204752943383763,0.00345480468682646,-0.0272467115245561,-0.0137038771521964,3.16814068232205e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,40332,0.0193666298942077,0.00327508572694857,0.0129474618693885,0.0257857979190269,3.42158417437428e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,-0.0459862035789202,0.00779547970261311,-0.0612653437960419,-0.0307070633617986,3.74305781796747e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,-0.015800044798625,0.0026837412696216,-0.0210601776870833,-0.0105399119101667,4.01866629211226e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,-0.0206532238638884,0.00350861162806771,-0.0275301026549011,-0.0137763450728757,4.042579368755e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,37986,-0.0210823208260548,0.00358590626233591,-0.0281106971002332,-0.0140539445518764,4.21925921059715e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,37482,-0.0299208831453419,0.00508972022542432,-0.0398967347871736,-0.0199450315035102,4.23650415737427e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37714,-0.0403030401153567,0.00687643051538651,-0.0537808439255142,-0.0268252363051991,4.70905032692485e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,37959,-0.0331394775532408,0.00565958862037235,-0.0442322712491706,-0.022046683857311,4.86755528725578e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C7,Complement component C7,37678,0.0181645841115373,0.00310419839233685,0.012080355262557,0.0242488129605175,4.98339413937304e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39980,-0.0272944515718392,0.00466728276517318,-0.0364423257915787,-0.0181465773520998,5.07394382140753e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40419,-0.0182194914659657,0.00311820275774173,-0.0243311688711395,-0.0121078140607919,5.22838354552681e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,40359,-0.0490914046508332,0.00841661141517449,-0.0655879630245752,-0.0325948462770912,5.56024072282332e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,37819,-0.0255427357650347,0.00438169295668322,-0.0341308539601338,-0.0169546175699355,5.69033905361931e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,0.0237049791820986,0.00406799695354082,0.0157317051531586,0.0316782532110386,5.74549031312115e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,40516,-0.0151819122780714,0.00260700207542571,-0.0202916363459058,-0.010072188210237,5.87234440683717e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,37714,-0.0425299013270353,0.00730262954952715,-0.0568430552441085,-0.0282167474099621,5.88167300467102e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,40471,-0.0148780898210816,0.00255638957012297,-0.0198886133785226,-0.00986756626364057,5.99855333080115e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,-0.0198007705469428,0.00340377373240621,-0.026472167062459,-0.0131293740314266,6.096419488303e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,40471,-0.0542516009996713,0.00934124372602746,-0.0725604387026851,-0.0359427632966575,6.45179574786019e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,-0.049770752954371,0.00857313383031586,-0.0665740952617901,-0.032967410646952,6.56487198181683e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,39980,-0.0420664339139466,0.00725045258490723,-0.0562773209803647,-0.0278555468475284,6.68427147082094e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,39980,-0.0304364663188365,0.00524704069632977,-0.0407206660836429,-0.0201522665540302,6.73269066309842e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37987,-0.0147529694174696,0.00254400237505092,-0.0197392140725694,-0.00976672476236981,6.81530880721355e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,40044,-0.0386804391102743,0.0066881113900992,-0.0517891374348687,-0.0255717407856798,7.4580225403376e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37562,-0.0355899383923163,0.00616513863313151,-0.0476736101132541,-0.0235062666713786,7.9744095465059e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,37562,-0.045215890642856,0.00783307324614141,-0.0605687142052931,-0.0298630670804188,7.99042303130011e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,40305,0.0160127431000268,0.00277671923496645,0.0105703733994926,0.0214551128005611,8.23026515678982e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,40444,0.023940341537282,0.00415458836806285,0.0157973483358789,0.0320833347386852,8.44594307388411e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,-0.0376742097411288,0.00656044668388216,-0.0505326852415379,-0.0248157342407198,9.52248667884569e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37942,-0.0365295168273391,0.00636292653462153,-0.0490008528351973,-0.0240581808194809,9.61496787160504e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,37628,-0.0236807628664458,0.00412488621008669,-0.0317655398382157,-0.0155959858946758,9.6223170221426e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,40359,-0.0253866950343328,0.00442896021841827,-0.0340674570624327,-0.016705933006233,1.0106622079974e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,37608,-0.0234215004566484,0.00408650758892122,-0.031431055330934,-0.0154119455823628,1.01777063311388e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,-0.0497229164962589,0.00869822854431011,-0.0667714444431067,-0.0326743885494111,1.11072705975695e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,40489,-0.0159844138640605,0.00279762821593725,-0.0214677651672975,-0.0105010625608235,1.12601339242414e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37987,-0.0405455023502297,0.0070958952602157,-0.0544534570602525,-0.0266375476402069,1.12717041336125e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,39923,-0.0424297484456369,0.00743254937570966,-0.0569975452220278,-0.0278619516692459,1.15971411538174e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40359,-0.0370995602703289,0.0065068410249465,-0.049852968679224,-0.0243461518614337,1.20777900766934e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,40359,-0.0356958577699578,0.00626127715712622,-0.0479679609979252,-0.0234237545419904,1.21184026810045e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,-0.015088257345513,0.0026474077444837,-0.020277176524701,-0.00989933816632493,1.22474772775388e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,-0.0271276992215229,0.00476181894987387,-0.0364608643632756,-0.0177945340797701,1.24153595924074e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,40291,-0.0158860522476782,0.00279550019037699,-0.0213652326208171,-0.0104068718745393,1.34899913671315e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,-0.0266505716726037,0.00470116062325352,-0.0358648464941806,-0.0174362968510268,1.46632640100219e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,40305,-0.0406767672201436,0.00718659604383057,-0.0547624954660515,-0.0265910389742357,1.53913933147441e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,39951,-0.0613609452404837,0.010858177495933,-0.0826429731325123,-0.0400789173484551,1.62203788315843e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37942,0.0336787379752469,0.00596596016406537,0.0219854560536787,0.045372019896815,1.68364169012238e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,37942,-0.0394222825105204,0.00699499300054539,-0.0531324687915893,-0.0257120962294514,1.77751522199915e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40359,0.00964425234346593,0.0017122785455575,0.00628818639417322,0.0130003182927586,1.80717169668103e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,39961,-0.0205580519971944,0.00365339072027908,-0.0277186978089415,-0.0133974061854474,1.86417180239509e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,40228,0.0329467905376248,0.00585849172556963,0.0214641467555083,0.0444294343197413,1.90006865063931e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,40434,-0.0339860298995019,0.00605197374098192,-0.0458478984318265,-0.0221241613671774,1.99034379482905e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,40274,-0.0268622782497756,0.00478461354558869,-0.0362401207991294,-0.0174844357004217,2.00669739144157e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,-0.0301897724688024,0.00538293801483376,-0.0407403309778765,-0.0196392139597282,2.07592566446758e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,-0.0301069058920964,0.00537441443051685,-0.0406407581759095,-0.0195730536082834,2.16180572119519e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,37959,-0.0328908476627793,0.00588863789742185,-0.0444325779417261,-0.0213491173838325,2.37560844177253e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37562,-0.0281026849093267,0.00504268311867585,-0.0379863438219314,-0.0182190259967221,2.55383267132073e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,39961,-0.0395725347019199,0.00710663404208321,-0.053501537424403,-0.0256435319794368,2.61366427636348e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40359,0.0421527761383491,0.0075729515487472,0.0273097911028046,0.0569957611738936,2.64518176744564e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,37901,-0.0190246625980725,0.00342673123439203,-0.0257410558174809,-0.0123082693786642,2.88032750907118e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,37855,-0.0262252777148675,0.00472448041760966,-0.0354852593333824,-0.0169652960963525,2.89544823558219e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,37987,-0.0288054673847515,0.00519025312258433,-0.0389783635050167,-0.0186325712644862,2.91178689388775e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,40044,-0.019351915185782,0.00349556820935521,-0.0262032288761182,-0.0125006014954458,3.1422140030963e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,40341,-0.0304134091659602,0.00550540590777644,-0.0412040047452021,-0.0196228135867184,3.36033098728045e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,37900,-0.0223094777086009,0.00404457958827593,-0.0302368537016217,-0.0143821017155801,3.53416734464457e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,40379,0.0180203994467451,0.00327255944085116,0.0116061829426769,0.0244346159508134,3.71667876227869e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,37541,-0.0417709000399452,0.00759997630750642,-0.0566668536026578,-0.0268749464772326,3.95350656310026e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,40044,-0.023644876304364,0.00430676119601733,-0.032086128248558,-0.0152036243601701,4.07806723855057e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37990,-0.0183614731791273,0.003345708705855,-0.0249190622426031,-0.0118038841156515,4.13663874346529e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40359,0.0153066355837222,0.00279016407265746,0.00983791400131357,0.0207753571661308,4.17586009831649e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,-0.0176751975137704,0.00322672643132276,-0.023999581319163,-0.0113508137083778,4.37243756780168e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,40015,-0.0258960993389516,0.0047319099632707,-0.0351706428669621,-0.016621555810941,4.50201811824693e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,39961,-0.035983492563932,0.00660014738943767,-0.0489197814472298,-0.0230472036806342,5.05897042698e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENG,Endoglin,40536,0.00909430183403,0.00167171902762153,0.00581773253989179,0.0123708711281682,5.4031693670673e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37879,-0.0222615032262628,0.00409283578699418,-0.0302834613687714,-0.0142395450837542,5.44760730469728e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,37671,0.0116833150259394,0.00214921664298354,0.00747085040569162,0.0158957796461871,5.54319560967839e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,-0.0268439007764844,0.00493839796174137,-0.0365231607814975,-0.0171646407714713,5.55375594210825e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,-0.0144719621420816,0.00266611987926931,-0.0196975571054494,-0.00924636717871371,5.77834740700663e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,-0.0445935883367577,0.00821570725319343,-0.0606963745530168,-0.0284908021204986,5.78952536537306e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,40332,-0.0352753504910637,0.00650202087786352,-0.0480193114116763,-0.0225313895704512,5.87076223815464e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40341,-0.0249874895062883,0.00460858791729977,-0.0340203218241958,-0.0159546571883807,5.98161545978415e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,-0.0221167967168928,0.00408287289255434,-0.0301192275862993,-0.0141143658474863,6.16824075185e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,40422,0.014990896476154,0.00277017946033341,0.00956134473390051,0.0204204482184075,6.33909451961473e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37714,-0.0294292683220649,0.00545106752643164,-0.0401133606738709,-0.0187451759702589,6.824029550588e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39897,-0.0303068336530819,0.00561509911730979,-0.0413124279230091,-0.0193012393831547,6.86182668994456e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37959,-0.0207783102254083,0.00386190106314143,-0.0283476363091655,-0.0132089841416511,7.55888148483459e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,40305,-0.0718513703707598,0.013356269267485,-0.0980296581350305,-0.0456730826064891,7.57113983518801e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37942,0.0141164095634204,0.00262748551234451,0.00896653795922516,0.0192662811676156,7.89015795593473e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,40177,-0.0177580873685664,0.0033076101660423,-0.0242410032940093,-0.0112751714431235,8.03618950026316e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,40489,-0.02388911387462,0.00445063135258799,-0.0326123513256925,-0.0151658764235476,8.09103766539228e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,38013,0.0161004735159745,0.00300725283063588,0.0102062579679282,0.0219946890640208,8.74906142396439e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37990,-0.0142488100151979,0.00266311840888618,-0.0194685220966148,-0.00902909793378101,8.91778777654927e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40424,0.0109637033808372,0.00206025658693656,0.00692560047044158,0.0150018062912329,1.04291262851256e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,40042,-0.0274645828727121,0.00516121428317826,-0.0375805628677415,-0.0173486028776827,1.04429721658965e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,37598,-0.0333140963041384,0.00626033102069448,-0.0455843451046996,-0.0210438475035772,1.04628696418202e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,40341,-0.0209689372320709,0.00394289482697007,-0.0286970110929322,-0.0132408633712095,1.06242281929944e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,40522,-0.0175888874716898,0.00330984906403673,-0.0240761916372018,-0.0111015833061778,1.08612896375689e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,37849,0.0151016423250915,0.00285352177682682,0.00950873964251097,0.0206945450076721,1.22704489701613e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,0.016641137796248,0.00314800035965009,0.0104710570913338,0.0228112185011622,1.26527682251629e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,40516,-0.0314716328336809,0.00596469645586949,-0.0431624378871851,-0.0197808277801767,1.33517094680137e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,37604,0.0178060814747807,0.003374715566469,0.0111916389645015,0.02442052398506,1.33896268497386e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,40435,-0.0228647334301581,0.00433790257008763,-0.0313670224675299,-0.0143624443927864,1.37506876353882e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,40173,-0.0534520037631016,0.0101561782083971,-0.0733581130515599,-0.0335458944746433,1.43582933314092e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37562,-0.0198765893979496,0.00377881771999963,-0.0272830721291489,-0.0124701066667504,1.46320965600414e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,37714,-0.0198536319230057,0.00378486007338699,-0.0272719576668442,-0.0124353061791673,1.58224309947157e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,-0.0355523814361783,0.0067897294864678,-0.0488602512296552,-0.0222445116427014,1.65982542052396e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,40042,-0.0243315378226598,0.0046486928380742,-0.0334429757852853,-0.0152200998600344,1.67977216713151e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,-0.0469053040716056,0.00898162283119378,-0.0645092848207454,-0.0293013233224658,1.79343290749181e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37959,0.0232390174076386,0.00445144926356944,0.0145141768510425,0.0319638579642347,1.81037634711608e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37942,-0.0111769689656637,0.00215684361081314,-0.0154043824428575,-0.00694955548846999,2.22573177842021e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,39961,-0.0267167548982423,0.00516761771362156,-0.0368452856169406,-0.0165882241795441,2.36961450238373e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,-0.0416437763723039,0.00806359258494355,-0.0574484178387933,-0.0258391349058145,2.44099265796628e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,40228,-0.0175354242332699,0.00340087444545667,-0.024201138146365,-0.0108697103201748,2.55124541201738e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,37942,-0.0485538087531804,0.0094277066661862,-0.0670321138189053,-0.0300755036874554,2.63988686847995e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,40044,-0.0354671176237029,0.00688835347894584,-0.0489682904424368,-0.0219659448049691,2.65273243484999e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,-0.0257837338789011,0.00501523782910733,-0.0356136000239515,-0.0159538677338508,2.76482906836511e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39925,-0.0220717614415869,0.0042958886347148,-0.0304917031656279,-0.0136518197175459,2.81233400523094e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,40271,-0.0272687880275663,0.00531218156877091,-0.0376806639023573,-0.0168569121527754,2.88146882309858e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,40422,-0.0132275483136141,0.00257739556865452,-0.0182792436281769,-0.0081758529990512,2.89829972187362e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,40471,-0.0330313768839326,0.00643793712850261,-0.0456497336557977,-0.0204130201120675,2.91977314928806e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAT,Catalase,37786,-0.0274741121368581,0.00536052889006619,-0.0379807487613878,-0.0169674755123284,3.01281007489244e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,37934,-0.0129946130760726,0.00254043118978528,-0.0179738582080518,-0.00801536794409349,3.17843616093245e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,-0.0256242975228372,0.00501602027309211,-0.0354556972580977,-0.0157928977875766,3.29186912403876e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,40044,-0.014859243926754,0.00290922413748054,-0.0205613232362159,-0.00915716461729215,3.30069680309586e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37539,-0.0206681150812048,0.00404903984928885,-0.0286042331858109,-0.0127319969765986,3.36414969966151e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,38013,0.0113247874984286,0.00222549105121055,0.00696282503805589,0.0156867499588013,3.65407691599928e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,-0.023442978443467,0.0046180117241164,-0.0324942814227351,-0.0143916754641988,3.8907086470893e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,-0.0142119787424848,0.00280290142005234,-0.0197056655257874,-0.00871829195918227,4.01280405154499e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,37598,-0.0260890616100946,0.00514568274875963,-0.0361745997976635,-0.0160035234225258,4.03042304473968e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,-0.0607732432071121,0.0119955037393072,-0.0842844305361542,-0.03726205587807,4.10094687117465e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,37911,-0.0284786692753455,0.00562695047709491,-0.0395074922104515,-0.0174498463402395,4.22301333047301e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,-0.0517399930181667,0.0102398696320625,-0.0718101374970092,-0.0316698485393242,4.40250387835728e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,40260,-0.0146153878333676,0.00290892856362163,-0.020316887818066,-0.00891388784866923,5.10732553062441e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,40042,-0.0367338427772437,0.00732087054877352,-0.0510827490528398,-0.0223849365016476,5.28728093079191e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,40411,-0.0143599595865395,0.00286779815723152,-0.0199808439747133,-0.0087390751983657,5.57842651814708e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,37987,0.012129040390351,0.00242662209991109,0.00737286107452526,0.0168852197061767,5.85540335899447e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40516,-0.0286619619286517,0.0057410709223585,-0.0399144609364744,-0.017409462920829,6.02452967515516e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40536,0.0161577193128345,0.00324073923329548,0.0098058704155754,0.0225095682100937,6.23441165069263e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRN,Progranulin,40262,-0.01185419037517,0.00237885919312253,-0.0165167543936902,-0.00719162635664982,6.32215468835608e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37562,-0.0573124141193494,0.0115020839243143,-0.0798564986110055,-0.0347683296276933,6.34747703618258e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,40341,-0.032956909516361,0.00661656917555178,-0.0459253851004425,-0.0199884339322795,6.39316620114879e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,40359,0.0165485008876057,0.00332773236475662,0.0100261454526827,0.0230708563225287,6.66438750563249e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,-0.0302841850860999,0.00609463707203974,-0.0422296737472978,-0.0183386964249021,6.81245037319522e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,40044,-0.0273441687785783,0.00550523474382482,-0.0381344288764749,-0.0165539086806816,6.87375387464535e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,40228,-0.0295981734266942,0.00596708885381773,-0.041293667580177,-0.0179026792732114,7.11398359537405e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,-0.0133493640943775,0.00269193681492314,-0.0186255602516268,-0.00807316793712811,7.15838501076844e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,40396,0.0148280286613801,0.00299284008847855,0.00896206208796211,0.020693995234798,7.32593543466937e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,40359,-0.0134333938599609,0.00271902856644688,-0.0187626898501968,-0.00810409786972502,7.87092585929065e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37900,-0.0266455758716528,0.00539500159801373,-0.0372197790037598,-0.0160713727395459,7.94929001383087e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37671,0.0129949870115345,0.00263306884821467,0.00783417206903378,0.0181558019540353,8.10025215024187e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,-0.0440191034569637,0.00892697780442367,-0.0615159799536341,-0.0265222269602933,8.27737049837362e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,40042,-0.021619025418793,0.00439531475694207,-0.0302338423423994,-0.0130042084951865,8.80301413618846e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,37598,-0.0570245593312274,0.0116006697399457,-0.0797618720215209,-0.0342872466409339,8.95668348260179e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,40042,-0.0240786066840969,0.00492493791334649,-0.033731484994256,-0.0144257283739378,1.02296822130648e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37671,-0.0183117804032084,0.00374655361272186,-0.0256550254841433,-0.0109685353222736,1.03253175265301e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,39961,-0.0236288952787189,0.00483927148597039,-0.0331138673912208,-0.0141439231662169,1.05664654387337e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37942,-0.0221145657730007,0.00453277630039823,-0.0309988073217813,-0.0132303242242202,1.07945257572368e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,0.0137527041064753,0.00282000257138445,0.00822549906656175,0.0192799091463888,1.09065223769594e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,-0.015002953340292,0.00308915800170999,-0.0210577030236436,-0.00894820365694044,1.20526876822878e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,40207,-0.021348646850124,0.0044023988371628,-0.0299773485709631,-0.0127199451292849,1.2506709758407e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,40024,-0.0201190121259405,0.00415001546156807,-0.0282530424306139,-0.011984981821267,1.2595574984615e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,40305,-0.0195648408852567,0.00404739569719001,-0.0274977364517491,-0.0116319453187643,1.35115792740363e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37714,-0.0360435173713953,0.00746536778372045,-0.0506756382274874,-0.0214113965153032,1.39382115072181e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,40437,-0.0384158923900956,0.00796100363159671,-0.0540194595080251,-0.022812325272166,1.40935355448742e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,37959,0.0211068109689739,0.00437861212271079,0.0125247312084607,0.029688890729487,1.4480570021446e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,39947,-0.0409067672659448,0.00852088658098695,-0.0576077049646793,-0.0242058295672104,1.59536990748905e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,40341,0.0221756900042409,0.00462087876549088,0.0131187676238787,0.031232612384603,1.60893331754819e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37562,-0.0296515365120336,0.00618826355037643,-0.0417805330707714,-0.0175225399532958,1.67289858499307e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,-0.041870835824483,0.00875768644443931,-0.059035901255584,-0.024705770393382,1.76271555859327e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39961,-0.0227968561481243,0.00477443367823764,-0.03215474615747,-0.0134389661387785,1.815498301358e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,-0.0164951361316805,0.00345886748587703,-0.0232745164039995,-0.00971575585936153,1.87184193161153e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,-0.0213184706476129,0.00448939026375048,-0.0301176755645639,-0.012519265730662,2.06963324797644e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39980,-0.0250466579346594,0.00527594896955693,-0.035387517914991,-0.0147057979543278,2.07961122942251e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,40341,0.019310125493832,0.00407418725077384,0.0113247184823152,0.0272955325053487,2.15967845831391e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",40314,-0.0507565790049902,0.0107118046832475,-0.0717517161841552,-0.0297614418258252,2.17303708627613e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40403,0.0127931026378192,0.00269992018929403,0.00750125906680293,0.0180849462088355,2.17348622302623e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,40305,-0.0130648509175483,0.00275878246827129,-0.0184720645553601,-0.0076576372797366,2.20156754575549e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37562,0.0187771881099832,0.00396651821197159,0.0110028124145189,0.0265515638054475,2.22525887342545e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,37942,-0.0337181717414746,0.00713025684724571,-0.0476934751620762,-0.019742868320873,2.28040363974319e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,0.0131080683710471,0.00277598338934197,0.00766714092793681,0.0185489958141573,2.3559786235808e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,39961,-0.02130926434532,0.00451487586100164,-0.0301584210328832,-0.0124601076577568,2.38150972743119e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39961,-0.0178563115070973,0.00378713277428988,-0.0252790917447054,-0.0104335312694891,2.43820095148802e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,-0.0202667555760025,0.00430154874269109,-0.028697791111677,-0.0118357200403279,2.48348621747503e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37628,-0.0148336497000562,0.00315103933644456,-0.0210096867994875,-0.00865761260062486,2.53275536339023e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,37900,-0.0301747464054911,0.00641627540392495,-0.042750646197184,-0.0175988466137982,2.59112002578228e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37901,-0.0523195043957471,0.0111330022273024,-0.0741401887612597,-0.0304988200302344,2.63388991673313e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,37562,-0.027905509631801,0.00594178433704975,-0.0395514069324185,-0.0162596123311835,2.67359854997297e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,40279,-0.0330084116170154,0.00702970865504549,-0.0467866405809046,-0.0192301826531263,2.68109664197792e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,37482,-0.0283692980081007,0.00604261496784293,-0.0402128233450728,-0.0165257726711285,2.69494422763951e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,0.0229660431638141,0.00489321643496321,0.0133753389512862,0.032556747376342,2.70881507967664e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,37643,-0.0650591794571104,0.0139037682867972,-0.092310565299233,-0.0378077936149879,2.90791170421725e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,37482,-0.0164928433776376,0.00352991706413325,-0.0234114808233387,-0.00957420593193639,3.00820867782796e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,-0.0308041926997535,0.00659741371726105,-0.0437351235855851,-0.0178732618139218,3.05475854235618e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,37900,-0.017188230320051,0.00368833245749616,-0.0244173619367435,-0.00995909870335854,3.18991495278765e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,-0.0120638199574625,0.00258997560838109,-0.0171401721498895,-0.00698746776503561,3.22043228178798e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,-0.0207145475678653,0.00445040987835486,-0.0294373509294408,-0.0119917442062897,3.27893488848737e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,37562,-0.0366863356601406,0.00789077564711456,-0.0521522559284851,-0.021220415391796,3.36364444350915e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,37598,-0.0284491666050144,0.00613793294006527,-0.0404795151675424,-0.0164188180424865,3.60413037795685e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,-0.0306990925471257,0.00663844535649098,-0.043710445445848,-0.0176877396484034,3.79172175807137e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,40379,0.0148803458322159,0.00322794863216923,0.00855356651316415,0.0212071251512676,4.06097570197164e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,-0.0538134155827856,0.0116795228268974,-0.0767052803235044,-0.0309215508420668,4.1070376969026e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37900,-0.0182652011176757,0.00396653680458678,-0.0260396132546657,-0.0104907889806856,4.1660006563779e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,37824,-0.0132288076606753,0.00287867840000285,-0.0188710173246809,-0.00758659799666975,4.35776693482572e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,-0.0183751228978353,0.00400843924382513,-0.0262316638157326,-0.0105185819799381,4.6013950625364e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37541,0.0150089313849026,0.0032850017063008,0.00857032804055299,0.0214475347292521,4.94708790878169e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,37698,0.013848314068411,0.00303485451738512,0.00789999921433621,0.0197966289224859,5.08591605954809e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,40357,0.0160736099606345,0.00353026857174288,0.00915428356001846,0.0229929363612505,5.32571862666608e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",40489,-0.0328529018279078,0.0072377789326657,-0.0470389485359326,-0.018666855119883,5.69092426078939e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,38013,-0.0116164719369447,0.00255924834680001,-0.0166325986966727,-0.00660034517721669,5.70031026706513e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,37901,-0.0317223964263359,0.0069922560322276,-0.045427218249502,-0.0180175746031698,5.76113336755999e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,37901,-0.0249117619464998,0.00550106404946968,-0.0356938474834603,-0.0141296764095392,5.99044964950092e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39980,-0.0233407067641718,0.00515598981542025,-0.0334464468023955,-0.0132349667259481,6.02968945065775e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,39946,-0.0250528827195829,0.00553497890067225,-0.0359014413649005,-0.0142043240742653,6.04769010404008e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,0.008973830231818,0.00198874658579904,0.00507588692365187,0.0128717735399841,6.46847563243555e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,-0.0138684606417997,0.00307939633555935,-0.019904077459496,-0.00783284382410338,6.73662355917703e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,40077,-0.0150863633452053,0.00335423837434736,-0.0216606705589261,-0.00851205613148444,6.91868211669407e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,-0.0204874851469772,0.00455784462170606,-0.0294208606055211,-0.0115541096884334,7.00755840870307e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,37572,-0.0266822771049016,0.00594122568312113,-0.038327079443819,-0.0150374747659842,7.14814129308276e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,40305,0.00935101190740523,0.00208234502939232,0.00526961564979629,0.0134324081650142,7.15186280757483e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,39934,-0.0274055953995051,0.00610803109188063,-0.0393773363395911,-0.015433854459419,7.28170917828794e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRL,Prolactin,40471,0.033665227055259,0.00751495554013463,0.0189359141965951,0.0483945399139229,7.524263591304e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.0155612233905619,0.00347397535635533,-0.0223702150890184,-0.00875223169210548,7.53806324536467e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37567,-0.0261667240170629,0.0058479000735997,-0.0376286081613183,-0.0147048398728075,7.72168246401626e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,38013,0.0330031096714212,0.00738289988619373,0.0185326258944815,0.0474735934483609,7.87767352858463e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,40221,0.0125626651446348,0.00281420776485255,0.00704681792552377,0.0180785123637458,8.09957955466327e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,40228,-0.021104791077517,0.00472998456442243,-0.030375560823785,-0.011834021331249,8.17923125747625e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37863,-0.0189847455349614,0.00425903912943665,-0.0273324622286573,-0.0106370288412656,8.35865024111149e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37562,-0.0443394514622334,0.00996164754693384,-0.0638642806542238,-0.0248146222702431,8.61703242537282e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37572,-0.0264870258449131,0.00596439121576939,-0.0381772326278211,-0.0147968190620051,9.03325320314301e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37598,-0.0136867416133035,0.00308660417707363,-0.0197364858003678,-0.0076369974262392,9.31474343796765e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,37628,-0.0128545756402021,0.00290351810548255,-0.0185454711269479,-0.00716368015345631,9.62136677592598e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,40471,0.0134167580388925,0.00303120138729607,0.00747560331979219,0.0193579127579928,9.65332438098374e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,40192,-0.0135355526695878,0.00305867530152758,-0.0195305562605819,-0.00754054907859375,9.69559218993939e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37942,-0.103574332454758,0.0234699267149688,-0.149575388816097,-0.0575732760934196,1.02707891290551e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,40305,-0.0154924791504635,0.00351797714521219,-0.0223877143550794,-0.00859724394584759,1.07065920254362e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37671,0.0108363286828778,0.00246562710715196,0.00600369955285997,0.0156689578128957,1.11657716267625e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,40225,-0.0250960656241194,0.00571226619019025,-0.0362921073568923,-0.0139000238913465,1.12337813024159e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,39961,-0.0225432804943733,0.00514668638931365,-0.032630785817428,-0.0124557751713185,1.19372923558006e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,0.0132888141424288,0.00303643407243517,0.00733740336045584,0.0192402249244017,1.21413026684668e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,40203,0.0134051340175079,0.00306484403648322,0.00739803970600082,0.019412228329015,1.2286429745012e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,40305,-0.0181786099995132,0.00415888175419351,-0.0263300182377325,-0.0100272017612939,1.24446906231357e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,-0.0231629216054317,0.00529943811723987,-0.0335498203152219,-0.0127760228956416,1.24729442698167e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,40341,0.0171767416875104,0.0039340540478126,0.00946599575379766,0.0248874876212231,1.27244494944962e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,40341,-0.0269232587369277,0.00616663531129632,-0.0390098639470685,-0.0148366535267869,1.27367928848322e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,37900,-0.0262672457605737,0.00602915759585858,-0.0380843946484565,-0.0144500968726909,1.33015052976378e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39980,-0.0256745796798898,0.00589697748910984,-0.0372326555585451,-0.0141165038012345,1.34620796145214e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,-0.037347995230668,0.00858697706615222,-0.0541784702803264,-0.0205175201810097,1.37544620721281e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,40422,-0.0326173740824955,0.00750963276260019,-0.0473362542971919,-0.0178984938677991,1.41156292417402e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,40044,0.0172748937157275,0.00398715394543103,0.00946007198268271,0.0250897154487723,1.48255047717248e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,39897,-0.0199003365571251,0.0046114593606543,-0.0289387969040075,-0.0108618762102427,1.60297978225214e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,40203,-0.016752866118937,0.00388629056635427,-0.0243699956289914,-0.00913573660888262,1.63682487293308e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37863,-0.0225184536095643,0.00523204622391114,-0.0327732642084301,-0.0122636430106985,1.6897130934678e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,40471,-0.0117944707632763,0.00274449480004282,-0.0171736805713603,-0.00641526095519241,1.73753454068639e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,37482,-0.0174542378857328,0.00406733582234402,-0.0254262160975271,-0.00948225967393856,1.78896740068609e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,-0.0385621146108951,0.00899582713490494,-0.0561939357953088,-0.0209302934264814,1.82442770484586e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,40044,-0.0205362812506671,0.00479275737651525,-0.029930085708637,-0.0111424767926972,1.83952931051259e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,-0.0395377349167865,0.00923285739192806,-0.0576341354049655,-0.0214413344286075,1.86077661992608e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,40044,-0.0217551926731383,0.00508986441782913,-0.0317313269320834,-0.0117790584141932,1.9294805781292e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37628,-0.00987562062163384,0.00231252528271407,-0.0144081701757534,-0.00534307106751426,1.96409050505896e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,40278,-0.0249505845221162,0.00584550181974589,-0.0364077680888181,-0.0134934009554143,1.98079976736905e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,40184,0.0196040070112649,0.00459306528759471,0.0106015990475793,0.0286064149749505,1.98232386820795e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37901,0.0212366495391452,0.00497801038021768,0.0114797491939185,0.0309935498843718,2.00287187330194e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40453,-0.0275364477746697,0.00647652591837111,-0.040230438574677,-0.0148424569746623,2.1332741099722e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,-0.0124196814063771,0.0029212497255839,-0.0181453308685215,-0.00669403194423268,2.13572250010259e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,-0.0242528661349973,0.00571524257336504,-0.0354547415787928,-0.0130509906912018,2.21266240409104e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39957,0.0117118583953908,0.00276560863432719,0.0062912654721095,0.0171324513186721,2.30052208259087e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,-0.0450657840544521,0.0106517369051282,-0.0659431883885033,-0.0241883797204009,2.34445517571615e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39980,-0.0148911049975954,0.00352839769060675,-0.0218067644711846,-0.00797544552400615,2.45299486746434e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,40044,-0.0345193920873733,0.00817970834150549,-0.0505516204367241,-0.0184871637380226,2.45548205038333e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.00997677073969579,0.0023649735168861,0.00534142264659903,0.0146121188327925,2.47236853421134e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,40341,0.0202999505152075,0.0048139994277864,0.0108645116367462,0.0297353893936689,2.4910141847305e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37714,0.0120599681687135,0.00286456205071154,0.00644542654931886,0.0176745097881081,2.5699016352025e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,40359,-0.027896079786944,0.00663859596067683,-0.0409077278698705,-0.0148844317040174,2.65886642340153e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,-0.0211897749394909,0.00504710794448753,-0.0310821065106865,-0.0112974433682954,2.70305526679551e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,40332,0.00798425466433311,0.00190436444749781,0.00425170034723739,0.0117168089814288,2.77259109539062e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,40411,-0.0151670259646861,0.00362177493034238,-0.0222657048281572,-0.00806834710121502,2.83267065893211e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,0.0214737080934272,0.00512818852957445,0.0114224585754613,0.0315249576113931,2.8402874859837e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,0.0402434914367385,0.00961280150684907,0.0214024004833144,0.0590845823901627,2.84878093557037e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F3,Tissue factor,40393,0.0115143804277458,0.00275048327658942,0.00612343320563049,0.016905327649861,2.85045347543136e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,-0.0300855769195071,0.00719962326139114,-0.0441968385118337,-0.0159743153271804,2.94646616476181e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37628,-0.0392554884087825,0.00940223556728464,-0.0576838701206604,-0.0208271066969046,2.99740066553659e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,37900,-0.0319442372074344,0.00766377739061113,-0.0469652408930322,-0.0169232335218366,3.0892195140852e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,40028,-0.0174546098136717,0.00419092339540726,-0.0256688196686699,-0.00924039995867345,3.1322140031526e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,37942,-0.0243440406724028,0.00584521453686126,-0.0358006611646509,-0.0128874201801547,3.13589546380956e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,40403,-0.0186474440841175,0.00448294876412543,-0.0274340236618034,-0.00986086450643169,3.20420686508321e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40536,0.0102699694981542,0.00247624611830097,0.0054165271062843,0.0151234118900241,3.38006358854103e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,-0.0252753999096875,0.00610130011252836,-0.0372339481302431,-0.0133168516891319,3.45495461278534e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',37562,-0.0175802198434838,0.00424807535405795,-0.0259064475374374,-0.00925399214953023,3.51926789647674e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.0141290041793339,0.00341435591822121,0.00743686657962038,0.0208211417790475,3.51978285733943e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,39961,-0.0334857408190167,0.00810828047745797,-0.0493779705548343,-0.0175935110831991,3.64948602111268e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,-0.0192844305475837,0.00467901761932019,-0.0284553050814512,-0.0101135560137161,3.78423892283566e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,40044,-0.0347710171173579,0.00844714171103737,-0.0513274148709911,-0.0182146193637246,3.86974646639335e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,37959,-0.0312461437733195,0.00760346842114433,-0.0461489418787624,-0.0163433456678766,3.9892806478357e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,39903,-0.045988639087866,0.0112163103877713,-0.0679726074478977,-0.0240046707278343,4.14981071912679e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,40042,-0.0224891421088356,0.00549734489843322,-0.0332639381097647,-0.0117143461079065,4.318440099946e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,37901,-0.0182537473627421,0.00447366329750329,-0.0270221274258485,-0.0094853672996356,4.52433065689824e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,40044,-0.0189028470093914,0.00464052381914445,-0.0279982736949145,-0.00980742032386827,4.6554927109965e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37598,-0.015437984193317,0.00379055480756794,-0.0228674716161502,-0.00800849677048383,4.67335727332292e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37942,0.0123766943572564,0.00305200254588694,0.00639476936731801,0.0183586193471948,5.03578782410882e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,37959,0.014461492308076,0.00356761060907651,0.00746897551428604,0.021454009101866,5.0728666217411e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,37562,0.01469894550322,0.00363761047620563,0.007569228969857,0.0218286620365831,5.35675235390281e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,-0.0120775002856794,0.00299652730586919,-0.0179506938051831,-0.00620430676617584,5.5972212897738e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,39980,-0.0174222031002538,0.00433219619985779,-0.0259133076519751,-0.00893109854853255,5.80864748761332e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,-0.0101548068583332,0.00252574451678197,-0.0151052661112258,-0.00520434760544051,5.83846018448102e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,37541,0.0110432894173147,0.00274935639830747,0.00565455087663201,0.0164320279579973,5.93531008634001e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,40536,0.0106426749705411,0.00265267286613082,0.00544343615292467,0.0158419137881575,6.04642898786114e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37714,-0.0169907469590854,0.00423897618848016,-0.0252991402885065,-0.00868235362966428,6.15128634568963e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,37901,-0.0167342829116771,0.00418219093607177,-0.0249313771463778,-0.00853718867697645,6.33276987134636e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",39961,-0.019561450686454,0.00489892070689325,-0.0291633352719648,-0.00995956610094327,6.55398557351422e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37562,-0.0147668301530587,0.0036981480156826,-0.0220152002637966,-0.0075184600423208,6.55890331877896e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,0.0134208853773389,0.00338520129684107,0.00678589083553042,0.0200558799191474,7.39176496294046e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,37942,0.014321263915455,0.00361253810878402,0.00724068922223828,0.0214018386086716,7.39844556455639e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,37714,0.0115107457911599,0.00290816667880015,0.00581073910071158,0.0172107524816082,7.59497935030812e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.0109302742261046,0.00276836279846685,0.00550428314110955,0.0163562653110996,7.9053289038878e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,37598,0.0103930887136952,0.00263322383873119,0.00523196998978207,0.0155542074376083,7.95794379991738e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,37787,-0.0239160926000897,0.00606726811228793,-0.035807938100174,-0.0120242471000053,8.12777624968409e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,37628,-0.0112574814727561,0.00286492235326913,-0.0168727292851636,-0.00564223366034863,8.55860077158248e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,40209,0.0490730979197437,0.0124931439397957,0.0245865357977441,0.0735596600417433,8.60195168037799e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,40228,-0.0505892516163223,0.0128909701441344,-0.0758555530988257,-0.0253229501338189,8.73170740829528e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,37714,-0.0206775669545305,0.00527029855183031,-0.0310073521161179,-0.0103477817929431,8.77430037121752e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39980,-0.0156169422163699,0.00398465727592902,-0.0234268704771907,-0.00780701395554897,8.91990559906335e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40359,-0.0134769514456437,0.00344364502432966,-0.0202264956933299,-0.0067274071979576,9.1319591869783e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,37998,0.0118251105225315,0.00303209618487818,0.00588220200017027,0.0177680190448927,9.66655251367525e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,39801,-0.0135143152550194,0.00346914681484033,-0.0203138430121065,-0.0067147874979324,9.83822641330142e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,39980,0.0323055127115996,0.00829360352904734,0.0160500497946668,0.0485609756285324,9.8515771939599e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MB,Myoglobin,40536,-0.0187008409770753,0.00482015989196862,-0.0281483543653338,-0.00925332758881683,0.000104996187088826
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40305,-0.0117330182218621,0.00303794667976779,-0.017687393714207,-0.00577864272951725,0.000112838333348321
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00560058290313742,0.00145195620977785,0.00275474873197284,0.008446417074302,0.00011519434063929
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,40288,-0.041003609402668,0.010639631367047,-0.0618572868820801,-0.0201499319232559,0.000116730773226757
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,-0.0108380251284493,0.00281261458075614,-0.0163507497067314,-0.00532530055016727,0.000117058948086897
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37901,-0.0204850887876041,0.00531763784390696,-0.0309076589616617,-0.0100625186135464,0.000117560891415894
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37900,-0.0154809241971702,0.00402915121758783,-0.0233780605836424,-0.0075837878106981,0.000122482008828387
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,37959,-0.0259403290817245,0.00675534875883057,-0.0391808126490324,-0.0126998455144166,0.000123611685550155
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.0139163680531294,0.00363194351419539,0.00679775876530642,0.0210349773409523,0.000127873092204988
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,-0.0273313313728587,0.00714891544603365,-0.0413432056470846,-0.0133194570986328,0.00013235257727839
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,40442,-0.0181570483260722,0.00477268712957429,-0.0275115151000378,-0.0088025815521066,0.000142697097889297
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37900,-0.0226719793331883,0.00595990657205061,-0.0343533962144075,-0.0109905624519691,0.000142960391222477
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39961,-0.0142564316424015,0.00375861226311866,-0.021623311678114,-0.00688955160668889,0.000149400544849122
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,40184,0.0245330162700763,0.00649412323049394,0.0118045347383082,0.0372614978018444,0.000158850212542795
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,40042,-0.0113179693795347,0.00299652554852702,-0.0171911594546477,-0.00544477930442175,0.000159298807855414
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,-0.0180679100432712,0.00478433919697701,-0.0274452148693461,-0.00869060521719623,0.000159646091031284
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,37598,-0.0122663132752543,0.00325194808887411,-0.0186401315294476,-0.00589249502106108,0.000162661447088919
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,37959,-0.0161943386715574,0.00429436440637447,-0.0246112929080514,-0.00777738443506349,0.000163243728442355
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,40305,0.0280553989647695,0.00746395528686465,0.0134260466025148,0.0426847513270242,0.000171353467107002
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,40396,-0.0108195082523237,0.00287847701584768,-0.0164613232033851,-0.0051776933012622,0.000171365737899307
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPL,Periplakin,37598,-0.0121592128159149,0.00324471898712871,-0.0185188620306871,-0.00579956360114259,0.000179451907930065
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40498,-0.0193447751606909,0.00516762997454657,-0.0294733299108022,-0.00921622041057962,0.000182142809276843
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,37541,-0.016768052318649,0.00448666951800465,-0.0255619245739381,-0.00797418006335987,0.000186794501624795
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37880,-0.0321400949512023,0.00860138090084704,-0.0489988015168625,-0.0152813883855421,0.000187283003904901
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,-0.0140146193376821,0.00375444128771005,-0.0213733242615938,-0.0066559144137704,0.000190134079310865
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSPN,Persephin,40341,-0.0362971833034096,0.0097418389875445,-0.0553911877189969,-0.0172031788878224,0.000195288393194011
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,40257,-0.0243277174727062,0.00653314116169094,-0.0371326741496204,-0.0115227607957919,0.000196975228983907
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,37942,-0.00973999617436657,0.00261908638799216,-0.0148734054948312,-0.00460658685390194,0.000200940552609527
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,37572,-0.0257332624415702,0.0069210581535248,-0.0392985364224789,-0.0121679884606616,0.000201553548896558
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,37598,0.0157034085865002,0.00422775489142862,0.00741700899930006,0.0239898081737003,0.000204560744134236
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,37987,0.0527690558588221,0.0142179425574175,0.0249018884462838,0.0806362232713604,0.000206908520074595
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,37628,-0.0217824108709298,0.00588046070283057,-0.0333081138484777,-0.0102567078933819,0.000212924329508697
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39961,-0.0148969513188888,0.00402257981743172,-0.022781207761055,-0.00701269487672264,0.000213523510346944
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,0.0209733662486907,0.00567573376546664,0.0098489280683761,0.0320978044290053,0.000220553140009562
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40489,0.0213517903968099,0.00578861489542744,0.0100061052017721,0.0326974755918477,0.000226250918007017
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,40411,0.00864681742425251,0.00234460849278114,0.00405138477840146,0.0132422500701035,0.000226811098668254
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,37942,0.00958988743175788,0.00260131659685092,0.00449130690193008,0.0146884679615857,0.000228204675387609
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,40070,-0.0198915587036327,0.00540479845825329,-0.0304849636818092,-0.00929815372545625,0.000233696154825916
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37598,-0.0204252181722889,0.0055524077255679,-0.031307937314402,-0.00954249903017578,0.000235431836293581
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,40203,0.0121095339222822,0.00329320675539279,0.00565484868171229,0.018564219162852,0.000236661443417456
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,40341,0.0215097543996125,0.00587937724876324,0.00998617499203657,0.0330333338071885,0.000254507224224382
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,40044,-0.0125667754178244,0.00343945950196264,-0.0193081160416712,-0.00582543479397762,0.000259329373351704
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,40332,-0.0127026898083465,0.00347936700507001,-0.0195222491382837,-0.00588313047840926,0.000262200392827791
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,-0.0266246870971737,0.00730249346586071,-0.0409375742902606,-0.0123117999040867,0.000267401978828063
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,39961,-0.0162329956965122,0.00445308505891659,-0.0249610424119887,-0.00750494898103566,0.00026791447146879
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37959,-0.0111181356801558,0.00305020008935758,-0.0170965278552966,-0.00513974350501494,0.000268341692877864
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,40042,-0.0224214214112368,0.00615309809970019,-0.0344814936866492,-0.0103613491358245,0.000269384616856922
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,-0.0165448675153034,0.00454226043434706,-0.0254476979666236,-0.00764203706398315,0.000271112154480123
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37901,-0.018547532783504,0.00509444070278382,-0.0285326365609603,-0.00856242900604775,0.000272875821406849
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,-0.0285392448183515,0.00786635486813299,-0.0439573003598922,-0.0131211892768108,0.000286525754007273
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37572,0.0134583053207556,0.00371409877328606,0.00617867172511496,0.0207379389163963,0.000291659883133605
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37671,-0.00912150799269716,0.00251801510404746,-0.0140568175966302,-0.00418619838876414,0.000292863231884685
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,40003,-0.0221829983644892,0.00613830703409162,-0.0342140801513088,-0.0101519165776696,0.000302620825461026
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37714,-0.0210754641207432,0.00583226216575007,-0.0325066979656133,-0.00964423027587307,0.000303091703078188
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,37987,0.00917446855077427,0.00254359295190462,0.00418902636504122,0.0141599107365073,0.000311000451734161
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,-0.0113946081048616,0.00315968927004318,-0.0175875990741462,-0.00520161713557696,0.000311624314917475
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,40228,-0.00799770823392009,0.00222130007280451,-0.0123514563766169,-0.00364396009122325,0.000318625646873406
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCT,Secretin,37572,-0.0163110819234559,0.00453015559842226,-0.0251901868963635,-0.00743197695054826,0.000318708136952704
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,40422,-0.0115617030029678,0.00321646194990547,-0.0178659684247825,-0.00525743758115306,0.000325943099035168
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,-0.0118246874119677,0.00330726299177117,-0.0183069228758392,-0.00534245194809625,0.000350765062629908
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,40044,-0.0211386800581972,0.00591357372495662,-0.0327292845591121,-0.00954807555728217,0.000351818948977205
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37998,-0.0206678952547575,0.00579082320932455,-0.0320179087450336,-0.00931788176448137,0.000359479486517453
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40293,0.0201982777747039,0.00567322617014068,0.00907875448122819,0.0313178010681797,0.000371543642295806
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37572,-0.0173494395246206,0.00487946684682501,-0.0269131945443976,-0.0077856845048436,0.000378442742320469
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,40359,-0.0274681526920513,0.00772576401988331,-0.0426106501710226,-0.01232565521308,0.000378505030224965
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,-0.0305617530424261,0.00860991802182395,-0.0474371923652011,-0.0136863137196512,0.000386928120929526
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,37900,0.0410150703310761,0.011554790265625,0.018367681410451,0.0636624592517012,0.000387109663966983
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,-0.0128776068197353,0.00363172734745959,-0.0199957924207561,-0.00575942121871449,0.00039266000354522
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,37671,0.0314465022439453,0.00888505235737755,0.0140317996234853,0.0488612048644053,0.000402629650795159
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,-0.0145248343095113,0.00410869449964522,-0.0225778755288159,-0.00647179309020667,0.00040873125160222
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,0.0094992304325611,0.00269290035583221,0.00422114573512996,0.0147773151299922,0.000420658390211363
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,40455,-0.0151211710131421,0.00428787007195669,-0.0235253963541772,-0.00671694567210699,0.000422270355163373
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,-0.0145377366217973,0.00412668337079682,-0.0226260360285591,-0.00644943721503557,0.00042813459286074
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,40411,0.00941155239096471,0.0026742727703604,0.00416997776105832,0.0146531270208711,0.000433901471550937
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37942,-0.0158574108286236,0.00450895390954136,-0.0246949604913246,-0.00701986116592249,0.000438100191486257
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40305,-0.0075562209225068,0.00215376485002898,-0.0117776000285636,-0.00333484181644999,0.000452097277526094
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.0163194209070866,0.0046542787664509,0.00719703452484279,0.0254418072893303,0.000455811935826408
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,37714,0.0121547229740546,0.00346658951081586,0.00536020753285549,0.0189492384152537,0.000455973305274749
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,-0.0156105415885621,0.00445394061111885,-0.024340265186355,-0.00688081799076914,0.000458294275777096
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,40359,-0.0119559224450156,0.00341699904845731,-0.0186532405799919,-0.00525860431003925,0.000468363967001752
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,40411,-0.010448681371875,0.00299509614630625,-0.0163190698186352,-0.00457829292511473,0.000486872267296442
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,37541,0.0125108043626273,0.00358784210265745,0.00547863384141866,0.0195429748838359,0.000490074308041137
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,0.0226135598514743,0.0065056138936072,0.00986255662000416,0.0353645630829444,0.00051058498069192
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40403,0.0112993086522699,0.00326222179750237,0.00490535392916526,0.0176932633753746,0.000534228704816372
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,39980,-0.0119109152050139,0.00344716991487076,-0.0186673682381606,-0.00515446217186723,0.000551203608415258
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.00525115354682678,0.00152272896666074,0.00226660477217173,0.00823570232148184,0.000565121873975001
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,-0.0133560350489612,0.00387712315096169,-0.0209551964248461,-0.0057568736730763,0.000573159342979181
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,40411,0.00923125055375418,0.00268614405384175,0.00396640820822435,0.014496092899284,0.000590526898202948
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,40341,0.00824666008455292,0.00240019471873262,0.003542278435837,0.0129510417332689,0.000592252917902808
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,40471,-0.00984859236578261,0.00287071336850389,-0.0154751905680502,-0.00422199416351499,0.000603516525454247
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,37998,0.0175496047328724,0.00513003534144945,0.00749473546363152,0.0276044740021134,0.000625865301069793
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,37967,0.0355911626832513,0.0104041021124963,0.0151991225427585,0.0559832028237441,0.000626040025639865
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,37900,-0.0177384784083967,0.00518926503197425,-0.0279094378710662,-0.00756751894572717,0.000631998041973912
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,37562,0.0141804634537201,0.00416352205941107,0.00601996021727437,0.0223409666901658,0.000661486220091835
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,40341,-0.0295769323941236,0.00870365755677358,-0.0466361012053998,-0.0125177635828474,0.000679926326406062
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,37482,-0.0121722877439522,0.00360771041561999,-0.0192434001585674,-0.00510117532933701,0.000743098237112972
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,40359,0.027703455629281,0.00822097916715441,0.0115903364616584,0.0438165747969037,0.000753882059660272
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,39961,-0.0145743714288633,0.00433692057207266,-0.0230747357501257,-0.00607400710760087,0.000779794736958008
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37562,-0.0149576485072334,0.00447256539132706,-0.0237238766742345,-0.00619142034023241,0.000827185432803036
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,0.0202897351737953,0.00607342851590649,0.00838581528261861,0.032193655064972,0.000837896449292893
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,37990,0.00847461133749513,0.00254569228458572,0.00348505445970712,0.0134641682152831,0.000873908186115501
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37562,0.00937546726122045,0.00281671231755676,0.00385471111880919,0.0148962234036317,0.000875510351236921
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,40305,-0.0146486351765272,0.00440511492265954,-0.0232826604249399,-0.00601460992811453,0.000885018248396124
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,40013,-0.0235940272427661,0.00710715494641539,-0.0375240509377402,-0.00966400354779189,0.00090302877825774
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,0.0282216607908894,0.00850763560141078,0.0115466950121242,0.0448966265696545,0.000911303701911118
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,0.00837035675092763,0.00252763312820062,0.00341619581965442,0.0133245176822008,0.000930349608212321
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37714,-0.0223439780012653,0.00676141841623869,-0.0355963580970931,-0.00909159790543747,0.000953544204599443
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,40305,0.0049195468409967,0.00149090671855042,0.00199736967263787,0.00784172400935552,0.000970012533589522
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.00729852408174564,0.00221537502891673,0.00295638902506886,0.0116406591384224,0.000988146213254142
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,39961,-0.01814708632215,0.00551501506590887,-0.0289565158513314,-0.00733765679296863,0.0010023721983886
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40305,-0.00664912408735654,0.0020242259037339,-0.010616606858675,-0.00268164131603809,0.00102285657815197
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,37901,-0.0188764948326353,0.00574862947743587,-0.0301438086084096,-0.00760918105686101,0.0010273327967531
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,-0.0126343032141484,0.00385116222533828,-0.0201825811758114,-0.00508602525248533,0.00103838989494138
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,40489,-0.00654121318286587,0.00199778635273947,-0.0104568744342352,-0.00262555193149652,0.00106174577762767
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,40017,-0.0178952201601582,0.00548393704094109,-0.0286437367604028,-0.0071467035599137,0.00110396618123086
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,0.0192515960218572,0.00590251815598569,0.00768266043612521,0.0308205316075891,0.00111072213556702
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37562,-0.0178156151479071,0.0054680387832213,-0.0285329711630208,-0.00709825913279332,0.00112431989425291
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,40228,0.0115190942051078,0.00353619803393476,0.00458814605859569,0.0184500423516199,0.00112643730968594
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,-0.0120245351494242,0.00369305043439352,-0.0192629140008355,-0.00478615629801293,0.00113276550296063
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,38013,-0.00609756600006277,0.00187619838792123,-0.00977491484038837,-0.00242021715973717,0.00115703403824612
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,37901,-0.00982773118787192,0.00302774102847646,-0.0157621036036858,-0.00389335877205805,0.00117368235909667
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C5,Complement C5,38013,-0.0048809785221377,0.00150639791216887,-0.00783351842998868,-0.00192843861428673,0.00119748321072312
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,37900,-0.0162850956279066,0.00502655600951215,-0.0261371454065505,-0.00643304584926281,0.00119899241052592
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37482,0.00962554424851973,0.0029773286615659,0.00378998007185057,0.0154611084251889,0.00122825382145846
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37572,-0.0168374613174682,0.00521015461861434,-0.0270493643699523,-0.0066255582649841,0.0012337601996649
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",37714,-0.0142375648700422,0.00440898066242538,-0.022879166968396,-0.0055959627716885,0.0012443090371928
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39980,-0.0145140844219613,0.00449743757209175,-0.0233290620632611,-0.00569910678066143,0.00125271818332376
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,-0.0154112323725364,0.0047808431846776,-0.0247816850145045,-0.00604077973056834,0.00126917927720833
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37598,0.0140408039606533,0.00436254118151326,0.00549022324488734,0.0225913846764193,0.00129179175297821
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,37628,-0.0166659167349163,0.00518309113405992,-0.0268247753576738,-0.00650705811215891,0.00130559016812244
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.0200115564907364,0.00623217253415996,-0.0322266146576899,-0.00779649832378286,0.00132579117098254
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,37998,-0.0284853554856198,0.00887614621248762,-0.0458826020620956,-0.0110881089091441,0.00133413487218824
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,-0.0141092654013219,0.00439690151274219,-0.0227271923662966,-0.00549133843634725,0.00133558439076606
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,-0.0278791741984601,0.00869985080831959,-0.0449308817827665,-0.0108274666141537,0.00135537803341525
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,-0.0076477893858858,0.00238740947142384,-0.0123271119498765,-0.00296846682189507,0.00136090901153522
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,37231,0.0219908346856705,0.00687961496680324,0.00850678935073617,0.0354748800206049,0.00139434099227345
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,37541,0.0138906758744291,0.00434657658398628,0.00537138576981598,0.0224099659790422,0.00139787377939784
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40332,0.0101318118222453,0.00318709964714299,0.00388509651384499,0.0163785271306455,0.00148064103502128
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37921,-0.0120655705405149,0.00379903454518846,-0.0195116782490843,-0.00461946283194554,0.00149679729639405
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37628,0.0122180282789621,0.00385161886022272,0.00466885531292557,0.0197672012449986,0.00151646345999295
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,-0.0370490888475111,0.0116850987544686,-0.0599518824062696,-0.0141462952887526,0.0015239938089412
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,40042,0.0106232150627327,0.00335203113375417,0.00405323404057457,0.0171931960848909,0.00153161131043435
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,-0.0161124420583613,0.00508822052036882,-0.0260853542782842,-0.00613952983843837,0.00154568117943021
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.00847419389016834,0.00267902148756937,0.00322331177453238,0.0137250760058043,0.00156353892466286
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0214719471446811,0.00679546382360384,-0.0347910562389446,-0.00815283805041757,0.00158202883006733
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,-0.0315602404401111,0.01002373522244,-0.0512067614760935,-0.0119137194041288,0.00164440964080581
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,-0.0261842960168566,0.00831659564535009,-0.0424848234817428,-0.00988376855197039,0.00164513035919142
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,38013,-0.00612260377068007,0.00196090869182051,-0.00996598480664826,-0.00227922273471187,0.00179803117613479
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.0109619064700767,0.00351322823638659,0.004075979126759,0.0178478338133944,0.00181119773618066
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,-0.0110596315076194,0.00354815500644644,-0.0180140153202544,-0.00410524769498439,0.00183086351879095
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,-0.0203999073675264,0.00655702728395695,-0.0332516808440821,-0.00754813389097083,0.00186761662898499
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,37981,-0.00450113310735515,0.00145006325404756,-0.00734325708528837,-0.00165900912942192,0.00191256254052208
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37900,-0.0161407577914818,0.00520865197531626,-0.0263497156631017,-0.00593179991986193,0.00194683337884627
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40489,0.0175358321669447,0.00567625443614093,0.00641037347210852,0.028661290861781,0.00200950471677681
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,37598,-0.00866362577231527,0.00280652733991888,-0.0141644193585563,-0.00316283218607426,0.00202638413168114
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37959,-0.0106855407101951,0.00346528887873064,-0.0174775069125071,-0.00389357450788302,0.0020492962527353
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,37541,0.0228579483274263,0.00745103322391991,0.00825392320854332,0.0374619734463093,0.00216113473385307
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,37959,-0.00909823322836647,0.00296641583473027,-0.0149124082644378,-0.00328405819229515,0.00216588821310679
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37572,0.00976401313465389,0.00318496936981798,0.00352147316981064,0.0160065530994971,0.00217636150922788
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,-0.0171142483771985,0.00558728431082492,-0.0280653256264153,-0.00616317112798162,0.00219453120413733
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FST,Follistatin,40396,-0.0156087481831066,0.00509719109919796,-0.0255992427375346,-0.00561825362867859,0.00220063829311323
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,40136,-0.00888805002538141,0.00290263228995676,-0.0145772093136967,-0.00319889073706617,0.00220187483777145
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,37482,0.0107845224309916,0.00353625271311151,0.003853467113293,0.0177155777486901,0.00229527268419529
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,37987,-0.00847333306669519,0.0027847209489558,-0.0139313861266486,-0.00301528000674182,0.00234841777580455
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37875,0.00807931283998929,0.00266579091746485,0.00285436264175818,0.0133042630382204,0.0024442186689335
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40305,-0.0114980771828049,0.00380905946475441,-0.0189638337337235,-0.00403232063188627,0.00254338110649698
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,-0.0102096113188541,0.0033834853555142,-0.0168412426156619,-0.00357798002204626,0.00255287803392342
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,37901,-0.017884724462688,0.00593105339341928,-0.0295095891137898,-0.00625985981158626,0.00257087238453982
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,37671,-0.0231972612960325,0.00771157753712221,-0.038311953268792,-0.00808256932327296,0.00263374103814748
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,40305,-0.0552724515835761,0.0183814805442131,-0.0913001534502338,-0.0192447497169184,0.00264284454155221
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,-0.0125215630247533,0.00416661405998107,-0.0206881265823162,-0.00435499946719037,0.00265894237155204
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,40489,-0.0178673552994873,0.00594870168810737,-0.0295268106081777,-0.00620789999079684,0.00267241830882872
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,-0.0250056935315213,0.00835256211521205,-0.041376715277337,-0.00863467178570572,0.00275972828878483
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,0.00767882447689361,0.00256777725683951,0.00264598105348817,0.012711667900299,0.00279076218699145
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,0.00935004187786408,0.00313369141967595,0.00320800669529921,0.015492077060429,0.0028529655083047
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,40044,-0.0118449846522984,0.00397197696596293,-0.0196300595055858,-0.0040599097990111,0.00286685137577647
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,-0.0161363778433147,0.00543018352961895,-0.0267795375613678,-0.00549321812526153,0.00296698971123679
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,40354,-0.0114161703729432,0.00384598097880457,-0.0189542930914001,-0.00387804765448622,0.00299861372809363
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLU,Clusterin,38013,0.0096737038711804,0.0032607184557407,0.00328269569792863,0.0160647120444322,0.00301500321133367
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,37562,0.00935346605787022,0.00315725326270505,0.00316524966296832,0.0155416824527721,0.00305667058565878
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,37714,0.0100366524732922,0.00340498263086967,0.00336288651678767,0.0167104184297968,0.00320770756900701
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,37934,-0.00914926953050037,0.0031047335330565,-0.0152345472552911,-0.00306399180570963,0.00321549852315773
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,37998,0.0145027828380483,0.0049259069394929,0.00484800523664221,0.0241575604394544,0.00324355966529646
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,40042,-0.0169513331174743,0.00576630878655144,-0.0282532983391152,-0.0056493678958335,0.00328991042671266
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,37671,-0.00980486339507248,0.00333612688437737,-0.0163436720884521,-0.00326605470169284,0.00329846750058366
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,0.0151159635843973,0.00515400411172063,0.00501411552542487,0.0252178116433697,0.00336437869818504
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,37572,-0.0150492365532617,0.00513140789912262,-0.0251067960355421,-0.00499167707098141,0.00336534014173081
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,-0.025687767574689,0.00878903213136318,-0.0429142705521609,-0.0084612645972172,0.00347600338771966
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,37541,-0.0251128657944663,0.00861128318845975,-0.0419909808438474,-0.00823475074508519,0.00354840059873253
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,37562,0.0104872447288606,0.00362620607529878,0.00337988082127495,0.0175946086364462,0.00383341039132142
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,-0.0135564440229187,0.00470856266964284,-0.0227852268554186,-0.00432766119041872,0.00399435141527233
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,-0.0113570944432237,0.00394586528210702,-0.0190909903961535,-0.00362319849029394,0.00400564050968371
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,37714,0.0103876156149201,0.00361967725221431,0.00329304820058004,0.0174821830292601,0.00411428916506145
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,0.0169388495363304,0.00590831153056798,0.00535855893641717,0.0285191401362437,0.00414992008468485
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,40341,0.0165465231559794,0.0057970281240747,0.00518434803279296,0.0279086982791658,0.00431860332347534
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,0.00826392039467722,0.00289696406872336,0.00258587081997943,0.013941969969375,0.00434289056488455
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.0137859866884821,0.00485058104016107,-0.0232931255271978,-0.00427884784976639,0.00448700695652076
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.019364871797288,0.00683100394870488,0.00597610405782642,0.0327536395367495,0.00459054741192927
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.00968220514036841,0.00341713551997155,0.00298461952122418,0.0163797907595126,0.00461090862400085
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,40309,-0.00751114243995088,0.00266334967403637,-0.0127313078010622,-0.00229097707883959,0.00480553302179004
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,40471,-0.00714820317975585,0.0025437500668146,-0.0121339533107125,-0.00216245304879923,0.00495854956374808
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37562,-0.013111998347871,0.00466893762607399,-0.022263116094976,-0.00396088060076595,0.00498701183809875
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,37671,-0.0234278111586932,0.0083508538623725,-0.0397954847289433,-0.00706013758844312,0.005032149566611
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,0.00828502473141522,0.00297560349503853,0.0024528418811397,0.0141172075816907,0.00537178660179595
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,0.00808249874383017,0.00290509206687253,0.00238851829276001,0.0137764791949003,0.00540692244932623
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,-0.00774121339411227,0.00279716981712298,-0.0132236662356733,-0.00225876055255123,0.00565624263329991
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,-0.0109381050497131,0.00395481308155408,-0.0186895386895591,-0.00318667140986709,0.00568654024016954
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,37562,-0.0104015624922333,0.00376227915051133,-0.0177756296272355,-0.0030274953572311,0.00570552765507098
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37482,-0.0210129422901452,0.00762157804522241,-0.0359512352587811,-0.00607464932150924,0.00584096502529885
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,40332,-0.0151314837393492,0.00548966018412843,-0.0258912177002409,-0.00437174977845749,0.00585151897286919
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,37987,0.00604481128737097,0.00220095552704591,0.00173093845436099,0.0103586841203809,0.00603239356786452
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,-0.0129301592893236,0.00472092386193201,-0.0221831700587103,-0.00367714851993687,0.00617254693478058
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37541,0.0115136041198584,0.00420829752782188,0.00326534096532754,0.0197618672743893,0.00622882494203243
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37482,0.00711756109544962,0.0026019444069831,0.00201775005776275,0.0122173721331365,0.00623740809418656
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37942,-0.0191692118020318,0.00701231879929106,-0.0329133566486423,-0.00542506695542136,0.00627186221141312
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39980,-0.0111239915314218,0.00407519922876525,-0.0191113820198017,-0.00313660104304195,0.00634671835323901
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,37482,0.00696104357802068,0.00255011098907943,0.001962826039425,0.0119592611166164,0.00634766909260897
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,40044,-0.0159444774919875,0.00584437231156549,-0.0273994472226559,-0.00448950776131913,0.00637569033714615
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,37598,0.0120120670922844,0.0044056355491557,0.00337702141593923,0.0206471127686296,0.00640903122742137
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,37959,-0.022157878836669,0.0081307565380068,-0.0380941616511623,-0.00622159602217565,0.00643467164414039
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,37714,0.00832477424151257,0.00305775209985618,0.00233158012579445,0.0143179683572307,0.00648718783109144
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,37562,0.0110051701218844,0.00405217071289408,0.00306291552461203,0.0189474247191568,0.0066188439439207
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,40044,-0.0158491839530122,0.00584262592925567,-0.0273007307743533,-0.00439763713167106,0.00668144309340596
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37901,-0.00692822969038942,0.00256091586196464,-0.0119476247798401,-0.00190883460093873,0.00683139286341292
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,37562,-0.0165982464888115,0.00614037633365625,-0.0286333841027778,-0.00456310887484527,0.00687780230119057
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37990,0.00663406750439051,0.00245750818464257,0.00181735146249108,0.0114507835462899,0.00695279460068933
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,37562,0.0138924371519338,0.00514686411812795,0.00380458348040298,0.0239802908234646,0.0069594621654183
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,37482,0.0084370808728388,0.00313243471042901,0.00229750884039794,0.0145766529052797,0.00708056024116684
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,40044,-0.0169237530459189,0.00628388501766638,-0.029240167680545,-0.00460733841129282,0.0070845680862494
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40489,-0.00998161957893212,0.00371198934982426,-0.0172571187045877,-0.00270612045327656,0.00717358663060211
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.0160191838895288,0.0059811809097701,-0.0277422984726782,-0.00429606930637939,0.00740799729702871
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,37990,0.00894073825359745,0.00334378536783145,0.00238691893264782,0.0154945575745471,0.00750788054242304
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,-0.00723430880736894,0.00271122153885493,-0.0125483030235246,-0.00192031459121328,0.00763190789162303
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,40355,0.0117893743362477,0.0044288289949902,0.00310886950606687,0.0204698791664284,0.0077764768552839
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,40391,0.0103309457439454,0.00388353258405993,0.0027192218791879,0.0179426696087028,0.00781740738660395
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,37714,0.00931387682027616,0.00350124518393276,0.00245143625976795,0.0161763173807844,0.00781971919015641
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,0.0101085299360897,0.00380940247404908,0.00264210108695345,0.0175749587852259,0.00797373568133167
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,40044,0.00839353062576492,0.00316787163462717,0.00218450222189566,0.0146025590296342,0.00806730756540604
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,37482,0.0118996796317946,0.00450697422860193,0.00306601014373481,0.0207333491198544,0.00829359790383792
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,39896,-0.00793574612762711,0.00300715421887328,-0.0138297683966187,-0.00204172385863549,0.00832453731598162
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,-0.0160302841053245,0.00608942435164045,-0.0279655558345398,-0.00409501237610924,0.00848632512815666
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,37987,-0.0168052599087069,0.00640908353802344,-0.0293670636432328,-0.00424345617418094,0.00874875361011365
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,37572,-0.00808363832445457,0.00308440654214631,-0.0141290751470613,-0.00203820150184781,0.00878226988921786
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39980,-0.0122083313180356,0.0046625455310866,-0.0213469205589654,-0.0030697420771059,0.00884332773869473
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,37562,0.0131489216042485,0.00503047239993029,0.00328919570038518,0.0230086475081119,0.00896295391734258
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,37541,0.0245844985692637,0.00941065461381625,0.00613961552618389,0.0430293816123436,0.00900087840941028
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37598,-0.00525601952206262,0.00201519769552656,-0.00920580700529468,-0.00130623203883056,0.00911252199682396
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,-0.019996578811019,0.00767050770072927,-0.0350307739044484,-0.00496238371758961,0.00914573879988584
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,-0.00894527016593046,0.00343724527985204,-0.0156822709144405,-0.00220826941742046,0.00926470096494301
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,40489,0.015498897483573,0.00596058403751695,0.00381615277003979,0.0271816421971062,0.00932463595496624
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40305,-0.00538655888153907,0.00207410944966854,-0.00945181340288941,-0.00132130436018873,0.00941160144146338
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,37598,0.00857991273203365,0.00331698210674062,0.00207862780282203,0.0150811976612453,0.00970169198163342
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,37598,-0.00961577867445087,0.00371802343530795,-0.0169031046076545,-0.00232845274124728,0.0097129936699653
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.010772882530243,0.00416628790240046,0.00260695824153813,0.0189388068189479,0.00972776206734384
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,37959,-0.00700239344264649,0.0027271368456381,-0.0123475816600972,-0.00165720522519582,0.0102490517157692
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,37541,0.0248528540632674,0.00970896561152738,0.00582328146467377,0.0438824266618611,0.0104848564900111
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,-0.00600674459738179,0.00234711617712304,-0.010607092304543,-0.00140639689022062,0.0105004709768851
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,37628,-0.0212277497007887,0.00830900319654218,-0.0375133959660114,-0.00494210343556606,0.0106363586377619
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.0122837842227326,0.00481459224486191,-0.021720385022662,-0.0028471834228033,0.0107413710488042
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,37959,-0.00762926358994742,0.00300088476910912,-0.0135109977374013,-0.00174752944249353,0.0110224287307036
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.00557035210502448,0.0021922430107117,0.00127355580402955,0.00986714840601941,0.0110650103709621
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LXN,Latexin,40183,0.016535704907351,0.00650797962050852,0.00378006485115434,0.0292913449635478,0.0110683209144886
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,-0.00753173389728824,0.00297593857781675,-0.0133645735098091,-0.00169889428476741,0.0113875818512723
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,40044,-0.015271846512387,0.00603586725459769,-0.0271021463313985,-0.00344154669337552,0.0114100757428312
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39961,-0.0353224037227702,0.0139836334698657,-0.0627303253237069,-0.00791448212183348,0.0115474166823934
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,40516,-0.0100991404272194,0.00401525813098343,-0.0179690463639469,-0.00222923449049188,0.0119064760436803
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,37598,0.00704228168755938,0.00280034138795729,0.0015536125671631,0.0125309508079557,0.0119220302056598
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40536,0.00726417154266674,0.00289488032473832,0.00159020610617964,0.0129381369791538,0.0121062460910121
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,0.00794178662560808,0.00317140708699551,0.00172582873509688,0.0141577445161193,0.0122854599156635
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,-0.0120023566782151,0.00480972443971027,-0.0214294165800472,-0.00257529677638293,0.0125924626676973
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40357,-0.0714346072849119,0.0287259931836765,-0.127737553924918,-0.015131660644906,0.0129014641869199
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,37628,-0.00699021188235315,0.00281998895830934,-0.0125173902406395,-0.00146303352406684,0.0131946355239093
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,40471,0.00713656308263489,0.00288677490621206,0.00147848426645925,0.0127946418988105,0.013440331838318
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,-0.0122071330123329,0.00495454828349997,-0.0219180476479929,-0.00249621837667299,0.0137587958831967
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,-0.0106039962498127,0.00430496256328527,-0.0190417228738518,-0.00216626962577356,0.0137829143491538
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,0.0107019429213721,0.00434882398599917,0.00217824790881378,0.0192256379339305,0.0138723846857014
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,0.0118764429221817,0.00484024732873496,0.00238955815786116,0.0213633276865022,0.0141529811764186
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,0.0139840411523352,0.00571103545356022,0.00279041166335714,0.0251776706413132,0.0143542904910893
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,37562,0.0128749596715997,0.00526338553209779,0.00255872402868804,0.0231911953145114,0.014452679835883
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,40403,0.0139693545939531,0.00571505463282882,0.00276784751360861,0.0251708616742976,0.0145237758389766
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,0.00764055169274792,0.00313020289063005,0.00150535402711302,0.0137757493583828,0.0146633612687945
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,-0.00515475329815261,0.00211369872615074,-0.00929760280140806,-0.00101190379489717,0.0147515752748073
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37572,0.0108286120026757,0.00444795473083986,0.00211062073022952,0.0195466032751218,0.0149250087643594
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,37541,0.0148398905740522,0.00610708631482493,0.00287000139699539,0.0268097797511091,0.0151144221450807
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,40536,0.00957224231377968,0.00394207274681869,0.00184577973001504,0.0172987048975443,0.015183789526176
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,40358,-0.0237632465906226,0.00979555789243569,-0.0429625400597966,-0.00456395312144866,0.0152806533094022
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,40044,-0.00759154401783745,0.00312937494705571,-0.0137251189140667,-0.00145796912160826,0.0152818364165205
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40273,-0.00799284229063249,0.00330182742632926,-0.0144644240462378,-0.00152126053502715,0.0155004349182963
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,40228,-0.0132734361202597,0.00548695362113145,-0.0240278652176774,-0.00251900702284205,0.0155706157298684
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,37714,0.00998691224898265,0.00413250981174595,0.00188719301796059,0.0180866314800047,0.0156766225680633
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,39857,0.015717041580477,0.00651454007642649,0.00294854303068105,0.0284855401302729,0.0158503819097012
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37714,-0.0110359179012325,0.00457472517470585,-0.0200023792436559,-0.00206945655880902,0.0158627858508999
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,40536,-0.00763486290250979,0.00316808774422312,-0.0138443148811871,-0.00142541092383248,0.0159668287575594
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,40305,-0.00619086661171008,0.00258102148573019,-0.0112496687237412,-0.00113206449967891,0.016468867121363
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,-0.00709280065803679,0.00296454070446298,-0.0129033004387842,-0.00128230087728935,0.0167437321781032
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,0.017404078267775,0.00727854337485098,0.00313813325306708,0.0316700232824829,0.0168096112971248
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37671,-0.012601220558672,0.00527760840772323,-0.0229453330378096,-0.00225710807953451,0.0169692284419696
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37981,0.00437682491049757,0.00183326275969581,0.000783629901493782,0.00797001991950135,0.016979311122934
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,37562,0.00944044679061532,0.00395696621051398,0.00168479301800792,0.0171961005632227,0.0170571006605678
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.00678777692031079,0.0028507909098608,0.00120022673698363,0.012375327103638,0.0172765763420671
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,37562,0.0108622573931234,0.00457018981151295,0.00190468536255801,0.0198198294236888,0.0174795821935238
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,0.0113324372927962,0.00477701637734168,0.00196948519320653,0.0206953893923859,0.0176928676716017
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,37598,-0.0097594029803297,0.00412448607687206,-0.0178433956909989,-0.00167541026966046,0.0179856317410053
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,37714,-0.00686655440866821,0.00291387267642593,-0.012577744854463,-0.00115536396287339,0.0184622994634643
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,37598,0.00631553653980462,0.00268983151096199,0.00104346677831912,0.0115876063012901,0.018892800849181
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,37900,-0.0124863553942741,0.00532827123735237,-0.0229297670194847,-0.00204294376906341,0.0191225583610986
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,0.00956297059312955,0.0040830011758112,0.00156028828853961,0.0175656528977195,0.0191883001012507
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,37562,0.0109280552865072,0.00468859719837556,0.00173840477769107,0.0201177057953232,0.0197804232482776
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,37541,0.0210891398341369,0.00906271227916759,0.00332622376696845,0.0388520559013054,0.0199792178974304
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39980,-0.00775454963397558,0.00333256413195402,-0.0142863753326055,-0.0012227239353457,0.0199832839831745
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,37482,0.0106329724751838,0.00457073104377507,0.00167433962938463,0.0195916053209829,0.0200168666876583
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,37598,-0.00386495848690089,0.00166162744287001,-0.00712174827492612,-0.000608168698875666,0.0200332599874098
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,39961,-0.0100389260839668,0.00431953728285026,-0.0185052191583533,-0.00157263300958028,0.0201343582248629
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37562,0.0074885719215792,0.00323221171741997,0.00115343695543605,0.0138237068877224,0.0205268622922008
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.00818041037682607,0.0035322428417922,0.00125721440691335,0.0151036063467388,0.0205750218452392
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,40341,0.00789150410523679,0.00342624442699548,0.00117606502832564,0.0146069431821479,0.0212775218523567
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,37482,-0.0124798916922814,0.00542354264381426,-0.0231100352741574,-0.00184974811040546,0.0214040039594292
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,0.00856751252682122,0.00372847118375131,0.00125970900666864,0.0158753160469738,0.021585309631045
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,37900,0.0131851119868216,0.00576720546509895,0.00188138927522762,0.0244888346984155,0.022256750790299
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,37562,-0.00836018520966092,0.00366146630707384,-0.0155366591715257,-0.00118371124779619,0.0224292862112927
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,40044,-0.0110854155211313,0.00486355462365407,-0.0206179825834933,-0.00155284845876934,0.0226637216173573
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37598,0.00666185652103455,0.00292738283852007,0.000924186157535215,0.0123995268845339,0.0228797553477036
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,37562,0.0125490532368614,0.00553158724453158,0.00170714223757952,0.0233909642361433,0.0233078089144423
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40465,0.00900092975280171,0.00397208656581651,0.00121564008380136,0.0167862194218021,0.0234618728778221
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,-0.0152887479832454,0.00675217951600101,-0.0285230198346074,-0.00205447613188342,0.023573781623655
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37562,-0.00911828250481556,0.0040574013839358,-0.0170707892173297,-0.00116577579230139,0.0246360935488754
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37541,0.0157836313183268,0.00702502588055533,0.00201458059243837,0.0295526820442153,0.0246712002148436
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40536,-0.00686219353247138,0.00305852843717696,-0.0128569092693382,-0.000867477795604526,0.0248700343356932
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37482,0.00565164373258744,0.00251953124242451,0.000713362497435394,0.0105899249677395,0.0249049740224409
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40465,-0.0139464068364418,0.00625824125791555,-0.0262125597019563,-0.00168025397092729,0.0258619112833152
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,-0.0118442241054756,0.00531494289343342,-0.0222615121766051,-0.0014269360343461,0.0258630321626563
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,-0.00488298817290789,0.00219983568425924,-0.00919466611405599,-0.000571310231759785,0.0264552348338497
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,37900,-0.00975469441758965,0.00439460584704483,-0.0183681218777975,-0.00114126695738177,0.0264559419383366
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,0.0143052270001996,0.0064502180650827,0.00166279959263749,0.0269476544077617,0.0265862804669305
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,0.015374506066893,0.00695453447303788,0.00174361849973872,0.0290053936340472,0.0270726547245648
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,40379,0.00642381084056176,0.00291206830203919,0.000716156968564945,0.0121314647125586,0.0274033184857482
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,40456,0.00934089757055984,0.0042350517284068,0.0010401961828825,0.0176415989582372,0.0274250635286318
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F2,Prothrombin,38013,-0.00319321240301848,0.00144911822582,-0.00603348412562567,-0.000352940680411289,0.0275723681193318
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37572,-0.0116899650405116,0.00531371819942631,-0.0221048527113872,-0.00127507736963605,0.0278271375038466
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,-0.0117201912284311,0.00533415679783304,-0.0221751385521838,-0.0012652439046783,0.0280233491175101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,37482,-0.0153173472246476,0.00703764456835822,-0.0291111305786297,-0.00152356387066545,0.0295367048683846
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,0.0170323372607142,0.00783623947154674,0.00167330789648264,0.0323913666249458,0.0297579321186701
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,-0.0222530749116191,0.0102427498234923,-0.042328864565664,-0.00217728525757429,0.0298306544843159
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40330,0.0103187853554983,0.00476772622497693,0.000974041954543529,0.0196635287564531,0.0304562625381
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37541,0.00821741971296929,0.00379768602718322,0.000773955099690175,0.0156608843262484,0.0304980030102697
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,40268,-0.00792102420568399,0.00366540649149959,-0.0151052209290232,-0.000736827482344792,0.0307085984760803
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37482,0.00998316532563743,0.00463481118136502,0.000898935410161989,0.0190673952411129,0.0312621404434577
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,40489,0.012610524586341,0.00585729711935392,0.00113022223240728,0.0240908269402747,0.0313367129664278
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERVV_1,,37562,0.0102507429302873,0.00476371001717241,0.000913871296629381,0.0195876145639452,0.0314281432844933
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,-0.0131045421278357,0.00611669317037206,-0.0250932607417649,-0.00111582351390646,0.0321778765658005
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,0.0080615745398087,0.00376336803013376,0.000685373200746535,0.0154377758788709,0.0322024374078438
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,37541,0.0102153389444034,0.00477823245965677,0.000850003323476149,0.0195806745653307,0.0325440788576762
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,0.0131598506179151,0.00617036369160541,0.00106593778236855,0.0252537634534617,0.0329636636152867
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37482,-0.00612470319610281,0.00287786343465407,-0.0117653155280248,-0.000484090864180823,0.0333382311868329
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37598,-0.00683628633855626,0.00321297455872804,-0.0131337164736632,-0.000538856203449296,0.0333794778310449
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37562,-0.00988457166722754,0.00465088709191119,-0.0190003103673735,-0.000768832967081601,0.0335794931702796
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,37525,-0.0200049947906145,0.00943108857710408,-0.0384899284017385,-0.00152006117949048,0.0339257963421174
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37598,0.00890045807764552,0.00420554846920041,0.000657583078012719,0.0171433330772783,0.0343328716726933
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,37541,0.0111702095534688,0.00528147557718304,0.000818517422190015,0.0215219016847475,0.0344505890568996
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,37577,0.0143710268078994,0.00679851191136519,0.00104594346162366,0.0276961101541752,0.0345469888221105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BSND,Barttin,37482,0.00711986103334904,0.00338317593373146,0.000488836203235379,0.0137508858634627,0.0353548002383425
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39980,-0.0102559000499487,0.00487700928660423,-0.019814838251693,-0.000696961848204438,0.0354898958543229
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,37482,0.0098661084216113,0.00471229068984288,0.000630018669519245,0.0191021981737033,0.0363062671316918
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,0.0111425306428224,0.00532884302211904,0.000697998319469069,0.0215870629661757,0.0365486156680086
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,37562,0.007493515730585,0.00358403930135003,0.000468798699938944,0.0145182327612311,0.0365650438776435
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37562,0.00787261362769513,0.00377036866826538,0.000482691037894983,0.0152625362174953,0.0368150800046796
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,0.00710205790935552,0.00340589123899978,0.000426511080915957,0.0137776047377951,0.0370680735619139
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37541,0.0103292171257061,0.00496136052050996,0.000604950505506619,0.0200534837459057,0.0373680258590365
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,37572,0.00608344754837506,0.00292878708282603,0.000343024866036045,0.0118238702307141,0.0378097271471398
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,37714,0.00806874938721391,0.0038968722335024,0.000430879809549213,0.0157066189648786,0.038418238554563
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,-0.00640121742594444,0.00309224694333514,-0.0124620214348813,-0.000340413417007578,0.0384637638726299
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,39695,0.00958271411467804,0.00463147443109507,0.000505024229731707,0.0186604039996244,0.0385589816960695
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,40500,-0.0123359777124071,0.00599026153499214,-0.0240768903209917,-0.00059506510382251,0.0394778944788708
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,37572,-0.0132688689797659,0.00644959903521421,-0.0259100830887858,-0.000627654870746048,0.0396754738895832
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37562,0.0145219853406912,0.00709016655922933,0.000625258884601732,0.0284187117967807,0.0405615774715653
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37598,0.0125666664535715,0.00615900744466266,0.000495011862032706,0.0246383210451103,0.0413332262918088
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,-0.0121238551534409,0.0059657271823564,-0.0238166804308594,-0.000431029876022353,0.0421483122542293
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,37482,0.00748870030724754,0.0036975963350888,0.000241411490473498,0.0147359891240216,0.0428580672908833
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,40303,-0.00442651536801927,0.00219000528168091,-0.00871892572011385,-0.000134105015924689,0.0432722166058879
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,40044,0.00598753517014324,0.00296231462536147,0.000181398504434758,0.0117936718358517,0.0432724564514615
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,40417,-0.0223124655119407,0.0110616922221129,-0.0439933822672819,-0.000631548756599501,0.0437024803590877
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,0.00809914864724008,0.00402346612372766,0.000213155044733869,0.0159851422497463,0.044137351129137
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,39903,-0.00842387549210685,0.00419394723847564,-0.0166440120795191,-0.000203738904694592,0.044599138010662
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,37572,-0.0152246439784671,0.00759329704187291,-0.030107506180538,-0.000341781776396171,0.0449823768812635
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,-0.00648162883701818,0.0032361500505785,-0.012824482936152,-0.000138774737884325,0.0452098307790932
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.00618961829013543,0.0030931767237272,-0.0122522446686407,-0.000126991911630112,0.0454068167553131
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,40490,-0.00527138909720122,0.00263827386463994,-0.0104424058718955,-0.000100372322506925,0.0457286705352427
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,40316,-0.0249335144739533,0.0125399304523911,-0.0495117781606398,-0.000355250787266708,0.046792408085751
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,40178,-0.00849171167996187,0.00427084452961186,-0.0168625669580011,-0.000120856401922635,0.0467960468030152
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.0149537076746632,0.00753658967962019,-0.0297254234467188,-0.000181991902607658,0.0472569443122837
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,37572,0.0116855989477797,0.00589280630030199,0.000135698599187771,0.0232354992963716,0.0473851378679962
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,37562,0.00675184049197636,0.00340537964712724,7.72963836069606e-05,0.0134263846003458,0.047421976267219
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37541,0.0106096324634075,0.00536759315736166,8.91498749786019e-05,0.0211301150518363,0.0481068113159789
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,37541,0.0154627829245278,0.00782594151465448,0.000123937555805032,0.0308016282932506,0.0481942364915128
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,-0.012638750442953,0.00639707624621016,-0.0251770198855249,-0.000100481000381061,0.0482058674670894
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.00664964813386893,0.00336597608198462,5.2335013179086e-05,0.0132469612545588,0.0482267989943027
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,37541,0.00660985894459927,0.00335069801503679,4.24908351271585e-05,0.0131772270540714,0.0485529081543624
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,37901,-0.0219949703902798,0.011155699808056,-0.0438601420140696,-0.000129798766490073,0.0486717295276266
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,37998,-0.00908728307635046,0.00462918011625171,-0.0181604761042038,-1.40900484970983e-05,0.0496615218921264
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,-0.0142843554524844,0.00728458996298969,-0.0285621517799442,-6.55912502459978e-06,0.049908092140558
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,37959,-0.00914587755506852,0.00467930021567353,-0.0183173059777886,2.55508676515904e-05,0.0506580381016785
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,-0.0168705346779933,0.0086449339653103,-0.0338146052500015,7.35358940148548e-05,0.0510195455483686
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,40374,-0.0127345080735633,0.0065294575215267,-0.0255322448157556,6.32286686290118e-05,0.0511559422975873
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.00530938398549853,0.00273109467101099,-0.0106623295406801,4.35615696830101e-05,0.0519101256241995
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,37598,-0.00570938653464164,0.00293745109611086,-0.0114667906830189,4.80176137356335e-05,0.0519585841557852
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,37551,-0.0132052253425954,0.00679467872857897,-0.0265227956506102,0.000112344965419387,0.0519813007166474
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,40359,-0.00762128316739748,0.00392415065815111,-0.0153126184573737,7.00521225787051e-05,0.05213675846284
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,40489,0.00478498990485691,0.002466719098545,-4.97795282912959e-05,0.00961975933800512,0.0524191355748669
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,37482,-0.0140245958771986,0.00723810814539467,-0.0282112878421722,0.000162096087774958,0.0526929898030054
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37714,-0.0101710008013466,0.00525890734324707,-0.0204784591941108,0.00013645759141768,0.0531279706488686
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,37598,0.011268511758822,0.00582682791132949,-0.000152070947383804,0.0226890944650278,0.0531466665911208
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,-0.0114880040234138,0.00594912285816819,-0.0231482848254235,0.00017227677859586,0.0534957964185679
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,40299,-0.0149807746544754,0.00776851748301791,-0.0302070689211905,0.0002455196122397,0.0538237855713025
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,37598,0.00656378733185385,0.00341362201622082,-0.00012691181993896,0.0132544864836467,0.0545239938846912
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,-0.0082574501740336,0.00429472510250167,-0.0166751113749369,0.000160211026869679,0.0545365271952213
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37900,-0.0116944662070627,0.0061116339326476,-0.023673268715052,0.000284336300926597,0.055708323185677
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,37541,0.00944079585103913,0.00495316192095352,-0.000267401514029772,0.019148993216108,0.0566702743825414
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,-0.00685358288523333,0.00360668938422624,-0.0139226940783168,0.000215528307850106,0.0574232605829074
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,0.0085652088652442,0.00452241041652235,-0.000298715551139608,0.017429133281628,0.0582538825477957
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,0.00935897510061687,0.00494951587118993,-0.000342076006915392,0.0190600262081491,0.0586577391485448
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,-0.0067086565034249,0.00354801433507243,-0.0136627646001669,0.000245451593317057,0.0586668975340446
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,-0.0133414111905978,0.00707471411883748,-0.0272078508635192,0.000525028482323702,0.0593453599310743
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,40044,0.0269489897946204,0.0143333670104506,-0.0011444095458628,0.0550423891351036,0.0601052208576658
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,40044,-0.0122742193135441,0.0065320797526408,-0.0250770956287201,0.000528657001631825,0.0602539032302265
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,39961,-0.00616667534402571,0.00328267170164495,-0.0126007118792498,0.000267361191198383,0.0603241889695002
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,37410,-0.00810674440996396,0.00433263191185169,-0.0165987029571933,0.000385214137265362,0.0613551197605889
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37562,-0.0105697472525755,0.00566991502551818,-0.0216827807025911,0.000543286197440169,0.0623186392688264
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.011732287111738,0.0062973987138063,-0.000610614367322352,0.0240751885907983,0.0624794359960486
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37572,0.007198908215665,0.00387235290601515,-0.000390903480124702,0.0147887199114547,0.0630420382683686
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,40489,0.00817766611204451,0.00441068572311313,-0.000467277905257215,0.0168226101293462,0.0637492437586607
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,-0.008378169422454,0.00452243474777905,-0.0172421415281009,0.00048580268319294,0.0639610493263633
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,39311,0.00876574908696303,0.00473682659704398,-0.000518431043243173,0.0180499292171692,0.0642537090422065
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,40267,-0.00625433847670582,0.0033853062425569,-0.0128895387121173,0.000380861758705706,0.0646940044001515
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,-0.00993249929553657,0.00537731883084004,-0.020472044203983,0.000607045612909907,0.0647537025742076
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,37763,-0.0113995886433602,0.00618631246248062,-0.0235247610698222,0.000725583783101856,0.0653933784560746
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,37562,0.00951275839487867,0.00517211758414832,-0.000624592070052036,0.0196501088598094,0.0659026968794666
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,0.00544166968921396,0.00296649015453764,-0.000372651013679819,0.0112559903921077,0.0666203183156157
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37562,0.0129445367432754,0.00705969101058381,-0.000892457637468919,0.0267815311240196,0.0667384212773088
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,39961,0.00593600464114745,0.00323975302185642,-0.000413911281691135,0.012285920563986,0.0669348562482379
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37942,-0.00509517584429201,0.00278247855999273,-0.0105488338218778,0.000358482133293734,0.0670980431304066
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,0.0171523977838921,0.00941332216677457,-0.00129771366298603,0.0356025092307703,0.0684565455687739
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,-0.00853953451281691,0.00469531415314352,-0.0177423502529782,0.000663281227344388,0.0689710472907841
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,-0.00481704360425109,0.00265780366264554,-0.0100263387830364,0.000392251574534171,0.069944179753525
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,0.0102714024469187,0.00569957347704807,-0.000899761568095507,0.0214425664619329,0.0715471221109943
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,39961,-0.00686385556755185,0.00384164575218392,-0.0143934812418323,0.00066577010672863,0.0740060576122752
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.0138268223670232,0.00774572246631783,-0.00135479366695972,0.0290084384010062,0.0742695915868006
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,37959,0.00941886453011131,0.00529661139892206,-0.000962493811775931,0.0198002228719985,0.0753801699342495
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,37541,0.00604359622791375,0.00341739199712407,-0.000654492086449431,0.0127416845422769,0.0770036470336451
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.00571692296405029,0.00323350120096952,-0.000620739389849972,0.0120545853179505,0.0770756588689449
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37901,-0.00459484652810098,0.00259891925672753,-0.00968872827128695,0.000499035215084985,0.0770863200513506
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,40359,-0.00779384957781984,0.00441462526129227,-0.0164465150899527,0.000858815934313003,0.0775054691945334
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37562,0.0073595581153015,0.00418084448084232,-0.000834897067149453,0.0155540132977525,0.0783795571156339
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,36179,-0.0180734422085515,0.0102850565737056,-0.0382321530930144,0.00208526867591151,0.0789008577563895
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,39961,-0.00561460231146005,0.00320194221386582,-0.0118904090506371,0.000661204427716959,0.0795361523373904
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37562,0.00901653606085975,0.00514432181584708,-0.00106633469820053,0.01909940681992,0.0796741109794564
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,39992,-0.00822741538099122,0.00470018894031549,-0.0174397857040096,0.000984954942027138,0.0800615407434734
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,37785,0.00720496859390395,0.00411958625541008,-0.000869420466699802,0.0152793576545077,0.0803219082571737
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,40044,-0.00663810531439134,0.00380038524376724,-0.0140868603921751,0.000810649763392449,0.0807103405217567
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,-0.00723367654838046,0.00414230264570675,-0.0153525897339657,0.000885236637204765,0.0807827799833731
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,37628,-0.0117233601121306,0.0067143913558054,-0.0248835671695091,0.00143684694524801,0.0808334084338509
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,0.00845206629590996,0.00484871034762186,-0.00105140598542889,0.0179555385772488,0.0813295328328876
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,37655,0.00636312244799881,0.00365249578548124,-0.000795769291544421,0.013522014187542,0.0815089865111906
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,37482,-0.0106224619514245,0.00614492054385798,-0.0226665062173862,0.0014215823145371,0.0838941305345443
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,0.00614414248831273,0.00356625175737023,-0.000845710956132919,0.0131339959327584,0.0849379352236812
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,37942,0.0066352344758436,0.00385155556368111,-0.000913814428971369,0.0141842833806586,0.0849582066110606
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,37541,0.00619331839380315,0.00360462032637935,-0.000871737445900383,0.0132583742335067,0.0857908860556511
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,37482,0.00778522545249953,0.00453116655852031,-0.00109586100220027,0.0166663119071993,0.0857929501306105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,40044,-0.00778036559385194,0.00454443536813786,-0.0166874589154021,0.00112672772769826,0.086904702966189
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,-0.0112315315027016,0.00656273595823855,-0.0240944939808492,0.00163143097544591,0.0870288473809089
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,-0.00447463604845364,0.00261568269095504,-0.00960137412272553,0.00065210202581824,0.0871568519470401
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,-0.0135525581146648,0.00796549268403778,-0.0291649237753789,0.00205980754604922,0.0888863234289802
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,-0.0110304228382887,0.00650148383794495,-0.0237733311606608,0.00171248548408339,0.0897958930799149
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,37457,0.00677375056967193,0.00400503261473422,-0.00107611335520714,0.014623614494551,0.0908016253011479
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,0.00700751919920381,0.00414636320956804,-0.00111935269154956,0.0151343910899572,0.0910440339456098
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,40489,-0.00486108994890789,0.0028766039073383,-0.010499233607291,0.000777053709475165,0.091072044439711
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.00815096672978552,0.00482394979668775,-0.00130397487172247,0.0176059083312935,0.0911122756426726
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.00967534372490882,0.0057296583672501,-0.00155478667490138,0.020905474124719,0.091311811229519
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,37714,-0.00736073501446823,0.00436456113142962,-0.0159152748320703,0.00119380480313383,0.0917273473367531
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,0.00501866290429579,0.002978284779528,-0.000818775263579084,0.0108561010721707,0.0919921941267416
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,37429,-0.00575393330464692,0.00344341171796869,-0.0125030202718655,0.000995153662571714,0.094746230980011
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,0.00909255753542438,0.00544754437040288,-0.00158462943056526,0.019769744501414,0.0951192513585685
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,-0.0063094610703142,0.00378110018562618,-0.0137204174341415,0.00110149529351311,0.0951997850913383
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,-0.00933834015350432,0.00560149059989199,-0.0203172617292926,0.00164058142228399,0.0955108970376272
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40411,-0.00443719723453998,0.00266382218169541,-0.00965828871066299,0.000783894241583032,0.095787674930872
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,37598,0.00919153834980026,0.0055202879669176,-0.00162822606535823,0.0200113027649588,0.0959272291813534
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,37572,-0.00862639407487939,0.00518886153732191,-0.0187965626880303,0.00154377453827155,0.0964398574557054
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,37541,0.0075384942691803,0.00454175417236052,-0.00136334390864632,0.0164403324470069,0.0969746305581931
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,40203,0.00738761240341123,0.00445462924445972,-0.00134346091572983,0.0161186857225523,0.0972541657816603
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,37482,0.00690695628344057,0.00417130244577538,-0.00126879651027918,0.0150827090771603,0.0977808864848771
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,37541,0.0149042354815486,0.0090189901263408,-0.00277298516607941,0.0325814561291765,0.0984486483089476
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALLD,Palladin,37598,0.00675711697910195,0.00409188308398687,-0.00126297386551231,0.0147772078237162,0.0986917189851859
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLPS,Colipase,40311,0.011092669516275,0.00672331095645432,-0.00208501995837547,0.0242703589909255,0.0989868830118712
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37944,-0.00359988276180879,0.00218193202860696,-0.00787646953787842,0.00067670401426085,0.0989948154498037
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,-0.0133008320448508,0.0081000342390011,-0.029176899153293,0.00257523506359134,0.100599404059161
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,-0.00912741635643302,0.00555857901004803,-0.0200222312161272,0.00176739850326111,0.100604752286366
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,37598,0.00353756456188276,0.00216339473552671,-0.000702689119749599,0.00777781824351511,0.102032862803394
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,-0.00434751081386248,0.00266155007056137,-0.00956414895216278,0.000869127324437807,0.102394435324546
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,40044,-0.00518514162780823,0.00319219143922143,-0.0114418368486822,0.00107155359306577,0.104327661969467
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,37562,-0.0142208578051226,0.00877392279031418,-0.0314177464741383,0.00297603086389324,0.105082540261167
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,37900,0.00913507215592458,0.00564351476133062,-0.00192621677628344,0.0201963610881326,0.105538526713757
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,0.00415195949379671,0.00256700401130539,-0.000879368368361858,0.00918328735595527,0.105808018064669
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,37482,0.00695638583824962,0.00430133385174851,-0.00147422851117747,0.0153870001876767,0.105845841603777
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,40042,-0.00968121367931859,0.00600315462082005,-0.0214473967361259,0.00208496937748871,0.106832612689603
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,37628,0.00283638340777197,0.00176145148094243,-0.000616061494875196,0.00628882831041914,0.107366481289653
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,37482,0.00992319237685415,0.00616896249020425,-0.00216797410394618,0.0220143588576545,0.107735179116708
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,37572,0.00596009731867448,0.00371361391257037,-0.00131858594996344,0.0132387805873124,0.108532867278311
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,37482,0.00576167597988914,0.00359205814639917,-0.00127875798705324,0.0128021099468315,0.108737386045182
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,-0.0139510527052759,0.00870309246313918,-0.0310091139330287,0.00310700852247688,0.108954577005331
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37714,-0.012289257219875,0.00766889111855324,-0.0273202838122393,0.00274176937248939,0.109072959513539
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37598,-0.00580188424789329,0.00363807772670583,-0.0129325165922367,0.00132874809645013,0.110788514504095
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,40044,-0.00690746169038394,0.00435928397267768,-0.0154516582768322,0.00163673489606433,0.113091069552909
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,40128,0.0270725807802239,0.0171571792876486,-0.00655549062356733,0.0607006521840151,0.114605179204236
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,37572,-0.00752327332675961,0.00477980586932568,-0.0168916928306379,0.00184514617711872,0.115518386805437
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,-0.0138057825223866,0.00877369863972073,-0.0310022318562392,0.00339066681146605,0.115617670682087
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,37901,-0.0164565921314983,0.01051370724728,-0.0370634583361671,0.00415027407317053,0.117547564954867
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37598,-0.00994719190928355,0.00636621469975208,-0.0224249727207976,0.00253058890223052,0.118195003007107
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39934,0.00822083208260562,0.00526590928673943,-0.00210035011940366,0.0185420142846149,0.118510692886788
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,-0.0140523916854716,0.00904297824287033,-0.0317766290414975,0.00367184567055421,0.120218737690432
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.00616450075614711,0.00397236281412503,-0.0139503318718322,0.00162133035953796,0.120722888644172
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,37572,-0.0051346901246635,0.00331851652922671,-0.0116389825219479,0.00136960227262086,0.121818708950818
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,40332,0.00733066125714309,0.00474004879374752,-0.00195983437860204,0.0166211568928882,0.121994837380798
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,37671,-0.00429675471773235,0.00278068532381939,-0.00974689795241836,0.00115338851695365,0.122318375309865
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,37598,-0.00327838851853279,0.00212233539480185,-0.00743816589234441,0.000881388855278832,0.122440973379684
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,40044,0.00450379762932725,0.00291651909612943,-0.00121257979908643,0.0102201750577409,0.122551145738788
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.0076829496675984,0.0049755838403754,-0.00206919465953738,0.0174350939947342,0.12258084525027
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,-0.0103834935026672,0.00673143402118906,-0.0235771041841978,0.00281011717886333,0.122966414142632
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,37482,0.00792297589343681,0.00514133405283917,-0.00215403885012797,0.0179999906370016,0.123332543243294
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,37598,0.00883938817925065,0.00573671001216323,-0.00240456344458929,0.0200833398030906,0.123378276177336
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,40276,-0.00505464680669335,0.00328454647742052,-0.0114923579024376,0.00138306428905086,0.123844377172791
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37572,-0.00446782345117408,0.00291231434905726,-0.0101759595753263,0.00124031267297816,0.125025617687083
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,39925,-0.00514273436441708,0.00335355560156704,-0.0117157033434885,0.00143023461465432,0.125168978290045
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,0.00794977936881699,0.00520199912614426,-0.00224613891842577,0.0181456976560598,0.126482991770897
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,37942,-0.00581907098166096,0.00380929337058645,-0.0132852859880104,0.00164714402468849,0.126635690321109
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,37562,0.00714137204208008,0.00467840786232113,-0.00202830736806933,0.0163110514522295,0.126921086789117
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,39961,-0.00889246844535712,0.00582734524523428,-0.0203140651260163,0.00252912823530208,0.127032837384456
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,40333,0.00984250758074932,0.00645122275962692,-0.00280188902811945,0.0224869041896181,0.127109258095133
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,40044,-0.00818292075902928,0.00537441224011293,-0.0187167687496506,0.00235092723159207,0.127886510542336
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37541,0.0113667854604979,0.00747638908193896,-0.00328693714010248,0.0260205080610982,0.128445262723344
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37541,0.0121678677904337,0.00800480951271503,-0.00352155885448771,0.0278572944353552,0.128517632275039
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,-0.0119156570763431,0.00787231829354913,-0.0273454009316994,0.00351408677901318,0.130143849676126
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,0.00602039314236075,0.00398361490168555,-0.00178749206494292,0.0138282783496644,0.130738754099333
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,37990,0.0156019867540716,0.0103388669856282,-0.00466219253775977,0.0358661660459029,0.131306387982145
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39961,0.00591284390650555,0.00394425354631071,-0.00181789304426344,0.0136435808572745,0.133867163346251
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,37482,0.00619064190198261,0.00413050143400212,-0.00190514090866154,0.0142864247126268,0.133959403433152
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,40227,-0.0077571606272587,0.00517649541066146,-0.0179030916321552,0.00238877037763776,0.134014261912779
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37541,0.0105070305443297,0.00702076936527107,-0.00325367741160161,0.024267738500261,0.134530859860188
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,40341,0.00570532277846632,0.00381442585246573,-0.00177095189236651,0.0131815974492991,0.134745831216191
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,37598,-0.00435941428100297,0.00291745405316318,-0.0100776242252028,0.00135879566319686,0.135133523042831
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37562,-0.00597988430554805,0.00401561166248278,-0.0138504831640143,0.00189071455291819,0.136469555236446
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,40236,-0.0101140572386352,0.00679314924083573,-0.0234286297506732,0.00320051527340282,0.136543866222018
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40278,0.00371067241532078,0.00251107990051305,-0.0012110441896848,0.00863238902032637,0.139502699925076
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,37482,0.00605446530512642,0.00410304773825706,-0.00198750826185742,0.0140964388721103,0.140074940449043
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.00586785754515741,0.00398449550446895,-0.00194175364360174,0.0136774687339166,0.140863364618736
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,37562,0.00653689867647214,0.00444739341344725,-0.00217999241388447,0.0152537897668287,0.141632626202231
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40451,-0.00429233861923153,0.00292703359293421,-0.0100293244613826,0.00144464722291952,0.142546298331665
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.00540515732076908,0.00368685836147895,-0.00182108506772966,0.0126313997092678,0.14265206147954
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARTN,Artemin,40044,-0.00641346882688492,0.00437483201019672,-0.0149881395668705,0.00216120191310066,0.142670626033326
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,37562,0.00788047169777993,0.00538370864246876,-0.00267159724145884,0.0184325406370187,0.14328278304921
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37900,0.00611892082160114,0.00420256175659433,-0.00211810022132375,0.014355941864526,0.145416562401838
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,40475,-0.00309909477724801,0.00213384712575471,-0.00728143514372725,0.00108324558923123,0.1464236443608
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,37714,-0.0104893837016536,0.00723281453672226,-0.0246657001936292,0.00368693279032205,0.147012680505543
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,0.0100352824594575,0.00692384032160826,-0.00353544457089466,0.0236060094898097,0.147255118964899
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37572,-0.0102596387894364,0.00715750829559479,-0.0242883550488022,0.00376907746992944,0.151764737948655
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,40228,-0.0060791334535301,0.00424836661824193,-0.0144059320252843,0.00224766511822409,0.15246885690025
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,0.00275777238609082,0.00192912129910256,-0.00102330536015019,0.00653885013233183,0.152869692313884
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,-0.0101095165565286,0.00707755588603386,-0.0239815260931549,0.0037624929800978,0.153198867973295
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.00412918743763097,0.00290682676235638,-0.00982656789184948,0.00156819301658754,0.155481192957701
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,39961,0.00912308719898662,0.00642401552627107,-0.00346798323250468,0.0217141576304779,0.155583141486527
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,40357,0.00323431130147506,0.0022780202970812,-0.0012306084808041,0.00769923108375421,0.155688315988164
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37562,0.00684257910878406,0.0048298903354358,-0.0026240059486701,0.0163091641662382,0.156589968808952
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,40305,-0.00265138852834445,0.00187571524922168,-0.00632779041681895,0.00102501336013005,0.157518211153481
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,40411,-0.0109966908395978,0.00778065379075321,-0.0262467722694741,0.00425339059027846,0.157575976559522
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,-0.00590738519503665,0.00418030274544318,-0.0141007785761053,0.00228600818603199,0.15763181428502
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,39961,0.0072765097391758,0.00516629459146069,-0.00284942766008715,0.0174024471384388,0.159015495973903
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37959,0.00481279260173077,0.00341856050806025,-0.00188758599406732,0.0115131711975289,0.159200914339725
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,37457,0.0113890988918417,0.0080990425227675,-0.00448502445278256,0.027263222236466,0.159680378894501
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VIM,Vimentin,40042,-0.0163327458527996,0.0116320112454945,-0.0391314878939688,0.00646599618836957,0.160302880051916
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39961,-0.0116920797362734,0.00833187065742297,-0.0280225462248224,0.00463838675227566,0.160548647585313
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37990,-0.00535129715788627,0.00381756740394262,-0.0128337292696138,0.00213113495384127,0.161011114589279
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,-0.00896000400415816,0.00639659077984679,-0.0214973219326579,0.00357731392434156,0.161312878605521
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,40044,-0.0123528873727397,0.00882831767122869,-0.029656390008348,0.0049506152628685,0.161762542759735
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37901,-0.0113454633633427,0.00811175048680664,-0.0272444943174837,0.00455356759079834,0.161942372059697
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37541,0.0125537737043766,0.00900881083097295,-0.00510349552433038,0.0302110429330836,0.163492446147392
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,37643,-0.0113999235570178,0.00818226807929754,-0.0274371689924409,0.00463732187840541,0.163568473012401
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,37648,-0.00786059655304362,0.00564295661756803,-0.018920791523477,0.00319959841738973,0.163645507756039
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,37642,0.00436547945922765,0.00314629432457826,-0.00180125741694573,0.010532216335401,0.165313170894078
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,39602,-0.00380100980705154,0.00274794975478295,-0.00918699132642613,0.00158497171232305,0.166618834230701
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,40341,-0.00933772738423362,0.00675335477130423,-0.0225743027359899,0.00389884796752268,0.166782493111875
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,40250,0.00688122444640005,0.00499430336908922,-0.00290761015701482,0.0166700590498149,0.168280031591438
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37598,-0.00398821319766278,0.00289979595027668,-0.00967181326020508,0.00169538686487952,0.169048659169036
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,-0.00500162247522142,0.00363674419657426,-0.012129641100507,0.00212639615006412,0.169057159850185
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37714,-0.00961299665638473,0.0069924309649918,-0.0233181613477687,0.0040921680349992,0.169225440860477
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,37541,0.00877465851985488,0.00638851292920192,-0.00374682682138089,0.0212961438610906,0.16961873440318
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESPL1,Separin,37482,0.00775042694369385,0.00565569238947674,-0.00333473013968057,0.0188355840270683,0.17059306704547
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.00435471892616427,0.00317950616084487,-0.00187711314909167,0.0105865510014202,0.170824366813507
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,39980,-0.010488797807495,0.0076602135671688,-0.0255028163991458,0.00452522078415589,0.170938889664477
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.00771236126927948,0.00565377496286528,-0.00336903765793647,0.0187937601964954,0.17255694252547
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,39871,0.00934503915508648,0.00686545530744253,-0.00411125324750087,0.0228013315576738,0.173480445987072
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,37714,-0.00798090368176332,0.00587173268974504,-0.0194894997536636,0.00352769239013696,0.174103926441013
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,0.00454688492892344,0.00335196007918129,-0.00202295682627188,0.0111167266841188,0.174968171835385
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,37857,-0.00952754355416125,0.00704224111530957,-0.023330336140168,0.00427524903184551,0.176106061291254
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,39961,-0.00912332856840698,0.00675872190311465,-0.0223704234985117,0.00412376636169774,0.177080584842145
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,37900,-0.00591677042590241,0.00439088886253314,-0.0145229125964674,0.00268937174466255,0.177838459697774
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,40042,-0.00434269038779378,0.00324632018827324,-0.0107054779568093,0.00202009718122178,0.181004937364728
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,37457,-0.00463281465259229,0.00346427462278742,-0.0114227929132556,0.00215716360807105,0.181144333302759
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,-0.0056576972910359,0.00423642184927174,-0.0139610841156085,0.0026456895335367,0.181735758294731
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,39961,-0.00792855720799241,0.00593765437201243,-0.0195663597771368,0.00370924536115196,0.18179737278571
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,-0.00388241432188174,0.00291000359109425,-0.00958602136042647,0.00182119271666298,0.182170084616016
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,40296,0.00626823271323,0.00470185312413452,-0.00294739941007366,0.0154838648365337,0.182504736875786
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.00618502007013815,0.00466946786260633,-0.00296713694057026,0.0153371770808466,0.185337382000366
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.00493066053623248,0.00372621910321848,-0.0122340499785407,0.00237272890607574,0.185779906032226
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,0.00836938323680859,0.00633109081086896,-0.00403955475249457,0.0207783212261118,0.186208126648992
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,0.00659623543109168,0.00499048581746702,-0.00318511677114368,0.016377587633327,0.186270153573939
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37562,-0.00498810052231694,0.00377734700973592,-0.0123917006613993,0.00241549961676546,0.18668113658893
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,40387,-0.00393889266935036,0.00298331572394008,-0.00978619148827291,0.00190840614957219,0.186751499040126
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37562,0.00505383888707374,0.00383752553589545,-0.00246771116328135,0.0125753889374288,0.18787756235745
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,38013,-0.0042351628422427,0.00321867139048913,-0.0105437587676014,0.00207343308311598,0.188259768773896
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37714,-0.00704294087123084,0.00536078925627393,-0.0175500878135277,0.00346420607106606,0.188940265278616
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,37598,-0.00665750712758413,0.00508144746032674,-0.0166171441498245,0.00330212989465629,0.190164744215721
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,0.00344128261641759,0.00262852817636633,-0.00171063260926043,0.00859319784209561,0.190487699794547
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,37541,-0.00837598961025276,0.00640689185279804,-0.0209334976417369,0.0041815184212314,0.191120037515364
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37900,-0.00496761395865001,0.00380212286251946,-0.0124197747691881,0.00248454685188812,0.191392369963203
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,40044,0.00789302319098474,0.00606763147641793,-0.0039995345027944,0.0197855808847639,0.193332143086434
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,37541,0.00960875121250832,0.00739831556810593,-0.0048919473009793,0.0241094497259959,0.19404385480137
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,37541,-0.00597087857486135,0.00461799520617217,-0.0150221491789588,0.0030803920292361,0.196048052241737
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,40411,0.00467083678626363,0.00363127978932432,-0.00244647160081205,0.0117881451733393,0.198364575385063
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,-0.00624727046842186,0.00486464121490242,-0.0157819672496306,0.00328742631278689,0.199084105762309
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,40355,0.0232150856593004,0.0180786636406189,-0.0122190950763126,0.0586492663949135,0.19912037910558
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.00458982635321994,0.00357884239187991,-0.00242470473486469,0.0116043574413046,0.19968963227759
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,37541,0.00695021435481845,0.00542239962999872,-0.00367768891997904,0.0175781176296159,0.199949592377983
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,37598,0.00542524277415909,0.00423999184960968,-0.00288514125107588,0.0137356267993941,0.200729246032116
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,37572,0.00441635927260964,0.00345392978630831,-0.00235334310855466,0.0111860616537739,0.201043772319597
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,37482,0.00568548131042598,0.00444710911466846,-0.00303085255432419,0.0144018151751762,0.201107658901057
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00812085039144659,0.00636429386678966,-0.00435316558746114,0.0205948663703543,0.201977231654861
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37541,0.00990784056286858,0.00777410280654204,-0.00532940093795383,0.025145082063691,0.20252044567363
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,40044,0.00624812445506001,0.00490356191865763,-0.00336285690550895,0.015859105815629,0.202611112881958
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,37598,0.0131494281075279,0.0103397594058143,-0.00711650032786817,0.0334153565429239,0.203489988134457
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.00517167161437424,0.00407618859911911,-0.00281765803989922,0.0131610012686477,0.204547963007371
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,39953,0.0110721223425112,0.00873749700197796,-0.00605337178136556,0.0281976164663881,0.205104208251627
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,39980,-0.00507788520238035,0.00400785229338203,-0.0129332756974091,0.00277750529264843,0.205179970987425
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37714,0.00505477715028447,0.00403411438847188,-0.00285208705112042,0.0129616413516894,0.210224927572085
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,40372,0.00331519762400391,0.00265389909176583,-0.00188644459585711,0.00851683984386493,0.211617617736314
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,37959,0.0044566324096012,0.0035707941368114,-0.00254212409854915,0.0114553889177515,0.212023841274236
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,37460,0.00594895814772075,0.0048046667912699,-0.00346818876316825,0.0153661050586097,0.21567816594289
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,0.00393793707502378,0.00318480542926263,-0.00230428156633097,0.0101801557163785,0.216300196740606
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,37959,0.00259803185221446,0.00210130540025249,-0.00152052673228041,0.00671659043670934,0.216335330291443
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,37572,-0.00739204142333107,0.00601685484288911,-0.0191850769153937,0.00440099406873158,0.219260463205538
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,37900,0.00553926073732694,0.00452156740496054,-0.00332301137639573,0.0144015328510496,0.220568291126308
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,-0.00537212295995547,0.00441280943236862,-0.014021229447398,0.00327698352748702,0.223472876442908
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.00433460129155545,0.00356114231348686,-0.0026452376428788,0.0113144402259897,0.223552280455079
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,-0.00679455240751481,0.00559277832649911,-0.0177563979274531,0.00416729311242345,0.224430023588995
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39530,-0.0033990827283028,0.00281394235175943,-0.00891440973775129,0.00211624428114569,0.227088029630456
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,37998,0.0107389520007984,0.00891950075849077,-0.00674326948584352,0.0282211734874403,0.228616115928861
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37562,0.00416373675526062,0.00350108964466728,-0.00269839894828726,0.0110258724588085,0.234355439287578
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,-0.00868619723618233,0.00730435329846229,-0.0230027297011684,0.00563033522880377,0.234390071629018
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37901,-0.00508714508293531,0.0042813999706701,-0.0134786890254487,0.00330439885957809,0.234776926782133
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,40042,-0.00386355570356095,0.00325423086539343,-0.0102418481997321,0.00251473679261018,0.235150735287442
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,40311,-0.00471006478169711,0.00397920652025276,-0.0125093095613925,0.00308917999799829,0.236561719306153
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.00814866700110576,0.00688683914395955,-0.00534953772105496,0.0216468717232665,0.236738237913315
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,37714,-0.00612010529668714,0.0051799519195837,-0.0162728110590712,0.00403260046569691,0.237425944563969
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,40359,-0.0136817259135394,0.0116067977411453,-0.0364310494861841,0.00906759765910539,0.238508059005684
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,40384,-0.00653306442127236,0.00556790633580798,-0.017446160839456,0.00438003199691128,0.240675790308194
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,37541,0.00734524880131558,0.00627467647656007,-0.00495311709274216,0.0196436146953733,0.241773698158679
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,-0.00450332009594322,0.00388306868419945,-0.0121141347169742,0.00310749452508771,0.246178281010092
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,37628,-0.00780736049239266,0.00673581025164,-0.0210095485856071,0.00539482760082174,0.246443521041994
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,37959,-0.00727879237090161,0.0062869105981731,-0.0196011371433209,0.00504355240151766,0.246978648042151
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",37541,0.00977770274739033,0.00846631020373814,-0.00681626525193642,0.0263716707467171,0.248154344926628
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,37572,-0.00396363682009621,0.00344137819184684,-0.010708738076116,0.0027814644359236,0.249441284667661
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,39961,-0.00545334543489392,0.0047509243143378,-0.014765157090996,0.00385846622120817,0.251048461494567
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,-0.00299297532099426,0.00261339489719769,-0.00811522931950173,0.00212927867751322,0.252129052123645
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37714,0.0051217180847699,0.00449446355785141,-0.00368743048861886,0.0139308666581587,0.254489572341541
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,39961,-0.00343893933375834,0.00301948234022738,-0.009357124720604,0.00247924605308732,0.254755425716625
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,37998,-0.0060235251170763,0.00529237728776818,-0.0163965846011019,0.00434953436694934,0.255077516046259
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,0.00431323708918174,0.00379123783055476,-0.00311758905870559,0.0117440632370691,0.255272364157224
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,37714,-0.00257423369651949,0.0022684862202882,-0.00702046668828436,0.00187199929524538,0.256487850531508
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,40314,0.00313127465586617,0.00276858315187462,-0.00229514832180807,0.00855769763354042,0.258071110006919
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40357,0.00437982212295918,0.00389901943299617,-0.00326225596571332,0.0120219002116317,0.261321223013688
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40272,0.00255042267096819,0.00227177395520575,-0.00190225428123508,0.00700309962317145,0.261600283599881
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,37628,0.00248708000121021,0.00221578868978658,-0.00185586583077149,0.00683002583319191,0.261697748341618
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37998,-0.00549402945854375,0.00489540964475996,-0.0150890323622733,0.00410097344518578,0.261762506980655
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,37942,-0.00756356957780605,0.00676915330447329,-0.0208311100545737,0.00570397089896161,0.263861059768638
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.00305091292453628,0.00273135000027498,-0.00230253307600268,0.00840435892507525,0.264011916389819
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,37541,-0.00810851536740443,0.00726485211998124,-0.0223476255225677,0.0061305947877588,0.26438721916482
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,-0.00581352504067716,0.0052347365510775,-0.0160736086807891,0.00444655859943474,0.266774960064577
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,40341,0.00496661800321933,0.00447647123249071,-0.00380726561246247,0.0137405016189011,0.267233920167987
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,-0.00403477925635385,0.00363727312490992,-0.0111638345811773,0.0030942760684696,0.267326204646113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,37598,-0.00515408529664282,0.00467092857852658,-0.0143091053105549,0.00400093471726928,0.269856716363863
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,0.0053790200396305,0.00488587044959114,-0.00419728604156813,0.0149553261208291,0.270945796617043
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,40044,-0.00689927164568171,0.00627472309562442,-0.0191977289131056,0.00539918562174215,0.271552170366127
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,37541,-0.0124986457425795,0.0113780005305142,-0.0347995267823873,0.00980223529722841,0.272009792639074
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,37959,-0.00395668076193255,0.0036099547606733,-0.0110321920928522,0.00311883056898712,0.273077666449754
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,37714,0.00462336499743245,0.00423031792712982,-0.003668058139742,0.0129147881346069,0.274452314660318
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37598,0.0099226869286647,0.00912929256280412,-0.00797072649443137,0.0278161003517608,0.277098085727499
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,40379,-0.0025648510504034,0.00236336231185797,-0.00719704118164501,0.00206733908083821,0.277825103274543
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37562,0.0103401720638177,0.00957857181620198,-0.00843382869593821,0.0291141728235735,0.280379925752034
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,40489,0.00331401788712821,0.00308552009967175,-0.00273360150822842,0.00936163728248483,0.282814250191482
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,37541,0.00525853489413097,0.00490018088489737,-0.00434581964026787,0.0148628894285298,0.28323223016422
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,40042,-0.00524704617677381,0.00489321589058516,-0.0148377493223207,0.00434365696877309,0.283597245863132
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,37598,-0.00275776345721627,0.00257933558661161,-0.00781326120697503,0.00229773429254249,0.285010045550981
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.00688928317791837,0.00649690614670448,-0.0196232192254591,0.00584465286962242,0.288984554062781
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,-0.00342022259220866,0.00322804820038293,-0.0097471970649592,0.00290675188054188,0.289376672100541
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,0.00260313135717278,0.00245743346541929,-0.00221343823504902,0.00741970094939459,0.289487233996772
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,40536,-0.00201111453576946,0.00190330952924664,-0.00574160121309287,0.00171937214155395,0.290691414884104
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,40258,0.0043255611277123,0.00411296578741328,-0.00373585181561773,0.0123869740710423,0.292958309308374
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,37572,0.00444350527963375,0.00425088738696976,-0.00388823399882698,0.0127752445580945,0.2958978684706
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,37562,0.00643682900957947,0.00619168337854104,-0.00569887041236097,0.0185725284315199,0.298548329348128
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,37987,0.00261650923673676,0.00251878690519269,-0.00232031309744092,0.00755333157091443,0.29891753684977
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,-0.0074736066499042,0.00722099557007502,-0.0216267579672512,0.00667954466744285,0.30069540256627
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,0.00341233607594191,0.00330364084501882,-0.00306279998029498,0.00988747213217879,0.30166898052284
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,37482,0.00613403602806846,0.00594030196943425,-0.00550895583202267,0.0177770278881596,0.301803971563186
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,0.00518499887600405,0.00502436407881161,-0.0046627547184667,0.0150327524704748,0.302104645843013
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,0.00616426328321939,0.00599229326647544,-0.00558063151907247,0.0179091580855113,0.303640338629697
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37562,-0.00398248760069134,0.00387183688305037,-0.0115712878914701,0.00360631269008738,0.303696831102041
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,37900,-0.00357237093143129,0.00348686958551986,-0.0104066353190502,0.00326189345618765,0.305607710244729
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,37598,-0.00493966807897663,0.00483972289525381,-0.0144255249536741,0.00454618879572084,0.307438593096598
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,37697,0.00988589547155585,0.00971777190937254,-0.00916093747081433,0.028932728413926,0.309029019437246
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,40044,-0.00491367859081607,0.00484741450223993,-0.0144146110152063,0.00458725383357419,0.310755979631357
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00388888380738333,0.00384849787362866,-0.00365417202492885,0.0114319396396955,0.312277347108066
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37959,-0.00773266387039368,0.00772918824162071,-0.0228818728239703,0.00741654508318292,0.317110862231926
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,0.00406742921083185,0.004081381296161,-0.00393207812964371,0.0120669365513074,0.318986054915996
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,37714,0.00441571342991408,0.0044482327765602,-0.00430282281214391,0.0131342496719721,0.320879463941428
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,37482,0.00919761831018761,0.00929469316184331,-0.00901998028702528,0.0274152169074005,0.322409616951692
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,-0.00672799868496651,0.00680619293493377,-0.0200681368374367,0.00661213946750367,0.322920005991378
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,37562,0.00721403564875886,0.00731767055022509,-0.00712859862968231,0.0215566699272,0.324230946204249
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,40359,0.00269586985328591,0.00274404142348416,-0.00268245133674304,0.00807419104331486,0.325895594428425
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,37562,0.00509257425049487,0.00519231379307036,-0.00508436078392303,0.0152695092849128,0.326713952892666
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,0.00431004130504079,0.00440443554925579,-0.00432265237150056,0.0129427349815821,0.327811463176236
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,37714,0.00595221702363358,0.0060860120437709,-0.00597636658215738,0.0178808006294245,0.328084261137666
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,37572,-0.00587306065812701,0.0060182525581118,-0.0176688356720261,0.00592271435577213,0.329144532980807
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,-0.00379588601096042,0.00389253430579585,-0.0114252532503203,0.00383348122839944,0.32949072573096
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00543120975477535,0.00556993702686528,-0.0054858668178806,0.0163482863274313,0.329531951967196
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37987,-0.00335501899117414,0.00344717555081134,-0.0101114830707644,0.0034014450884161,0.330438475590146
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,40042,-0.00580868347084138,0.00598639506944405,-0.0175420178069517,0.00592465086526895,0.331905010598325
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37942,-0.00316083951601956,0.00325811922706935,-0.00954675320107549,0.00322507416903636,0.331992924319411
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37598,-0.00752646399016073,0.00775854234452069,-0.0227332069854213,0.00768027900509983,0.332020788176327
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,39961,-0.00465136642075829,0.00479492450397846,-0.0140494184485561,0.00474668560703949,0.332031510198575
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.00522356909445791,0.00540576190796865,-0.0158188624340765,0.00537172424516064,0.333910517811706
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.00213160872570306,0.00221330541581138,-0.00220646988928724,0.00646968734069337,0.335517796478274
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,40305,0.00830288703905111,0.00863049051403766,-0.0086128743684627,0.0252186484465649,0.336043605985278
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37688,0.0049702250295166,0.00518192896745494,-0.00518635574669508,0.0151268058057283,0.337502856539982
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,37482,0.00675936550104546,0.00706896073655833,-0.00709579754260885,0.0206145285446998,0.338987135919656
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,-0.00313325617796515,0.00328661288470336,-0.00957501743198373,0.00330850507605343,0.340435368006367
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00568233583422773,0.00596961459487119,-0.0060181087717198,0.0173827804401753,0.341177196567907
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.00464115711783944,0.00488225343029409,-0.00492805960553699,0.0142103738412159,0.341815942842664
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,37714,0.00537871263891993,0.00567474233801202,-0.00574378234358364,0.0165012076214235,0.343231336746147
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,-0.00868220266975088,0.00924443279145803,-0.0268012909410086,0.00943688560150685,0.347654687034196
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.00232932353265743,0.00248031273472851,-0.00253208942741046,0.00719073649272531,0.347680747924118
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,37628,0.00580514458220076,0.00619577344643055,-0.00633857137280311,0.0179488605372046,0.348800234439654
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGN,Cingulin,37572,-0.00386299876221802,0.00414601373417836,-0.0119891856812076,0.00426318815677156,0.35148906049202
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37959,-0.00674099493603232,0.0072644762490341,-0.0209793683841392,0.00749737851207452,0.353455500426206
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,37959,-0.0145759359750838,0.0158511636701546,-0.0456442167685868,0.0164923448184192,0.357824438866442
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,37998,-0.00810893177221169,0.00896705334772015,-0.0256843563337432,0.00946649278931981,0.365850925358992
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.00316152413839307,0.00350085529635286,-0.00370015224245852,0.0100232005192447,0.366501730739314
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,39961,0.00312479507721538,0.00346336136469126,-0.00366339319757949,0.00991298335201026,0.366941574533181
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36973,-0.00445544274149634,0.00495051563733272,-0.0141584533906685,0.00524756790767579,0.368139852482264
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,0.00361810067452983,0.00406518046739406,-0.00434965304156253,0.0115858543906222,0.373470135212101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,40042,-0.00420804501317301,0.00479596112078677,-0.0136081288099151,0.00519203878356906,0.380275153200454
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39980,-0.0040115817153709,0.00457255543268786,-0.0129737903634391,0.00495062693269731,0.380327923337947
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,-0.00217509009198311,0.00249202126962031,-0.00705945178043891,0.00270927159647269,0.382776413398417
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,37598,0.00890424947171631,0.0102063505500493,-0.0111001976063803,0.0289086965498129,0.382993885035557
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,40042,0.0109733104217161,0.0126062759399711,-0.0137349904206273,0.0356816112640595,0.38406024207126
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,39831,-0.00503849248589936,0.00581146318065013,-0.0164289603199736,0.00635197534817489,0.385959881962499
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTTG1,Securin,37714,-0.00353195956413692,0.00407933150912503,-0.011527449322022,0.00446353019374813,0.386605515803866
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,39980,0.00477109575291203,0.00553057996864932,-0.00606884098564063,0.0156110324914647,0.388329238076683
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37572,0.00305019971120451,0.00355792839787364,-0.00392333994862782,0.0100237393710368,0.391296678307959
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",40042,-0.0071218283308717,0.00832172180988869,-0.0234324030782535,0.00918874641651014,0.392114999401351
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.00696195280721016,0.00814195351157802,-0.0229201816899031,0.00899627607548276,0.392527086101712
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,0.0144329868266156,0.0170798845753428,-0.0190435869410564,0.0479095605942875,0.398110038064948
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,37942,0.00253973563037277,0.00300709869557288,-0.00335417781295008,0.00843364907369562,0.398360317470304
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,37541,0.00506791729109444,0.00600088250352985,-0.00669381241582406,0.0168296469980129,0.398389487586615
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,37598,-0.00527860201970575,0.00625085760765784,-0.0175302829307151,0.00697307889130363,0.398427522973845
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,40182,-0.00237831265175718,0.00281767759365073,-0.00790096073531261,0.00314433543179825,0.398644014102831
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,39980,-0.00256299870028606,0.00304658848053629,-0.00853431212213719,0.00340831472156507,0.400210528653338
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",40042,-0.00359837913005482,0.00428961877794775,-0.0120060319348324,0.00480927367472277,0.401562109091109
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,37998,0.00189160035930061,0.00226084462895306,-0.00253965511344739,0.0063228558320486,0.40278800055208
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37714,-0.00370338780543195,0.0044378793277065,-0.0124016312877367,0.00499485567687279,0.4040171735509
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37482,0.00518552198943464,0.00626503288990129,-0.00709394247477187,0.0174649864536412,0.407859712706673
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,37810,0.0024676465859703,0.00298512496415429,-0.00338319834377212,0.00831849151571271,0.408451556941439
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.00516297087713261,0.00628421456613471,-0.00715408967249143,0.0174800314267566,0.411332287689194
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37697,-0.00814940396461924,0.00994285814815531,-0.0276374059350036,0.0113385980057652,0.412445304730298
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37482,0.00262008836349454,0.00321080590622046,-0.00367309121269756,0.00891326793968663,0.414502451160813
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,37598,0.00347786260934706,0.00428298007219904,-0.00491677833216307,0.0118725035508572,0.416795242906764
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,-0.00231851974704878,0.00286006935225228,-0.00792425567746326,0.00328721618336569,0.417580460347399
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,-0.0036284863723281,0.00450175270394705,-0.0124519216720643,0.00519494892740812,0.420248029990468
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37959,-0.00268398803796482,0.00333386160529143,-0.00921835678433602,0.00385038070840638,0.420794136760608
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,37766,0.00262428790958623,0.00326041687236161,-0.00376612916024252,0.00901470497941498,0.420895590024855
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,37598,-0.00529496809698921,0.00661291523948301,-0.0182562819663759,0.00766634577239749,0.423319211599899
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,39980,-0.00666599363736883,0.00833175583387803,-0.0229962350717698,0.0096642477970321,0.423682081294719
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,39961,-0.00278611307725135,0.00349998940519052,-0.00964609231142477,0.00407386615692207,0.426024040590541
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,-0.00448324691816726,0.00563474005410299,-0.0155273374242091,0.00656084358787459,0.426253399276783
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,37562,0.00364277724721443,0.00462730831934315,-0.00542674705869814,0.012712301553127,0.431158773284976
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00454427616586758,0.00577309896753802,-0.00677099781050694,0.0158595501422421,0.431210147851389
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37541,-0.00929187200091802,0.0118212565834897,-0.0324615349045579,0.0138777909027219,0.431863660839395
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37883,-0.00325413188628302,0.00414393429955092,-0.0113762431134028,0.00486797934083679,0.432305653164811
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40490,0.00347408931045088,0.00444489058790371,-0.0052378962418404,0.0121860748627422,0.434466141008799
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37572,0.00299344625681442,0.00383217445617536,-0.00451761567728928,0.0105045081909181,0.434737090998262
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,40044,0.00259576753850943,0.00336407531447356,-0.00399782007785873,0.0091893551548776,0.440354786150857
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,37541,-0.00595095548946895,0.00772991353441004,-0.0211015860169126,0.00919967503797473,0.441396510475842
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.00527560030774795,0.00685513771400669,-0.00816046961170515,0.0187116702272011,0.441560751318645
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,40411,-0.0016195889524707,0.00210939183119801,-0.0057539969416188,0.0025148190366774,0.442617964583157
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,39961,-0.00283741159455852,0.00370428519997049,-0.0100978105865007,0.00442298739738363,0.443699343280574
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",37900,-0.00334741486423838,0.00437689651563642,-0.0119261320348858,0.00523130230640901,0.444408910613053
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,0.00383479606475004,0.00502866746472345,-0.00602139216610793,0.013690984295608,0.445723504174516
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.00351782611748545,0.00464972840962393,-0.00559564156537746,0.0126312938003484,0.4493210832695
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,-0.00169848448664345,0.00224605994222202,-0.00610076197339861,0.0027037930001117,0.449536642656886
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,37598,-0.00567865498612087,0.00751373838801147,-0.0204055822266233,0.00904827225438161,0.449800893378246
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37901,0.00363623833953348,0.00482494161261291,-0.00582064722118782,0.0130931239002548,0.451082428329314
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,40176,0.00196589347557118,0.00261238069371075,-0.00315437268410189,0.00708615963524426,0.451743975693157
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,-0.00495995942192156,0.00659228127936974,-0.0178808307294863,0.00796091188564313,0.451830735197924
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37598,-0.0079758802279543,0.0106075157471602,-0.0287666110923882,0.0128148506364796,0.452119605790402
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HLA_A,,37959,0.00241932795543597,0.00322196449620196,-0.00389572245711988,0.00873437836799181,0.452734362076386
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,37482,-0.00425668951053392,0.00568286226776827,-0.0153950995553597,0.00688172053429188,0.453846792305723
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39980,-0.00429935937155108,0.00575889154132292,-0.015586786792544,0.00698806804944184,0.455340367308401
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37482,-0.00434130015416938,0.00586139613059435,-0.0158296365701343,0.00714703626179556,0.458913120125294
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,-0.00213484753171748,0.00288255171889234,-0.00778464890074646,0.00351495383731151,0.458940608730338
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,37572,-0.00503572018022419,0.00680571514765431,-0.0183749218696266,0.00830348150917826,0.459358618626687
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,0.00367611354233185,0.00499603081517791,-0.00611610685541685,0.0134683339400806,0.461861455805289
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,0.00372885421069583,0.00506961411606242,-0.00620758945678652,0.0136652978781782,0.462029927897188
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,37934,0.00338029063901182,0.00459600358458561,-0.00562787638677596,0.0123884576647996,0.462057106302551
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TTN,Titin,37562,0.00474142823705595,0.00646904124612254,-0.00793789260534422,0.0174207490794561,0.463607267202475
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,40332,-0.0031493618193636,0.00430450586269779,-0.0115861933102513,0.00528746967152407,0.464397258247238
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37714,0.0048213379404088,0.00663408927722996,-0.00818147704296192,0.0178241529237795,0.467390692715892
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,-0.00209259917518773,0.00288150930239342,-0.00774035740787883,0.00355515905750337,0.467716716395128
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,40042,-0.00388662320634292,0.00535454545288354,-0.0143815322939947,0.00660828588130882,0.467938605664598
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,40422,0.00145206990333112,0.00201021562191373,-0.00248795271561978,0.00539209252228203,0.470092755673626
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37562,-0.00342875050948623,0.00476453198466284,-0.0127672331994254,0.00590973218045293,0.471759154899513
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37572,0.00261401664191221,0.0036392025315235,-0.00451882031987385,0.00974685360369828,0.472588938266674
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,-0.00335160534932563,0.00467711434336975,-0.0125187494623303,0.00581553876367908,0.473635661208053
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,40332,-0.00356846588737417,0.00498036093414432,-0.013329973318297,0.00619304154354869,0.473688584308053
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,37482,0.0021891302118626,0.00305768950959327,-0.00380394122694021,0.00818220165066542,0.474039615476213
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,-0.00423983754815157,0.00595432018677106,-0.0159103051142229,0.00743063001791971,0.476437628450308
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37598,-0.00479018274673224,0.00672865004586978,-0.017978336836637,0.00839797134317253,0.476534109534065
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,39961,-0.00371323417920654,0.0052227817636375,-0.013949886435936,0.00652341807752295,0.477114345405352
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,40398,-0.0103705843133373,0.0146373260048216,-0.0390597432827877,0.0183185746561131,0.478643521777448
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,37990,0.00203372668872708,0.00287514544611077,-0.00360155838565004,0.0076690117631042,0.479362784659354
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,40497,-0.00206114081531467,0.00293055371547538,-0.00780502609764642,0.00368274446701708,0.481861499786541
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,37482,-0.00286872141205395,0.00409736401774564,-0.0108995548868354,0.0051621120627275,0.483853449266539
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,-0.00239354905842832,0.00342087503969812,-0.00909846413623663,0.00431136601937999,0.484131601936413
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,-0.00379605093704109,0.00542697770708099,-0.0144329272429198,0.00684082536883766,0.484265853358049
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,40442,-0.00155784630008299,0.00222759990098804,-0.00592394210601954,0.00280824950585356,0.484350705115389
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.00157506376465177,0.00225811297542435,-0.00285083766717995,0.0060009651964835,0.48549176113519
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,37572,0.00228569460184856,0.00328735323551161,-0.0041575177397542,0.00872890694345132,0.486880029200553
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,37598,0.00397511973367265,0.00573818606235011,-0.00727172494853357,0.0152219644158789,0.488479639621392
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,40044,-0.00361033601486412,0.00524877543067462,-0.0138979358589864,0.00667726382925813,0.491561577363831
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.00576309335154295,0.008393146800382,-0.0222136610802917,0.0106874743772058,0.492319724795367
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,37598,0.00189681404674012,0.00276774168062814,-0.00352795964729104,0.00732158774077128,0.493148326837752
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37990,0.00185147330478489,0.00271759024243297,-0.00347500357038373,0.00717795017995351,0.495698208325082
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,39980,0.0112764591483592,0.0165763771453678,-0.0212132400565616,0.0437661583532801,0.496341861004189
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,40305,-0.00215498488065316,0.00316922535419874,-0.0083666665748827,0.00405669681357638,0.496532043811888
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VIT,Vitrin,37990,0.00246288937427696,0.00362858336962828,-0.00464913403019447,0.00957491277874838,0.497309905657981
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,40042,0.00714979098377131,0.0105614097796921,-0.0135505721844252,0.0278501541519679,0.498433026476178
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,-0.00172579300071264,0.00255409215698713,-0.00673181362840742,0.00328022762698214,0.499244752284408
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37572,-0.00256436810384898,0.00383103340849546,-0.0100731935845001,0.00494445737680212,0.503273048379807
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,40044,-0.00315045638382178,0.00471398812654584,-0.0123898731118516,0.00608896034420807,0.503938722801124
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37901,-0.00360546951534183,0.00541168599116711,-0.0142123740580294,0.00700143502734571,0.50527057306326
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,37541,0.00294962425949351,0.00444184153126112,-0.00575638514177828,0.0116556336607653,0.506667213055415
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,37959,-0.00249869665502624,0.00376510823902779,-0.0098783088035207,0.00488091549346823,0.506928637795324
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,40044,-0.00350843781104781,0.00529353068759356,-0.0138837579587312,0.00686688233663557,0.507482285119673
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,37562,0.00424700058483435,0.00644981196016054,-0.0083946308570803,0.016888632026749,0.510248438087133
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,40536,-0.00460165364414619,0.00701728734926375,-0.0183555368487031,0.00915222956041076,0.511988184968024
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37572,-0.00505400399498794,0.00771240893149581,-0.0201703255007197,0.0100623175107439,0.51228090021752
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,37900,0.00257969997143849,0.00396550864447379,-0.00519269697173014,0.0103520969146071,0.515358172261744
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00430646497087784,0.00662260426922857,-0.00867383939681016,0.0172867693385658,0.515530777779525
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,37352,0.00248601129125197,0.00382486788395702,-0.00501072976130379,0.00998275234380774,0.515729606225384
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,0.00323598000605069,0.00499280703709059,-0.00654992178664686,0.0130218817987482,0.516913154212133
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,40536,-0.00167479214894427,0.00259841801938428,-0.00676769146693744,0.00341810716904891,0.519232574521793
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,0.00268559748221227,0.00417458688308183,-0.00549659280862811,0.0108677877730527,0.520027375558624
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,37572,-0.00366560609030329,0.00571980720356526,-0.0148764282092912,0.00754521602868462,0.521623652840344
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,37900,0.00173857815666531,0.00272571092548147,-0.00360381525727836,0.00708097157060899,0.52358614277925
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,37482,-0.00341876568211913,0.00536251095308337,-0.0139292871501625,0.00709175578592428,0.52379038251147
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,37482,-0.00399968461174623,0.00632561234110803,-0.016397884800318,0.00839851557682551,0.527201965359297
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,40044,0.00316367156852266,0.00501327194092174,-0.00666234143568395,0.0129896845727293,0.528011042631345
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,40458,-0.00185075531056318,0.00293850788979057,-0.00761023077455271,0.00390872015342634,0.528815944385986
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,37482,-0.00385355246729366,0.00614518807589001,-0.0158981210960381,0.00819101616145075,0.530614804731902
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.00213086977545178,0.00339992392623313,-0.00453298111996517,0.00879472067086872,0.530840363956051
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,37714,-0.0104162622198099,0.0168616753713792,-0.0434651459477131,0.0226326215080934,0.536752229971977
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,0.00250355151098946,0.00405662785951115,-0.00544743909365238,0.0104545421156313,0.537145919883961
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,37998,-0.00280111047254166,0.00454423934436354,-0.0117078195874942,0.00610559864241088,0.537634908981437
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,-0.00168066896578447,0.0027418761700234,-0.00705474625903034,0.0036934083274614,0.539909450293355
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.00299738078169693,0.0048938167379683,-0.00659450002472093,0.0125892615881148,0.540228716812045
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,37901,-0.0155925422101868,0.0256052759594311,-0.0657788830906718,0.0345937986702982,0.542562445510405
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,37541,-0.00584909834951517,0.00961782201985222,-0.0247000295084255,0.0130018328093952,0.543097173738405
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,37998,-0.00261137050722499,0.00430526898325468,-0.0110496977144042,0.00582695669995419,0.544158274540878
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,-0.00211732675711893,0.00350693751863476,-0.00899092429364307,0.0047562707794052,0.54601754134609
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,37531,0.00520415930034631,0.00865193513509081,-0.0117536335644317,0.0221619521651243,0.547515873496538
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37942,-0.00235901126385571,0.00392723727079895,-0.0100563963146216,0.00533837378691023,0.548063508783817
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,37598,-0.00285292297400544,0.00475499994208276,-0.0121727228604876,0.00646687691247677,0.548527367974836
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,37598,-0.00187624703756872,0.00314480320794288,-0.00804006132513677,0.00428756724999933,0.550772546729082
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,-0.0025847101792089,0.00433428641608447,-0.0110799115547345,0.00591049119631667,0.550957871760821
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.00138259041892239,0.00232870382441958,-0.00594684991478477,0.00318166907694,0.552711533986096
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,40359,-0.00183292036969883,0.00311108271843255,-0.00793064249782663,0.00426480175842896,0.555763418670274
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,0.00280643402138035,0.00478336406742434,-0.00656895955077136,0.0121818275935321,0.557410462372131
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37482,0.00285237469292351,0.00486663376423042,-0.00668622748496812,0.0123909768708151,0.557812856540707
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,-0.00547395500622826,0.00933989718208196,-0.0237801534831089,0.0128322434706524,0.557829572562022
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37692,-0.00318853507327818,0.00549931358875761,-0.0139671897072431,0.00759011956068674,0.562055309604031
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEB,Nebulin,37562,-0.00206391675883214,0.00358909137463074,-0.00909853585310839,0.00497070233544411,0.565265510607027
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,37562,-0.0027368962754517,0.00476941742742219,-0.0120849544331992,0.00661116188229578,0.566083967057552
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,37998,0.00250607396971143,0.00438687893786847,-0.00609220874851078,0.0111043566879336,0.567828948493436
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37761,-0.00252529634901571,0.00442203952750544,-0.0111924938229264,0.00614190112489495,0.567961493129869
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37901,-0.00309423064200664,0.00544161333170383,-0.0137597927721461,0.00757133148813286,0.569620990206765
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.0018191739336371,0.00320153888753734,-0.00445584228593609,0.00809419015321029,0.569896277319061
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,40044,0.00216713358233754,0.00381545599229051,-0.00531116016255186,0.00964542732722695,0.570051230226854
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37562,0.00324650884949625,0.00571579637804939,-0.00795645205148055,0.0144494697504731,0.570052238028098
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,-0.00492650184969722,0.00874048874801424,-0.0220578597958051,0.0122048560964107,0.573007804519454
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.00289042371814674,0.00512947437653763,-0.00716334605986702,0.0129441934961605,0.573108755046229
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,-0.00404466272380881,0.00718330181836544,-0.0181239342878051,0.0100346088401875,0.573400540396665
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,37562,0.00469709472115106,0.0083744939344422,-0.0117169133903557,0.0211111028326578,0.574888233568988
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,40044,0.00157161296899996,0.00281694124894895,-0.00394959187893998,0.00709281781693991,0.576910634216522
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,39934,-0.00195448435774592,0.00352698839233245,-0.00886738160671752,0.00495841289122569,0.579483471911049
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,39980,0.00773984460616548,0.0140617972292279,-0.0198212779631211,0.0353009671754521,0.58204168137619
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,37541,-0.00588638282456242,0.0107028332982035,-0.0268639360890412,0.0150911704399164,0.582340004214651
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,37598,0.00188203199024616,0.00342878276702191,-0.00483838223311679,0.00860244621360911,0.583088778755066
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37714,0.00203184970495524,0.00371939916158213,-0.00525817265174574,0.00932187206165621,0.584879653884501
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,40341,-0.00299326960587272,0.0054794486750463,-0.0137329890089635,0.00774644979721803,0.584886622850342
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.00267611991668899,0.00492948180373699,-0.0069856644186355,0.0123379042520135,0.58722127491025
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39961,0.00269342964016348,0.0050461436064829,-0.00719701182854299,0.01258387110887,0.593515237201327
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,37598,0.00185252151331682,0.00347229332935615,-0.00495317341222123,0.00865821643885488,0.593685963371187
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.00151827573406034,0.00287177006250931,-0.00411039358845791,0.00714694505657859,0.597028132519187
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,40228,-0.000628140010982603,0.00119632638388573,-0.00297293972339864,0.00171665970143344,0.599550673056349
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,37942,0.00119994324077949,0.00228648946535596,-0.00328157611131818,0.00568146259287717,0.599732810697921
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37628,-0.00192873034368017,0.00370574594769425,-0.0091919924011609,0.00533453171380056,0.602744636336392
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37562,-0.00607052369343146,0.0117767811715202,-0.0291530147896111,0.0170119674027481,0.606236505245606
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,40048,-0.00210093112253319,0.00407904602970994,-0.0100958613407647,0.00589399909569829,0.606522217305087
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.00611213182764281,0.0118969293472329,-0.0172058496929336,0.0294301133482192,0.607429140590754
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,40305,0.00113640649420572,0.00221201272395498,-0.00319913844474603,0.00547195143315748,0.607438704822009
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,37562,0.0020291207611619,0.00400012121330577,-0.0058111168169174,0.0098693583392412,0.611977552779569
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,37562,0.00169640663030602,0.00335472674084077,-0.00487885778174188,0.00827167104235393,0.613092237692539
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,37572,0.00195663649679889,0.00388036698913632,-0.00564888280190829,0.00956215579550608,0.614101157716657
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,37671,-0.00189230809347416,0.00376482069662045,-0.00927135665885024,0.00548674047190192,0.615233503506215
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,-0.00283219253566628,0.00563505326411484,-0.0138768969333314,0.00821251186199881,0.615250785107644
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,37482,0.0033791842586429,0.00673110451867246,-0.00981378059795513,0.0165721491152409,0.615658260251271
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,40419,-0.001647670951704,0.00328256902246755,-0.00808150623574041,0.0047861643323324,0.615712736079971
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,37959,-0.00125911825160169,0.00252296975583597,-0.00620413897304019,0.00368590246983682,0.617743857117148
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00278251829903021,0.00561008631446655,-0.00821325087732422,0.0137782874753847,0.619913367414534
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.00687253772416479,0.0139639392188612,-0.0204967831448032,0.0342418585931328,0.622612232701477
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,37482,0.00204552594290895,0.00415770141519714,-0.00610356883087745,0.0101946207166954,0.62273836970029
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,37942,-0.00448721770491559,0.00934295835376216,-0.0227994160782894,0.0138249806684582,0.631037490973864
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00212934647834831,0.00445387382735344,-0.00660024622326443,0.010858939179961,0.632594888833129
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,37942,0.00275639806370695,0.00587664733959545,-0.00876183072190012,0.014274626849314,0.639046752186058
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,40042,0.00155288799381158,0.00331528806342202,-0.00494507661049558,0.00805085259811874,0.639503593061787
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,37482,0.005390782075348,0.0115239181642184,-0.0171960975265201,0.0279776616772161,0.639942074974391
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,37482,-0.00248111305430822,0.00532130371136558,-0.0129108683285848,0.00794864221996832,0.641036933937996
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,37959,0.00200950043818126,0.00431696051867376,-0.00645174217841932,0.0104707430547818,0.641588352540216
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,0.00193206529526527,0.00420032846677607,-0.00630057849961584,0.0101647090901464,0.645538286505816
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,-0.00313240663544523,0.00681211212128438,-0.0164841463931626,0.0102193331222722,0.645645418900676
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,39878,0.00316739307146181,0.00689646878396099,-0.0103496857451017,0.0166844718880254,0.646041361272483
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37900,-0.00259643657256909,0.00566270295164736,-0.0136953343577979,0.00850246121265974,0.646589602547877
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,37598,0.00213427746593656,0.00466976055613064,-0.00701845322407949,0.0112870081559526,0.647648292293593
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,40332,-0.00140858102111089,0.0030859811043326,-0.00745710398560278,0.00463994194338101,0.648076167612176
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,39802,0.00115872925046048,0.0025781327648417,-0.00389441096862924,0.00621186946955021,0.653116917743262
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPGN,Epigen,37900,-0.00218342083843928,0.0048716023264041,-0.0117317613981913,0.00736491972131274,0.654020723251743
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,37598,0.00240263892942546,0.00536669863173233,-0.00811609038876992,0.0129213682476208,0.65438140894987
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.00279098828844797,0.00627865903642928,-0.00951518342295342,0.0150971599998494,0.656672845553882
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,37900,-0.00162273958080075,0.003655450456581,-0.0087874224756995,0.00554194331409801,0.657105190406651
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,40042,-0.00220264541915729,0.00502038172668066,-0.0120425936034514,0.0076373027651368,0.660855566564597
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,37598,0.00113679127027961,0.00262298876937937,-0.00400426671770396,0.00627784925826319,0.664734651908989
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,40042,-0.00269860998167195,0.00624109571255179,-0.0149311575782735,0.00953393761492955,0.665461333354953
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37998,-0.00109964188617925,0.00254826591479713,-0.00609424307918163,0.00389495930682313,0.66609313625054
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37901,-0.00544150522056376,0.0126810859642549,-0.0302964337105033,0.0194134232693758,0.667854385523583
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37900,0.00196038844281082,0.00459369696648514,-0.00704325761150004,0.0109640344971217,0.669563777910715
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.00228511179817468,0.00536907922113385,-0.012808507071597,0.00823828347524767,0.670401946063063
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,37482,0.00141037959261622,0.00331438627846596,-0.00508581751317706,0.00790657669840951,0.670455449744165
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,37482,-0.0037102256981096,0.00876633273542538,-0.0208922378595434,0.0134717864633241,0.672130227119524
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.00229463846699933,0.00542174501083683,-0.00833198175424086,0.0129212586882395,0.672134022419682
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,0.00566399308150384,0.0135513975139276,-0.0208967460457942,0.0322247322088018,0.675980237715184
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,37987,0.00256870929064635,0.00618591025179866,-0.00955567480287903,0.0146930933841717,0.677964291648516
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,-0.00175112214009887,0.00423668408708122,-0.0100550229507781,0.00655277867058032,0.679376189047777
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,40471,-0.0051900060354382,0.0126060695259192,-0.0298979023062399,0.0195178902353635,0.68055976195625
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,37482,0.00163774224045326,0.00404176337224619,-0.00628411396914927,0.00955959845005579,0.685333570898566
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39961,0.00221279913325708,0.00549897754875608,-0.00856519686230484,0.012990795128819,0.687393801808105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,37572,0.0018495077625303,0.00460454602503339,-0.00717540244653515,0.0108744179715957,0.687933486454068
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,37541,-0.00289535438075661,0.00722342710917982,-0.0170532715147491,0.0112625627532358,0.688553046162155
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,40182,0.00269718250185911,0.00681479911296668,-0.0106598237595556,0.0160541887632738,0.692270393113448
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37541,0.00155793032531906,0.00397571615275602,-0.00623447333408273,0.00935033398472085,0.695166887956859
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.0101414241538099,0.0258954211936539,-0.0608964496933717,0.0406136013857518,0.69533794154689
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.00143871965879471,0.0036873892198753,-0.00578856321216087,0.00866600252975029,0.696413966404637
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,37572,0.00253131096598124,0.00653278171946317,-0.0102729412041666,0.0153355631361291,0.69840845364502
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,40228,-0.00131951619608667,0.00347337298535925,-0.00812732724739081,0.00548829485521747,0.704028651195776
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,0.00151661830673736,0.00401056415737023,-0.00634408744170829,0.00937732405518301,0.705320911323506
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,37572,-0.00160056193396856,0.00424300768660037,-0.00991685699970528,0.00671573313176817,0.706013667254903
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00320670572426621,0.00855861395514338,-0.0135681776278148,0.0199815890763472,0.7079076310096
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,37482,0.00152886685702774,0.00412991688903544,-0.00656577024548171,0.0096235039595372,0.711244612494293
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.00329820350928141,0.00893926633353915,-0.0142227585044553,0.0208191655230181,0.712165885830789
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,40044,-0.0017035797783805,0.00462026132657436,-0.0107592919784662,0.00735213242170524,0.712341926396084
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37628,-0.00209731672572127,0.00571457099321081,-0.0132978758724145,0.00910324242097191,0.713615883038649
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37598,-0.00079544902527524,0.00220490800710988,-0.0051170687192106,0.00352617066866012,0.718282489580133
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,-0.00145656560049928,0.00404037422130838,-0.0093756990742637,0.00646256787326513,0.718476939705171
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37598,-0.00332621621012216,0.00923225920724837,-0.021421444256329,0.0147690118360846,0.71864209557599
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,37541,-0.00151489053304694,0.00429835569899403,-0.00993966770307524,0.00690988663698136,0.724517811749387
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,37482,-0.00273207017083424,0.00778481742607879,-0.0179903123259487,0.0125261719842802,0.725632642134697
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37714,-0.00232292594722081,0.00670892479570283,-0.0154724185467984,0.0108265666523567,0.729164731943965
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37714,-0.00254490214846967,0.00737251908549463,-0.0169950395560391,0.0119052352590998,0.729958816798552
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,37562,0.00169519612627066,0.00494251950713304,-0.0079921421077101,0.0113825343602514,0.731617363774942
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37714,-0.00284578214424073,0.00834531374632056,-0.019202597087029,0.0135110327985476,0.733106263281383
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,37598,0.00160935808020546,0.00475172117424312,-0.00770401542131105,0.010922731581722,0.734849058858934
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,37562,0.00159625535031086,0.00471695363292879,-0.00764897377022958,0.0108414844708513,0.735061084738528
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,-0.00224409839715325,0.00665435647489208,-0.0152866370879417,0.0107984402936352,0.735942450417081
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,40403,0.00153833794046596,0.00456469018905289,-0.0074084548300777,0.0104851307110096,0.736115166350166
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39980,0.0010950849241727,0.00324972858846548,-0.00527438310921964,0.00746455295756503,0.736138529738228
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37598,0.00134375183526374,0.00404462567832385,-0.00658371449425101,0.0092712181647785,0.739719797929726
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40516,0.000848788096523796,0.00256555889788667,-0.00417970734333408,0.00587728353638167,0.740770074962654
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,37482,-0.00237565129258446,0.00727910520615897,-0.016642697496656,0.0118913949114871,0.744152820342496
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,37541,-0.00276951276953183,0.00852361554412207,-0.0194757992360111,0.0139367736969474,0.745245071562574
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,37482,0.00258760626853255,0.00798122968310055,-0.0130556039103445,0.0182308164474096,0.745783137190965
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,37562,-0.0015202238223261,0.00470190460094507,-0.0107359568401784,0.00769550919552624,0.746457417271828
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,40044,-0.00251374233799,0.00781736705391583,-0.017835781763665,0.012808297087685,0.74779135104805
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,-0.00156983306985511,0.00488962809436007,-0.0111535041348009,0.00801383799509062,0.748174041308435
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.000832632768474316,0.00260726669397765,-0.00427760995172188,0.00594287548867051,0.749465423697564
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,40359,0.00137973293575016,0.00432729159403388,-0.00710175858855625,0.00986122446005657,0.749848651362535
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,37541,-0.0014629505715075,0.00462994318609511,-0.0105376392162539,0.00761173807323892,0.752025821465211
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,37900,-0.0025058086418878,0.00795393735045921,-0.0180955258487879,0.0130839085650122,0.75273615050279
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HLA_DRA,,40288,0.00110646910693692,0.00353600476625603,-0.0058241002349249,0.00803703844879875,0.754349324038819
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.0026120529395456,0.00849290974636547,-0.0192581560424219,0.0140340501633307,0.758424440583915
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,37598,0.000916208786277305,0.00300356297497596,-0.00497077464467557,0.00680319221723018,0.76034002577124
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00216379861118657,0.00722575692931715,-0.0119986849702751,0.0163262821926482,0.764596646648802
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,37572,0.000799257945860855,0.00268050169296521,-0.00445452537235096,0.00605304126407267,0.765574507270339
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,0.00159123984586492,0.00541252409602004,-0.00901730738233435,0.0121997870740642,0.768768507989298
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39980,0.00141942594468931,0.00489149349248295,-0.00816790130057728,0.0110067531899559,0.77168047735936
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,37572,-0.00263823399176927,0.00913944172272361,-0.0205515397683076,0.015275071784769,0.772842556597444
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.00142948895398587,0.00499116229927672,-0.0083531891525965,0.0112121670605682,0.774573248426448
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,37598,0.00107718236219739,0.00382663329472686,-0.00642301889546725,0.00857738361986204,0.778334346859156
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,-0.000996295455638233,0.00356218103418874,-0.00797817028264816,0.00598557937137169,0.77972207313832
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,40044,-0.00110413387662704,0.00404469119456065,-0.00903172861796592,0.00682346086471184,0.784869530029422
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,37572,-0.00062489408871392,0.00230644040998185,-0.00514551729227834,0.0038957291148505,0.786445735589835
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,37959,-0.000973903266723439,0.0036906660040824,-0.00820760863472494,0.00625980210127807,0.791874257913007
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.000758983937884233,0.0029018102394867,-0.00644653200727816,0.0049285641315097,0.793668274049811
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,-0.00148099339083531,0.00580730454250467,-0.0128633102941445,0.00990132351247384,0.798709051008809
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,37572,-0.00218010014151133,0.00858137463626192,-0.0189995944285847,0.014639394145562,0.799460739229315
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,39980,-0.0022149028020864,0.00877543275073325,-0.0194147509935236,0.0149849453893508,0.800736687337509
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.00135546175230268,0.00553987557627989,-0.0122136178818113,0.00950269437720591,0.806712960594866
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,-0.00287866282471831,0.0118024696035465,-0.0260115032476694,0.0202541775982327,0.807308821258793
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,37671,-0.00123628467511369,0.00508323443653067,-0.0111994241707138,0.00872685482048643,0.807847831034155
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,40406,0.000947231623560429,0.00395154194858924,-0.00679779059567449,0.00869225384279534,0.810556689494847
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,0.00112845479281273,0.00479348881860399,-0.00826678329165109,0.0105236928772766,0.813891030614043
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37572,0.00116031322256366,0.00493401596602838,-0.00851035807085196,0.0108309845159793,0.814083497589553
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,-0.00082529460372559,0.00350996448449097,-0.00770482499332789,0.00605423578587671,0.814112143367532
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,40042,-0.000624656085302907,0.00271891876614412,-0.00595373686694537,0.00470442469633956,0.818293484103475
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,-0.00253824171057665,0.0112226699889631,-0.0245346748889443,0.019458191467791,0.821071901432557
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.000422939336178947,0.00187344980316146,-0.00324902227801751,0.00409490095037541,0.821395930117133
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.0013843301062233,0.00622799129580186,-0.0108225328335484,0.0135911930459949,0.824102817608881
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,37541,0.00110702443959264,0.00501166611879183,-0.00871584115323934,0.0109298900324246,0.825181916123166
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,37598,-0.00132370383760474,0.00616564211956651,-0.0134083623919551,0.0107609547167456,0.830012080247373
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37572,-0.00205951773061618,0.0100290945526285,-0.021716543053768,0.0175975075925357,0.837298505461653
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,37714,0.00149880874647567,0.00748996500924358,-0.0131815226716418,0.0161791401645931,0.841398472061722
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,-0.00332447528765452,0.0176348085784231,-0.0378887001013638,0.0312397495260548,0.850473180522141
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,40359,0.000490648366063025,0.00260482439028504,-0.00461480743889565,0.0055961041710217,0.850595760041409
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,-0.000654527014505294,0.00349259060359799,-0.00750000459755735,0.00619095056854677,0.851346433230112
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37598,-0.000888904959838726,0.00482278789801629,-0.0103415692399506,0.00856375932027319,0.853770359921325
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,37671,0.000767745957588471,0.00426549071691263,-0.00759261584756028,0.00912810776273722,0.857163125575435
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,37562,-0.00116521632986456,0.00647497487003647,-0.013856167075136,0.0115257344154069,0.857189194995717
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,0.00112404239874082,0.00629784073355384,-0.0112197254390247,0.0134678102365064,0.858348281012342
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,38013,0.000306470296564159,0.00176132524890307,-0.00314572719128585,0.00375866778441417,0.861868191878529
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.00215485228909605,0.0124280788402675,-0.0222041822378282,0.0265138868160203,0.862350452549454
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,0.00047131641594142,0.00277699734998605,-0.00497159839003123,0.00591423122191407,0.865231702675348
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,-0.000541792782981739,0.00321918357116205,-0.00685139258245935,0.00576780701649587,0.866348850840942
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,37572,-0.00115007259402686,0.00688528356602804,-0.0146452283834418,0.0123450831953881,0.867346312002555
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,37714,0.00096314354701241,0.00599969646212711,-0.0107962615187567,0.0127225486127816,0.872464425113112
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37572,0.00065930605535747,0.00412519216582905,-0.00742607058966747,0.00874468270038241,0.873021921760422
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,40042,-0.00112021802381492,0.00712529475744445,-0.015085795748406,0.0128453597007762,0.875075805085919
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,37937,-0.000358613155679751,0.00229794519829212,-0.00486258574433231,0.00414535943297281,0.875989494403979
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,37714,0.00129843775756617,0.00841245129928045,-0.0151899667890235,0.0177868423041558,0.877338382739212
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,37572,-0.00105055624615719,0.00692125883387796,-0.014616223560558,0.0125151110682436,0.879357368602337
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,37572,-0.000722961508820868,0.00481903905827361,-0.0101682780630371,0.00872235504539541,0.880749624659561
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,-0.000799764927500045,0.00554469607413034,-0.0116673692327955,0.0100678393777954,0.885313437128615
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.000493903367284238,0.00357675471048411,-0.00651653586526463,0.0075043425998331,0.890173766038542
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,-0.000717728406820986,0.00571515512901321,-0.0119194324596869,0.0104839756460449,0.900063669769045
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,40396,-0.00101705549827461,0.00813304227221599,-0.0169578183518179,0.0149237073552687,0.900483736430045
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37482,0.000650330685297202,0.00550739116786873,-0.0101441560037255,0.0114448173743199,0.906003509950686
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.000903605071058671,0.00813874781245149,-0.0168555507834636,0.0150483406413462,0.911598144250144
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,37541,0.000664110981235,0.006432812033374,-0.011944200604178,0.013272422566648,0.917775621967986
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,-0.000603022706265576,0.00591123753123584,-0.0121890482674878,0.0109830028549567,0.918747965969832
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,37880,0.000511128924787498,0.0050429530898909,-0.00937305913139867,0.0103953169809737,0.919270105302188
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37562,0.000963597369755103,0.00952493140227924,-0.0177052681787122,0.0196324629182224,0.919420386726461
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,-0.000553599206785925,0.005570335635173,-0.011471457051725,0.0103642586381532,0.920835346752586
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,-0.000337359105220524,0.00339541877143725,-0.00699237989723754,0.00631766168679649,0.920855954828279
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,37562,0.000706920299811013,0.00714509808127714,-0.0132974719394922,0.0147113125391142,0.921189167072566
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,39980,0.000866633347285839,0.00920066605987271,-0.0171666721300647,0.0188999388246364,0.924957491448548
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,37998,-0.000526017069247212,0.00562826919555905,-0.011557424692543,0.0105053905540485,0.925539645012963
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37572,-0.00059550132172166,0.00663313321989221,-0.0135964424327104,0.0124054397892671,0.928465973328479
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,-0.000557301510877282,0.00644909532732264,-0.0131975283524296,0.0120829253306751,0.931137276664817
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NENF,Neudesin,37900,-0.000918414057497113,0.0106578514513266,-0.0218078029020972,0.019970974787103,0.931330547726122
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,37990,-0.000418809839631938,0.00491351151901778,-0.0100492924169068,0.00921167273764291,0.932074744588166
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,-0.00031891558000703,0.00376376450109558,-0.00769589400215437,0.00705806284214031,0.932474843341854
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37942,-0.000321582634449576,0.00392793130346316,-0.00802032798923737,0.00737716272033821,0.934750718645113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,37900,0.000271677274328867,0.00333620095604165,-0.00626727659951277,0.00681063114817051,0.935098717335328
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,37541,-0.000455360845009438,0.00576558725511867,-0.011755911865042,0.0108451901750231,0.93705046077991
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,40044,0.000238575291484887,0.00307881202964698,-0.00579589628662319,0.00627304686959296,0.938235219180649
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,37874,0.00043442285679267,0.00560688208582359,-0.0105550660314216,0.0114239117450069,0.938242624375466
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.000568852210093563,0.00837962398662906,-0.0169929152238865,0.0158552108036994,0.945878066459565
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,-0.000157826643288475,0.00264834482815544,-0.00534858250647313,0.00503292921989618,0.952479523467013
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,37598,0.000482701563329011,0.00876202349267109,-0.0166908644823063,0.0176562676089643,0.95606744648065
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,39980,-0.000578739626170132,0.0105509067103351,-0.0212585167784269,0.0201010375260866,0.956256980890209
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.000319899862472485,0.00598221860818971,-0.0120450483345243,0.0114052486095793,0.957354172828401
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.00026567563376094,0.00497557006881671,-0.0100177929686417,0.00948644170111981,0.95741719566829
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,37598,0.000143769026768214,0.00274178931704437,-0.00523013803463874,0.00551767608817517,0.958181923072105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37572,-0.000431743388929112,0.00825922296344039,-0.0166198203972723,0.015756333619414,0.958311091742648
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,37572,-0.000285264064777027,0.00592565502488004,-0.0118995479135419,0.0113290197839878,0.961604992735057
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37572,-0.000199077060128591,0.00423979738512166,-0.00850907993496704,0.00811092581470986,0.962550301050004
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37779,-3.13677336087155e-05,0.000800790637949044,-0.00160091738398884,0.00153818191677141,0.968754677575277
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,37714,-0.000190921171418438,0.00545244701111499,-0.0108777173132038,0.0104958749703669,0.97206776006003
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,37942,-0.000180053085405906,0.00528633911328767,-0.0105412777474497,0.0101811715766379,0.972829752661314
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,37562,-0.000352018916557541,0.01090441179604,-0.0217246660367959,0.0210206282036808,0.974247457984503
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,9.69826550378212e-05,0.00323994986723212,-0.00625331908473713,0.00644728439481278,0.97612062743354
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40357,7.39338999409541e-05,0.00261126314021326,-0.00504414185487704,0.00519200965475895,0.977412498935783
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,37572,0.000170039635456022,0.00658400405731209,-0.0127346083168757,0.0130746875877877,0.979396377625867
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37959,-8.9722827796264e-05,0.00363504514089189,-0.00721441130394437,0.00703496564835184,0.980308397154065
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37572,0.00011843907855559,0.00490239033308591,-0.0094902459742928,0.00972712413140398,0.98072578633387
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,-0.000135033978730121,0.00566097515971557,-0.0112305452917726,0.0109604773343124,0.98096984195644
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,37482,-0.000188182258262238,0.00799621054984431,-0.0158607549359571,0.0154843904194326,0.981224734223771
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,40453,-6.9657844409335e-05,0.0030549971209053,-0.00605745220138371,0.00591813651256504,0.981809071404702
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,37482,-0.000121685730129251,0.0060193078941553,-0.0119195292026736,0.0116761577424151,0.983871453162809
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,37671,-5.06181994158664e-05,0.00315127608266163,-0.00622711932143266,0.00612588292260093,0.987184563279612
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,37572,-9.4485098429503e-05,0.0062917880782778,-0.012426389731854,0.012237419534995,0.988018679235312
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,40341,-7.97621430164e-05,0.00565870357912791,-0.0111708211581071,0.0110112968720743,0.98875398352266
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,5.91759999986398e-05,0.00454203025653334,-0.00884320330280671,0.00896155530280399,0.989605225747385
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,-5.15383757855291e-05,0.00401546653244444,-0.00792185277937664,0.00781877602780558,0.989759622852992
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,40044,-7.34999901848697e-05,0.00653614210660042,-0.0128843385191217,0.0127373385387519,0.991027990191238
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,37598,6.16423860878612e-05,0.00687132011538525,-0.0134061450400672,0.013529429812243,0.992842436057225
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37562,-2.26463442380184e-05,0.00620310822895353,-0.0121807384729869,0.0121354457845109,0.997087140341089
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,2.68524222196619e-05,0.00765877139156044,-0.0149843395052388,0.0150380443496781,0.997202594277371
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37628,-6.57711282834676e-06,0.00420898664516351,-0.00825619093734883,0.00824303671169214,0.998753221257947
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,37562,-1.34909099276892e-06,0.00424375139076309,-0.00831910181688842,0.00831640363490289,0.99974635688321
